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Summary: Abstract
This work investigated the biocompatibility o f soluble phosphate based glasses as 
scaffolds for supporting the in vitro morphogenesis the hard-soft tissue interface 
(enthesis) as an approach dealing with ligaments and tendons clinical problems.
The short term response o f human oral osteoblasts (HOB), oral fibroblasts (HOF) and 
flexor tendon fibroblasts (HTF) was assessed on glass discs o f various compositions, 
and different dissolution rates, o f  the generic ternary form (CaO)o.ox-(Na20)0.oy- 
(P2 0 5 )o.5 through evaluating the maintenance o f the seeded cell attachment, survival, 
proliferation and phenotype by using SEM, immunocytochemistry and the 
CyQUANT cell density kit. Subsequently, the most biocompatible ternary glass 
compositions were utilised for fibre production.
The effect of fibre diameter o f  cell adhesion and survival was determined and 
quaternary glass fibres, o f the generic composition (CaO)o.46-(Na2 0 )o.ox-(Fe2 0 3 )o.oy- 
(P2C>5)o.5o, where characterised in terms o f  diameter and solubility profiles.
Three-dimensional scaffolds were produced from these fibres and the long term 
viability, morphology and population growth o f the seeded HOB and HOF cells were 
determined using immunocytochemistry and direct cell count. This was coupled with 
application of qPCR experiments to evaluate the maintenance o f differentiation o f the 
seeded cell population.
The role o f extrinsic factor inclusion in enhancing in vitro, scaffold associated, tissue 
morphogenesis was also investigated by stimulating osteogenic differentiation in the 
seeded HOB cell population. An open lamellar flow bioreactor providing nutrients, 
oxygen and waste perfusion to the cell-scaffold culture was deigned and assessed. The 
feasibility o f simulating the anatomical architecture o f the enthesis has also been 
addressed as cells were seeded in co-culture on a continuous fibre arrangement.
In this study, quaternary phosphate based glass fibre scaffolds containing 3 mol% iron 
oxide (Fe2 0 3 ), o f approximately 30 pm in diameter, and o f the composition (CaO)o.46- 
(Na20 )o.oi-(Fe2 0 3 )o.o3-(P2 0 5 )o.5o have been shown to support HOB and HOF 
attachment, well spread morphology, survival and proliferation with no negative 
impact o f cell differentiation. Induction o f osteogenesis in the scaffold culture has 
resulted in up-regulating HOB related gene transcription and the flow culture system, 
at certain flow rates, has been verified for future use. The Co-culture system design 
has been successfully implemented as HOB and HOF cells were seeded with an 
acellular separation zone across the fibre scaffold arrangement.
5
Papers/Communications
Papers
Bitar, M., Salih, V., Mudera, V., Knowles, J.C. and Lewis, M.P. (2004).
Soluble phosphate glasses: in vitro studies using human cells o f hard and soft tissue 
origin. Biomaterials.25,2283-92.
Bitar, M., Knowles, J.C., Lewis, M.P., Salih, V. (2005).
Soluble Phosphate Glass Fibers for Repair o f Bone-Ligament Interface. Journal o f 
Materials Science: Materials in Medicine. 16, 1131 -  1136.
Published abstracts
Bitar, M., Ahmed, I., Knowles, J.C., Salih, V. and Lewis, M.P.
Development o f novel soluble glasses for tissue engineering o f hard tissue. European 
Cells and Materials, Vol. 4. Suppl. 2, 2002 (pages 138-139) ISSN 1473-2262
Bitar, M., Knowles, J.C., Salih, V. and Lewis, M.P.
Biocompatible phosphate glass fibre scaffolds: Engineering o f the hard/soft tissue 
interface. European Cells and Materials Vol. 7. Suppl. 1, 2004 (page 26) ISSN 1473- 
2262
Oral Presentations
September 2002. Cell adhesion and migration: the Interface with Tissue Engineering. 
The University o f Nottingham, Centre for mathematical Medicine 
Bitar, M., Knowles, J.C., Salih, V. and Lewis, M.P. Development o f Novel Soluble 
Glasses for Hard Tissue Engineering.
September 2005. European Society for Biomaterials Conference, Sorrento, Italy.
Bitar, M., Knowles, J.C., Salih, V. and Lewis, M.P. Phosphate-Based Glass Fibre 
System: An Inductive Approach to the Hard-Soft Interface Repair.
Poster presentations
September 2002. Tissue and Cell Engineering Society (TCES) 2002. The University 
o f Glasgow.
Bitar, M., Ahmed, I., Knowles, J.C., Salih, V. and Lewis, M.P.
Development o f novel soluble glasses for tissue engineering o f hard tissue.
6
Acknowledgements
I would like to thank my primary supervisor, Dr Mark Lewis, for leading this project 
and providing me with mentorship, excellent scientific advice and academic support 
throughout. Most o f all, I thank him for encouraging creativity and independent 
thinking.
I would also like to express my sincere gratitude for my supervisor, Dr Vehid Salih, 
for granting me training and prompt scientific advice; for his tremendous help in 
editing this thesis and most o f  all; for his encouragement when motivation was 
needed.
I greatly appreciate the help o f Professor Jonathan C Knowles, Dr Iftikhar Ahmed, 
Andrea A Sinanan and Nicky Mordan whose contribution was vital for the conduct o f 
this work.
I acknowledge the help o f Dr Chris Irwin at Queen’s University, Belfast, in providing 
the primary oral fibroblasts and that o f Dr Vivek Mudera at The Institute o f 
Orthopaedics and Musculo-Skeletal Science, UCL, in providing the primary human 
tendon fibroblasts.
Finally, I thank Dr Iolo ap Gwynn at the Institute o f Biological Sciences, 
The University o f Wales, for kindly performing the SEM analysis o f the glass fibres.
This project was funded by The EPSRC and The Lord Dowding Fund.
7
Table of Contents
Declaration...................................................................................................................................4
Summary: A bstract.....................................................................................................................5
Papers/Communications.............................................................................................................6
Acknowledgements.....................................................................................................................7
Table o f  Contents........................................................................................................................8
List o f Abbreviations............................................................................................................... 14
List o f Figures............................................................................................................................16
List o f tables.............................................................................................................................. 20
C hap ter One: In tro d u c tio n ................................................................................................. 21
1.1 Introduction........................................................................................................................ 22
1.2 Aetiology and mechanisms o f in jury ............................................................................ 22
1.2.1 Overuse Injuries.........................................................................................................22
1.2.2 Aging and limited m obility..................................................................................... 24
1.2.3 Endogenous factors...................................................................................................24
1.3 Pathology and healing...................................................................................................... 25
1.4 Conventional surgical intervention................................................................................27
1.5 Disadvantages o f surgical management........................................................................ 28
1.5.1 Significant failure rate and surgical complications............................................. 28
1.5.2 Autograft associated donor site m orbidity............................................................29
1.5.3 Allograft availability and limitations o f  u s e .........................................................29
1.5.4 Alloplast mechanical failure and short lifetim e................................................... 30
1.6 Development, Structure and biomechanical properties..............................................31
1.6.1 Introduction................................................................................................................. 31
1.6.2 B one............................................................................................................................. 33
1.6.2.1 Fetal bone formation..........................................................................................33
1.6.2.2 Bone cells............................................................................................................ 35
1.6.2.3 Bone structural properties and architecture................................................... 36
1.6.2.4 Bone mineralisation...........................................................................................40
1.6.2.5 Bone remodelling............................................................................................... 40
1.6.3 Ligaments and tendons.............................................................................................. 43
1.6.3.1 Development.......................................................................................................43
1.6.3.2 Biochemical and structural properties............................................................ 43
1.6.3.3 The fibroblast, ECM turnover and collagen synthesis................................. 47
1.6.4 The enthesis: The hard-soft tissue interface...........................................................49
1.7 Tissue Engineering: Repair through regeneration........................................................51
1.7.1 Introduction................................................................................................................. 51
1.7.2 Conductive tissue regeneration............................................................................... 51
1.7.3. The inductive approach........................................................................................... 52
1.7.5 The role o f extrinsic factors and culture environment........................................54
1.7.6 The biocompatible scaffold......................................................................................55
1.7.6.1 Introduction......................................................................................................... 55
1.7.6.2 The concept o f biocom patibility.....................................................................55
1.7.6.3 The in vivo bioactivity......................................................................................56
1.7.6.4 The importance o f biodegradability............................................................... 56
1.8 Biomaterials for tissue engineering................................................................................57
1.8.1 Naturally derived polymers......................................................................................57
1.8.2 Synthetic polymers....................................................................................................57
1.8.3 Ceramics and bioactive glasses...............................................................................58
1.9 Phosphate based glasses...................................................................................................59
1.9.1 Chemical and physical characteristics.................................................................. 59
1.9.2 Bioactivity and biocompatibility............................................................................ 60
1.10 Summary: A Glass fibre scaffolding system for the hard-soft tissue engineering 
 62
1.11 Aims o f this study........................................................................................................... 63
C hap ter Two: M aterials and M ethods............................................................................46
2.1 Cell Culture.........................................................................................................................65
2.1.1 The in vitro cell culture environment..................................................................... 65
2.1.2 Isolating primary human cells..................................................................................65
2.1.3 The MG-63 cell line...................................................................................................66
2.1.4 Expanding the primary cell population..................................................................67
2.1.5 Establishing primary cell s tocks............................................................................. 67
2.1.6 Cell seeding considerations...................................................................................... 67
2.2 Preparation of glass substrates.........................................................................................70
2.2.1 Introduction................................................................................................................. 70
2.2.2 Glass batch calculations............................................................................................71
2.2.3 Glass disc production................................................................................................ 74
9
2.2.4 Glass fibre fabrication............................................................................................... 75
2.2.5 Glass fibre scaffold preparation.............................................................................. 77
2.3 Co-culture scaffold system............................................................................................... 79
2.4 Glass fibre characterisation..............................................................................................80
2.4.1 Solubility measurement.............................................................................................80
2.4.2 Assessment o f fibre diam eters................................................................................ 80
2.4.3 Scanning electron m icroscopy................................................................................81
2.5 The flow culture system ................................................................................................... 82
2.5.1 Introduction.................................................................................................................82
2.5.2 The flow c e ll ...............................................................................................................82
2.5.3 Open flow perfusion system ................................................................................... 84
2.6 Cell viability assessment..................................................................................................88
2.6.1 Introduction.................................................................................................................88
2.6.2 Scanning Electron M icroscopy...............................................................................88
2.6.3 The CyQUANT cell viability kit............................................................................ 88
2.6.3.1 Introduction.........................................................................................................88
2.6.3.2 Assay preparation...............................................................................................89
2.6.3.3 Fluorescent evaluation o f cell density............................................................89
2.6.4 Direct cell count.........................................................................................................90
2.7 Fluorescence Immunocytochemistry.............................................................................91
2.7.1 Introduction................................................................................................................. 91
2.7.1.2 The function and structure o f antibodies........................................................91
2.7.1.3 Immunocytochemical assay form ats.............................................................. 92
2.7.2 Preparation o f control surfaces............................................................................... 94
2.7.3 Fluorescent Immunolabelling o f ECM turnover associated...............................94
2.7.4 Fluorescent Immunolabelling o f the cytoskeleton...............................................96
2.8 The CellTracker™ assay: Co-culture assessment........................................................96
2.8.1 Co-culture cell population identification...............................................................97
2.9 Fluorescence microscopy................................................................................................. 97
2.10 Quantitative polymerase chain reaction...................................................................... 99
2.10.1 Introduction: mRNA synthesis and function specific gene..............................99
2.10.2 Quantitave Polymerase Chain Reaction (qPCR): an overview......................100
2.10.3 Total RNA extraction............................................................................................ 103
2.10.4 Preparation of cD N A ............................................................................................ 104
2.10.5 Relative quantification o f gene expression and regulation............................ 105
10
2.11 Statistical analysis....................................................................................................... 107
Chapter Three: Results O n e ............................................................................................. 108
3.1 Introduction.......................................................................................................................109
3.2 Experimental protocol..................................................................................................... 110
3.2.1 The CyQUANT assay .............................................................................................110
3.2.2 Scanning Electron M icroscopy............................................................................. I l l
3.2.3 Fluorescence Immunocytochemistry...................................................................111
3.3 Results................................................................................................................................113
3.3.1 Initial evaluation o f biocompatibility: MG-63 cell attachment t o ..................113
3.3.2 Characterisation o f primary cell phenotype........................................................116
3.3.3 Evaluation o f ternary glasses biocompatibility: Craniofacial..........................120
3.3.3.1 Preservation o f cell phenotype...................................................................... 120
3.3.3.2 Cell morphology and attachment patterns................................................... 122
3.3.3.3 Cell survival and proliferation...................................................................... 124
3.3.4 Evaluation o f ternary glasses biocompatibility: Oral and tendon................... 127
3.3.4.1 Preservation o f cell phenotype...................................................................... 127
3.3.4.2 Cell morphology and attachment patterns................................................... 128
3.3.4.3 Cell survival and proliferation...................................................................... 131
3.4 Summary........................................................................................................................... 134
Chapter Four: Results Two................................................................................................136
4.1 Introduction.......................................................................................................................137
4.2 Experimental protocol..................................................................................................... 138
4.2.1 Scaffold Preparation.................................................................................................138
4.2.1.1 Ternary glass fibre system ..............................................................................138
4.2.1.2 Quaternary glass fibre system ........................................................................139
4.2.2 Glass fibre characterisation.................................................................................... 139
4.2.3 Cell density evaluation............................................................................................ 140
4.2.3 Immunocytochemistry............................................................................................ 140
4.2.4 The CellTracker™ assay.........................................................................................140
4.3 Results............................................................................................................................... 141
4.3.1 Cell attachment and survival in relation to fibre diameter...............................141
4.3.1.1 Craniofacial osteoblasts................................................................................141
11
4.3.1.1 Oral fibroblasts..................................................................................................144
4.3.2 Quaternary glass fibre characterisation................................................................ 146
4.3.2.1 Solubility profiles............................................................................................. 146
4.3.2.2 Glass fibre diam eter.........................................................................................148
4.3.2.3 Glass fibre surface topography evaluation....................................................150
4.3.3 Biocompatibility o f quaternary glass fibres: Craniofacial................................152
4.3.3.1 Cell survival and proliferation...................................................................... 152
4.3.3.2 Maintenance o f cell m orphology..................................................................153
4.3.4 Biocompatibility o f quaternary glass fibres: Oral fibroblasts..........................155
4.3.4.1 Cell survival and proliferation...................................................................... 155
4.3.4.2 Maintenance o f cell m orphology..................................................................156
4.3.5 Co-culture evaluation..............................................................................................158
4.4 Sum m ary........................................................................................................................160
C hap ter Five: Results T h re e .............................................................................................162
5.1 Introduction...................................................................................................................... 163
5.2 Experimental protocol.....................................................................................................164
5.2.1 Assessment o f glass fibre biocom patibility........................................................164
5.2.2 Stimulation o f HOB culture mineralisation........................................................164
5.2.3 The laminar flow system se tu p ............................................................................. 164
5.2.3 Quantification o f gene expression and regulation..............................................165
5.3 Results................................................................................................................................ 167
5.3.1 Maintenance o f differentiation............................................................................ 167
5.3.1.1 Craniofacial osteoblasts.................................................................................. 167
5.3.1.2 Oral fibroblasts..................................................................................................170
5.3.2. Gene regulation: Induction o f osteogenesis.................................................... 172
5.3.3 Gene regulation: The effect o f flow culture conditions....................................167
5.3.3.1 Craniofacial osteoblasts..................................................................................175
5.3.3.2 Oral fibroblasts..................................................................................................178
5.4 Summary...........................................................................................................................180
12
C h ap ter Six: Discussion.......................................................................................................182
6.1 Introduction:...................................................................................................................... 183
6.2 Biocompatibility o f ternary glass compositions...........................................................185
6.2.1 Introduction................................................................................................................185
6.2.2 Cell attachment and survival.................................................................................. 185
6.2.3. Cell morphology and phenotype....................................................................... 186
6.2.4 Cell proliferation....................................................................................................188
6.3 The glass fibre system ..................................................................................................... 189
6.3.1 Introduction.............................................................................................................. 189
6.3.2 The effect o f fibre diameter on cell attachment and viability........................... 190
6.3.3 Glass fibre structural modification.......................................................................191
6.3.4 Cell viability, proliferation and m orphology.....................................................191
6.3.5 Maintenance o f cell differentiation..................................................................... 193
6.4 Extrinsic factor inclusion: The affect on cell function.............................................195
6.4.1 Induction o f osteogenesis: enhancing scaffold associated.............................. 195
6.4.2 The effects o f flow culture conditions................................................................196
6.5 Contiguous HOB-HOF co-culture implementation................................................. 197
6 . 6  Quaternary Phosphate based fibre scaffolds: Future w o rk .....................................199
6.7 C onclusion.......................................................................................................................202
A ppendix ................................................................................................................................ 183
1. Reagents and K it............................................................................................................203
2. Media and Solutions...................................................................................................... 205
3. Antibody concentrations.............................................................................................. 207
4. Equipm ent.......................................................................................................................207
5. Software..........................................................................................................................207
References.............................................................................................................................. 183
13
List of Abbreviations
°c Degrees Celsius, temperature
Pg Microgram, weight
pi Microlitre, volume
jiM Micro molar, concentration
fim Micrometer, length
AA Ascorbic acid
ACL Anterior cruciate ligament
ANOVA Analysis o f  variance
BMP Bone morphogenic protein
BSA Bovine serum albumin
BSP Bone Sialoprotein
C aO Calcium oxide
Cbfa-1 Core binding factor alpha 1
cDNA Complementary DNA
CM FDA 5-chloromethylfluorescein diacetate
co2 Carbon dioxide
COL1A1 Collagen type I alpha polypeptide 1 subunit
CO L-I Collagen, type 1
Ct Threshold Cycle
Cy3 Carbocyanine 3
DAPI 4 ’ ,6-Diamidino-2-pheny indole
dH 20 Distilled water
D-MEM Dulbecco’s Modified Eagles Medium
DMSO Dimethylsulphoxide
DNA Deoxyribonucleic Acid
dNTP Deoxynucleotide
ECM Extracellular matrix
EDI UCL Eastman Dental Institute
EDTA Ethylenediaminetetraacetic acid
EGF Epidermal growth factor
Em Emission
Ex Excitation
Fab fragment antigen binding
FAM Fluorescent reporter dye fragment
FCM Fibroblast conditioned medium
FCS Fetal calf serum
FDA Food and Drug Administration (USA)
Fe2C>3 Iron oxide
FITC Fluorescein isothiocynate
Gla gamma-carboxy glutamate
GM General medium
h Hour, time
HA Hydroxyapatite
HOB Human osteoblast
HOF Human oral fibroblast
HTF Human tendon fibroblast
Hz Hertz, frequency
14
IGF Insulin-like growth factor
IgG Immunoglobulin G
IL Interleukin
IU International unit, drug potency
min Minute, time
ml Millilitre, volume
mm Millimetre, length
mM Millimolar, concentration
mRNA Messenger RNA
MSCs Mesenchymal stem cells
N Newton, force
NCP noncollagenous protein
nm Nanometer, length
OC Osteocalcin
ON Osteonectin
O P Osteopontin
P-4-H Prolyl-4-hydroxylase
P4HA3 Prolyl-4-hydroxylase alpha polypeptide III subunit
PBS Phosphate buffered saline
PDGF Platelet derived growth factor
PI Propidium iodine
PLA Polylactic acid
PLAGA Polylactide-co-glycolide acid
qPC R Quantitative polymerase chain reaction
r/min Revolution per minute, rotational speed
Re Reynolds number, flow characteristics
RGD Arginine-glycine-aspartate (Arg-Asp-Gly)
RNA Ribonucleic acid
RQ Relative quantification
RT Room temperature
SD Standard Deviation
SE Secondary electron
sec second, time
SVCT1 Sodium-dependent vitamin-C transporter 1
TCP Tricalcium phosphate
TGF Transforming growth factor
15
List of Figures
Figure 1.1 A typical stress-strain curve for tendons and ligaments 
Figure 1.2 Wound healing mechanism and response in tendons and ligaments 
Figure 1.3 Schematic illustration o f surgical reconstruction o f the anterior cruciate 
ligament (posterior view)
Figure 1.4 Transverse Sections o f the Human embryo at 20 days (A) and 4 weeks (B) 
in utero
Figure 1.5 Schematic illustration o f endochondral and intramembranous bone 
formation
Figure 1.6 A three dimensional reproduction o f lamellar bone architecture 
Figure 1.7 Schematic illustration o f Bone Remodelling Unit (BRU)
Figure 1.8 Schematic o f the hierarchal arrangement o f the tendon subunits
Figure 1.9 X I28000 Transmission Electron Microscope image o f Tendon collagen
fibrils
Figure 1.10 A schematic o f the mechanisms involved in collagen Synthesis 
Figure 1.11 Histological Sections through an enthesis 
Figure 1.12 The concept o f inductive tissue engineering
Figure 1.13 Basic molecular unit o f a ternary phosphate based glass composition 
(Ca0-Na20 -P 20 5)
Figure 2.1 Primary cells in culture 
Figure 2.2 The haemocytometer
Figure 2.3 Density as a function o f temperature in the phases o f glass formation 
Figure 2.4 Glass rods and polished glass discs prior to in vitro assessment 
Figure 2.5 The glass fibre rig
Figure 2.6 A schematic illustration o f the stepper motor mechanism 
Figure 2.8 Co-culture scaffold design
Figure 2.9 Confocal scanning laser microscope image o f velocity profiles in a flow 
chamber
Figure 2.10 Components and dimensions o f the flow chamber
Figure 2.11 The open flow culture system
Figure 2.12 The open flow culture system unit configuration
Figure 2.13 The flow chamber-scaffold arrangement inside the incubator
16
Figure 2.14 Generic configuration o f glass discs for CyQUANT cell viability assay 
Figure 2.15 A schematic illustration o f the antibody structure 
Figure 2.16 Immunocytochemical assay formats
Figure 2.17 Excitation and emission light control in a fluorescent microscope 
Figure 2.18 Gene transcription, mRNA synthesis and translation 
Figure 2.18 (A), cDNA synthesis from mRNA and (B), cDNA PCR amplification 
Figure 2.20 The TaqMan® probe function during PCR
Figure2.21 Example o f qPCR assay 96 well plate configuration to investigate the 
expression o f four genes simultaneously
Figure 3.1 CyQUANT assay Optiplate configuration for (A), MG-63 cells and (B), 
Primary HOB and HOF cells
Figure 3.2 Fluorescent Immunocytochemistry assay 24-wellplate configuration 
Figure 3.3 CyQUANT evaluation o f MG-63 cell density on ternary glass discs 
Figure 3.4 Scanning electron micrographs o f MG-63 cells seeded on ternary glass 
discs
Figure 3.5 X63 objective Leica DMIRB fluorescent microscope images o f MG-63 
cells cultured on 13 mm borosilicate coverslips at 24 h time point 
Figure 3.6 Leica DMIRB fluorescent microscope images o f HOB cells cultured on 13 
mm borosilicate coverslips at 24 h time point
Figure 3.7 Leica DMIRB fluorescent microscope images o f HOF and HTF cells 
cultured on 13 mm borosilicate coverslips at 24 h time point
Figure 3.8 X63 objective Leica DMIRB fluorescent microscope images o f HOB cells 
Labelled for BSP
Figure 3.9 X63 objective Leica DMIRB fluorescent microscope images o f HOB cells 
Labelled for ON
Figure 3.10 X63 objective Leica DMIRB fluorescent microscope images o f HOB 
cells Labelled for OP
Figure 3.11 HOB cell Morphology on ternary glass compositions
Figure 3.12 CyQUANT analysis o f attached HOB cell survival and proliferation
Figure 3.13 CyQUANT analysis o f attached HOB cell density in relation to glass
composition
Figure 3.14 X63 objective Leica DMIRB fluorescent microscope images o f HOF 
cells Labelled against P-4-H
17
Figure 3.15 X20 objective Leica DMIRB fluorescent microscope images o f HTF 
cells Labelled against P-4-H
Figure 3.16 HOB cell Morphology on ternary glass compositions
Figure 3.17 HTF cell Morphology on ternary glass compositions
Figure 3.18 CyQUANT analysis o f attached HOF cell survival and proliferation
Figure 3.19 CyQUANT analysis o f attached HOF cell density in relation to glass
composition
Figure 4.1 HOB cell attachment and survival on ternary glass fibres o f various 
diameters
Figure 4.2 HOB cell attachment and survival on fibres of various diameters
Figure 4.3 HOF cell attachment and survival on ternary glass fibres o f various
diameters
Figure 4.4 HOF cell attachment and survival profiles on fibres o f various diameters
Figure 4.5 Light photograph o f glass fibres during solubility profiling
Figure 4.6 glass fibre weight loss rates for various compositions and at different time
points
Figure 4.7 Glass solubility rates as a function o f F2O3 content
Figure 4.8 Analysis o f fibre diameter values frequency for each glass composition
Figure 4.9 SEM micrographs o f ternary and quaternary glass fibre surfaces
Figure 4.10 HOB cell survival and proliferation on quaternary glass fibres generated
at 800 r/min
Figure 4.11 HOB cell Morphology on quaternary glass fibres at day 14 in culture 
Figure 4.12 HOB cell Morphology on quaternary glass fibres at day 21 in culture 
Figure 4.13 HOF cell survival and proliferation on quaternary glass fibres generated 
at 800 r/min
Figure 4.14 HOF cell Morphology on quaternary glass fibres at day 14 in culture 
Figure 4.15 HOF cell Morphology on quaternary glass fibres at day 21 in culture 
Figure 4.16 X20 objective Leica DMIRB fluorescence micrographs o f HOF cells 
labelled with CellTracker™ dye
Figure 4.17 X10 objective fluorescent microscope image o f HOB and HOF cells in 
co-culture
Figure 5.1 qPCR 96 wellplate assay configuration for HOB (a) and HOF (b) used 
throughout the experimental work
Figure 5.2 Relative quantification o f ON (a) and Cbfa-1 (b) gene expression
18
Figure 5.3 Relative quantification o f COL1A1 gene expression in HOB cells 
Figure 5.4 Relative quantification o f COL1A1 gene expression in HOF cells 
Figure 5.5 Relative quantification o f P4HA3 gene expression in HOF cells 
Figure 5.6 The effect o f osteogenic medium on ON and Cbfa-1 gene regulation 
Figure 5.7 The effect o f osteogenic medium on COL1A1 gene regulation 
Figure 5.8 The effect o f laminar GM flow on ON and Cbfa-1 gene transcription 
Figure 5.9 The effect o f laminar GM flow on COL1A1 gene transcription in HOB 
cells
Figure 5.10 The effect o f laminar GM flow on COL1A1 gene transcription in HOF 
cells
Figure 5.11 The effect o f laminar GM flow on P4HA3 gene transcription in HOF 
cells
Figure 6.2 The sequence o f events involved in the cell transplantation approach for 
inductive tissue regeneration
Figure 6.1 Integrin mediated cell adhesion to biocompatible substrates
19
List of tables
Table 1.1 Risk Factors That Contribute to Overuse Injuries
Table 1.2 Intramembranous proteins and factors involved in bone metabolism and 
cell function
Table 2.1 Precursor weights for ternary glass production 
Table 2.2 Precursor weights for quaternary glass production
Table 3.1 Ternary phosphate based glass compositions considered for the initial 
biocompatibility assessment
Table 3.2 An evaluation o f MG63 cell attachment after 24 h in culture on glass 
surfaces o f various compositions
Table 4.1 Quaternary glass fibre compositions used for biocompatibility testing 
Table 4.2 Estimated fibre diameter at various drum rotational speeds
20
CHAPTER ONE 
INTRODUCTION
21
1.1 Introduction
The hard-soft tissue interfaces, whether osteotendinous or osteoligamentous, are 
integral units supporting the posture and mobility of the musculoskeletal system. The 
soft connective tissue components o f the interface, i.e. ligaments and tendons, 
undergo injury, disease and degradation throughout life leading to a wide range o f 
medical conditions.
1.2 Aetiology and mechanisms of injury
1.2.1 Overuse Injuries
As dense connective tissue structures, and owing to considerable tensile strength, 
tendons and ligaments transmit physical loads and forces with minimal energy loss 
between muscle/bone and bone/bone respectively providing the necessary framework 
crucial for movement and skeletal stability. Tendons and ligaments are also elastic 
and capable o f extending 4-8% beyond their resting length, thus preserving their 
structural integrity when higher levels o f activity are to be met. Loss o f elasticity may 
occur however, when the tissue is subjected to stresses exceeding its resistance 
capacity. As seen from Figure 1.1, a tendon or a ligament commences longitudinal 
elongation as strain surpasses a certain level at a point termed the “toe” region after 
which, resistance to the increasing stress follows a linear (Ng et al., 2004). It is at 
strain levels above 4%, and beyond the elasticity threshold, that permanent loss o f 
functional structure and injury may occur.
Such acute overloading is of common occurrence in strenuous exercises resulting in 
the partial or complete rupturing of, for example, the Achilles tendon or the anterior 
cruciate (ACL) ligament of the knee. Tissue injury may also result from repetitive 
strain a phenomenon often associated with athletic exercise. Chronic repetitive 
microtrauma frequently leads to the formation o f multiple microscopic cracks within 
the tendon matrix, where the eventual coalescence o f these micro-defects will 
culminate in various forms of tendinopathies. Exercise mediated overuse injuries have 
shown to be exacerbated when combined with the presence o f certain intrinsic
22
contributing factors. Table 1.1 summarises the risk factors associated with overuse 
injuries o f tendons and ligaments.
«A
(A
Q)
CO
Strain %
4%-8%<1.5% 1.5%-4% >8%
Figure 1.1 Typical stress-strain curve for tendons and ligaments
Toe region (I), linear region (II) and failure region (III and IV) (Goh et al., 2003; Ng 
et al., 2004)
Table 1.1 Risk Factors That Contribute to Overuse Injuries
(O'Connor et al., 1997)
Intrinsic Extrinsic
Malignant Training errors
Muscle imbalance Equipment
Inflexibility Environment
Muscle weaknesses Techniques
Instability Sport-acquired deficiencies
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1.2.2 Aging and limited mobility
Elderly individuals are susceptible to ligament, Tendon and other musculoskeletal 
injuries at a rate similar to those in the young (Goh et al., 2003; Dressier et al., 2005). 
Age associated biomechanical changes, however, increase the tissue susceptibility to 
physical damage and pose a negative impact on its healing capacity. Aging tendons 
and ligaments undergo degenerative quantitative and qualitative changes in terms o f 
both, collagenous and noncollagenous components of the extracellular matrix (ECM). 
This might be attributed to the slow metabolic rate of the cellular component 
contributing to the matrix turnover and an increasingly limited vascularisation 
resulting, ultimately, in stiffness and the loss o f elasticity. The lack o f physical stimuli 
required to maintain an efficient structure through functional homeostasis whether 
associated with aging or due to disability and disease, will also increase the 
predisposition o f tendons and ligaments to injuries, particularly those of the chronic 
nature (Kjaer, 2004). It has been reported that immobilisation o f the Achilles tendon 
induced the thinning and disorientation o f collagen fibres and decreased the strength 
and resistance capacity by 20% (Matsumoto et al., 2003).
1.2.3 Endogenous factors
Various pathological conditions may either directly generate deficiencies in ligaments 
and tendons, or indirectly predispose such structures to acute or chronic traumatic 
injury. Familial hypercholesterolemia, a common hereditary condition (Descamps et 
al., 2 0 0 1 ), induces the formation o f tendon xanthomata where tissue structure is 
altered by the presence of lipid deposits (Tall et al., 1978). Various genetic disorders 
such as ochronosis, mucopolysaccharidoses and osteogenesis imperfecta are 
associated with collagen synthesis deficiency thus directly causing connective tissue 
abnormalities (Jozsa et al., 1981; Jarvinen et al., 1997; M isof et al., 1997; Cortes and 
Maloney, 2004). Chronic inflammatory conditions, primarily rheumatoid arthritis, 
lead to the occurrence of degenerative changes in tendons and ligaments via the 
inflammation of the synovial envelope. Again, this is followed by an increased 
vulnerability to microtrauma (Kramer et al., 2003; Bring et al., 2005). Other
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infectious, iatrogenic, endocrine, metabolic and tumorogenic factors may also 
contribute to the induction o f tendons and ligaments pathology (Hayem, 2001).
1.3 Pathology and healing
Trauma to the tendon or ligament, whether acute or chronic, usually results in the 
complete or partial tearing o f the structure. Following injury, a predominantly 
intrinsic repair process is initiated and can be divided into several overlapping phases 
where the duration o f each phase is dependant on the nature and location o f the defect. 
Associated with pain, swelling, heat and redness the first phase, immediately 
preceding injury, is characterised by an inflammatory response (Weintraub, 2003). 
This is instigated, and ensuing blood vessel rupture, by haematoma formation and the 
injury site infiltration by inflammatory cells and macrophages and followed, at later 
stages, by angiogenesis and the invasion o f fibroblasts, tissue constituting proteins 
and tissue growth factors from the surrounding structures so that the formation o f a 
new ECM is initiated (Fenwick et al., 2002). The second phase o f the repair process is 
dominated by the presence o f a disorganised matrix o f granulation tissue, the 
proliferation o f fibroblasts and the synthesis o f collagen as the main constituting 
protein o f the fibre structure. Within the granulation tissue, stimulated by mechanical 
stress and induced by the presence o f transforming growth factor-P (TGF-P) and 
finbronectin, fibroblasts undergo differentiation into protomyofibroblasts and 
subsequently differentiate into mature myofibroblasts (Lygoe et al., 2004). This 
differentiation process has been shown to be primarily controlled by the formation o f 
TGF-p/av intergin complexes on the cell membrane followed by the activation of 
differentiation mediated by Smad proteins (Smad2 in particular) (Lan, 2003). 
Myofibroblasts express smooth muscle cell characteristics expressing alpha smooth 
muscle actin (a-SM actin, an actin isoform) and play a major role in adult wound 
healing, wound contraction and scar formation (Grinnell, 1994; Hakkinen et al., 2000; 
Van Beuerden et al., 2005). The final stage o f repair, and scar formation, is the 
remodelling and maturation process where the fibroblasts assume a round morphology 
and slow their metabolic rate; the newly formed fibrils are cross-linked and oriented 
parallel to the ligament or tendon longitudinal axis; and the fibrils constituting 
collagen is converted to a type similar to that o f the normal tissue (Lin et al., 2004).
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Figure 1.2 illustrates the healing process and the approximate duration o f each phase. 
The scar tissue, however, is o f inferior biomechanical properties when compared to 
the uninjured structure (Ferguson and O'Kane, 2004). The healed tissue is 
increasingly hypercellular and collagen fibrils are characterised by distorted cross 
linking and orientation, small diameter and composed largely of Type III collagen 
thus greatly compromising the function and stress resistance o f the structure (Maffulli 
et al., 2002). Furthermore and due to the presence of blood clotting associated fibrin, 
during chronic injury and prolonged healing, adhesion formation among tissue layers 
may occur thus contributing to the loss o f functional elasticity (Kader et al., 2002; 
Weintraub, 2003).
Hemostasis/
Inflammation
Proliferation/
Fibroplasia
Weeks
Remodelling/
Maturation
Months -Days Years
Figure 1.2 Wound healing mechanism and response in tendons and ligaments
(Lin et al., 2004).
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1.4 Conventional surgical intervention
Ensuing injury and intrinsic repair, tendons and ligaments may never regain their 
original functional structure and surgical reconstruction, in a considerable number o f 
cases, is an inevitable choice when attempting to replace the damaged tissue. This is 
highlighted by the fact that in the United States, surgical reconstruction is performed 
on almost 50% o f all ACL injury cases (Kartus et al., 2001; Herrington et al., 2005). 
In 1993, the number o f patients undergoing surgery to repair deficient tendons and 
ligaments was estimated at 120,000 annually (Langer and Vacanti, 1993). The extent 
and form of the operative procedure is related to the nature, site and severity o f injury 
(Coleman et al., 2000). Partial or complete ruptures are directly sutured whereas in 
chronic injury conditions, open tenetomy is conducted by making multiple 
longitudinal incisions in the structure (Maffulli, 1999; Kader et al., 2002). This is 
conducted to detect intratendinous lesions; to remove fibrotic adhesions and 
degenerated tissue formations; and to restore vascularity. Surgical reconstruction 
using variety o f graft material is another approach aimed at completely replacing 
dysfunctional structures (Figure 1.3). Various anatomical sites can be utilised as 
sources for autogenic or allogenic graft tissue such as the gracilis muscle ligament, the 
hamstring muscle ligament and the patellar tendon o f the knee. Synthetic alloplast 
material has also been used or evaluated for repair purposes. These include polymer- 
carbon fibre composites as non-degradable scaffolds to aid tissue growth, Gore-Tex 
(polytetrafluoroethylene-PTFE) as permanent prosthesis (Roolker et al., 2000; Kimura 
et al., 2003); Dacron (polyethylene terepthalate) as both permanent prosthesis and 
graft augmentation supporting device (Wredmark and Engstrom, 1993; Brekke and 
Toth, 1998; Kimura et al., 2003); Marlex mesh (Polypropylene) (Choksey et al., 
1996); ligament augmentation devices (polypropylene) (Van Kampen, 1994; 
Steenbrugge et al., 2001); and collagen prosthesis (Kato et al., 1991).
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Femur
AM
M eniscus —
Bone tunnel
Surgical Guiding 
Wire mesh
Figure 1.3 Schematic illustration of surgical reconstruction of the an terio r 
cruciate ligament (posterior view)
The anteromedial (AM) and posterolateral (PL) bundles of the ACL were replaced 
using hamstring tendon autografts. (Yasuda et al., 2005)
1.5 Disadvantages of surgical management
1.5.1 Significant failure rate and surgical complications
Surgical management of chronic tendon and ligament lesions, particularly where 
extended chronic degradation is present, have been shown to be associated with an 
unpredictable outcome. Previous studies have concluded that as high as 29-54% of 
patients suffered poor results following surgery and several re-operation procedures, 
therefore, may need to be conducted (Coleman et al., 2000; Cook et al., 2002; Kader 
et al., 2002). Full recovery however, even with prolonged post operative rehabilitation 
strategy, is not guaranteed as in many patients the return to normal function and 
activity level is less than satisfactory (Cook et al., 2002). The high incidence o f 
complications associated with, or ensuing, surgery may also compromise the
Tibia
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outcome. Such complications may include delayed wound healing, deep infections, 
necrosis and re-rupture o f the repaired tissue and adherence o f tissue to skin (Nistor, 
1981). Failure o f the tendon/ligament graft integration into bone, following surgery, is 
another common complication. It has been shown that the inferior bonding between 
the hard and soft tissues, at the graft augmentation site, often resulted in structural 
laxity and in many cases, failure o f treatment (Martinek et al., 2002; Song et al.,
2004).
1.5.2 Autograft associated donor site morbidity
Despite advances in developing alternative allograft and artificial replacements, 
autograft augmentation remains the most widely used technique when treating tendon 
and ligament defects (Kartus et al., 2001). Secondary complications however, due to 
the damage inflicted on the donor tissue, are evident in many cases. It has been 
suggested that the use o f muscle tendons as graft sources resulted in reduced strength, 
compromised extensor mechanisms and nerve damage (Comley and Krishnan, 1999; 
Kartus et al., 2001; Soon et al., 2004). The use o f patellar tendon grafts, to reconstruct 
the ACL, has also been shown to be associated with pain and discomfort, reduced 
range o f motion o f the knee and altered mechanical function (Kartus et al., 2000; 
Eriksson et al., 2001). The presence o f such complications was detected up to two 
years following surgery (Kartus et al., 1999). Histopathology findings confirmed the 
presence o f hypertrophic scar formation in the donor tissue. Manifested by poorly 
aligned collagen fibrils, increased cellular content and hypervascularity the 
histological appearance of the regenerated tissue, at the harvest site, was markedly 
different from normal (Berg, 1992; Linder et al., 1994; Proctor et al., 1997; Sanchis- 
Alfonso et al., 1999).
1.5.3 Allograft availability and limitations of use
When, in some cases, allograft augmentation is the only option at hand, a familiar 
scenario emerges. The demand simply exceeds availability. Many o f the patients on 
the transplant waiting lists will die before a transplant organ or tissue is available for 
them (Vacanti et al., 1998; Alberto, 2004).Allograft use is also associated with the
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risk o f infectious disease transfer and unreliable graft incorporation (Brekke and Toth,
1998). Furthermore and being genetically alien to the host tissue, allografts are 
extremely liable to immunorejection and the use o f immunosuppressant agents is a 
requirement.
1.5.4 Alloplast mechanical failure and short lifetime
Synthetic materials used as augmentation devices lack the fundamental capacity of 
normal tissues to self-repair and to adapt to biomechanical stimuli. Despite continuous 
efforts to improve both morphological and biological fixation properties o f these 
devices, long term clinical outcome remains poor and the in vivo lifetime is 
unpredictable (Hench, 1998). Whether as a result of poor abrasion resistance or 
mechanical mismatch, alloplasts are susceptible to fatigue failure and limited 
integration into normal tissue (Cooper et al., 2005).
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1.6 Development, Structure and biomechanical properties
1.6.1 Introduction
Ligament, tendon and bone, components of the hard-soft interface, are all connective 
tissue structures and all follow closely related developmental pathways. During early 
foetal life, and by the end o f the second week in utero, the embryonic structure is 
formed by three distinct germ layers: the ectoderm, the mesoderm and the endoderm. 
The middle layer, the mesoderm, will eventually give rise to skeletal, connective and 
muscle tissues o f the body (Figure 1.4A) (Mitchell and Sharma, 2004). By the end of 
the third week, the paraxial (medial) regions o f the mesoderm undergo differentiation 
and paired tissue blocks, or somites, are formed on either side of the primitive neural 
tube. The somites undergo further development whereby cell populations aggregate 
into sclerotomes evolving later into axial bone and cartilage; and dermomytotomes 
from which the skeletal muscles and connective tissue are to be formed (Figure 1.4B). 
The distal parts o f the mesoderm, or the lateral plate, will form the basis o f the 
musculoskeletal system o f the limbs. The somites and the lateral plate are composed 
by a loose connective tissue network, the mesenchyme, formed by the mesoderm cells 
except for the head region where it is, entirely, induced by the invasion o f neural crest 
cells migrating from the ectoderm (Armitage et al., 1990). As well as their primary 
function forming fetal structures, the pluripotent stellate-shaped cells o f the 
embryonic mesenchyme persist in the adult bone marrow, and various other tissue 
structures, as multipotent mesenchymal stem cells capable o f differentiating into 
connective tissue cells (Winslow, 2001).
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A B
Figure 1.4 Transverse Sections of the Hum an em bryo at 20 days (A) and 4 
weeks (B) in utero
(i) Ectoderm, (ii) Mesoderm, (iii) Endoderm, (iv) Neural crest cells, (v) Lateral 
plate mesoderm, (vi) Medial plate mesoderm, (vii) Neural Tube, (viii) Sclerotome, 
(ix) Dermomyotome and (x) a Somite. (Mitchell and Sharma, 2004).
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1.6.2 Bone
1.6.2.1 Fetal bone formation
During morphogenesis, bone development in the embryo occurs via two different 
processes. Commencing by the second month of development and stimulated by 
various factors, FGF (fibroblast growth factor) in particular, endochondral ossification 
is preceded by the formation o f mesenchymal cell condensations (Orintz, 2005). 
Within the condensed matrix, the mesenchymal cells undergo differentiation into 
highly proliferative chondroprogenitor cells that later differente into cartilage 
synthesising cells. This process is preceded by the activation of transcription factors 
Sox 9, Sox 5 and Sox 6 whereby the cells, highly expressing collagen type II, form 
the cartilaginous template (anlagen) of the future bone (Orintz, 2005 ; Tuan, 2004). 
Following peripheral capillary proliferation, the peripheral cells of the anlagen adopt 
an osteoblastic fate and a “collar” o f bone is thereby formed around the middle o f the 
cartilaginous template. This process is highly regulated by bone morphogenic proteins 
2 and 7 (BMP2, BMP) and characterised by an up-regualtion in cbfal and collagen 
type I expression by the cells (Forriol and Shapiro, 2005). Simultaneously, centrally 
located chondroblasts undergo hypertrophy, the cartilaginous structure becomes 
increasingly vascularised and several ossification centres begin to emerge within the 
hypertrophic cartilage (Zelzer and Olsen, 2003). The hyaline cartilage is gradually 
replaced by bone except for the growth plate regions where post-natal longitudinal 
growth occurs. The cancellous tissue nature at the centre of newly formed bones 
permits the hosting of the bone marrow (Sommerfeldt and Rubin, 2001; Zelzer and 
Olsen, 2003). Intramembranous ossification takes place in the head region 
mesenchyme, and throughout the development o f the skull, maxilla and mandible. 
This type of bone formation is initiated by the aggregation and condensation of 
clusters of mesenchymal cells differentiating directly into bone forming cells or 
osteoblasts (Sommerfeldt and Rubin, 2001). An ossification centre is hereby formed 
where the osteoblasts begin the synthesis o f the bone matrix (osteoid) which, in turn, 
undergoes mineralisation within days. As the new formed bone continues to grow 
around the embryonic blood vessels the surrounding mesenchyme undergoes fibrous 
condensation so that the precursor structure o f the periosteum is laid (Sommerfeldt
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and Rubin, 2001). Maturation into compact bone ensues at the peripheral level 
whereas a cancellous, central zone housing the haematopoietic marrow tissue persists. 
Figure 1.5 summarises the endochondral and intramembranous ossification processes.
Gellsfrom cranial neural crest, 
somites and lateral plate mesoderm
Mesenchymal cell condensation
Osteoblast differentiation 
Bone matrix production
Membranous
ossification
\
Cartilage
anlage
Growth of capillaries around 
the cartilage anlagen
Bone
collar
Hypertrophic cartilage with
high-level VEGFexpression
Endochondral ossification
Figure 1.5 Schematic illustration of endochondral and intram em branous bone 
formation (Zelzer and Olsen, 2003).
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1.6.2.2 Bone cells
Osteoprogenitor cells originate from the multipotent mesenchymal stem cells of the 
bone marrow. The process by which MSC commitment to the osteoblastic 
monopotent progeny is conducted is not fully understood however, certain factors 
appear to plav a major role in regulating such an event particularly the TGF-f) 
superfamily (including BMPs) and parathyroid hormone (PTH) (Abuin et al., 1995). 
Osteoprogenitor cells give rise to preostoblasts that are of distinct elongated 
morphology and commonly located near bone surfaces which, in turn, undergo 
differentiation into osteoblasts(Weiss, 1983). The osteoblast expresses several stages 
o f differentiation generating the bone matrix through collagen type I synthesis and 
regulating bone mineralisation (Gay et al., 2000; Sommerfeldt and Rubin, 2001). 
Osteoblasts are of cubodial morphology and are located at the bone surface and once 
active can be characterised for synthesising osteopontin (OP), bone sialo protein 
(BSP), osteonectin (ON), alkaline phosphatise (ALP) and osteocalcin (OC). 
Additionaly, osteoblasts have been shown to be capable of producing BMP where his 
appears to be directly linked to the activation o f differentiation pathways of 
osteoprogenitor cells into osteoblasts (Mackie, 2003). Osteoblasts lay down an 
estimated 0.5-1.5 pm of osteoid every day (Weiss, 1983) and once entrapped in the 
newly synthesised bone matrix, changes in cell morphology and function take place 
giving rise to what is commonly referred to as the mature bone cell, the osteocyte. 
Characterised by a rounded morphology, a relatively large nucleus and a low content 
o f cytoplasmic organelles, osteocytes are the most abundant cells in the mature and 
mineralised bone (Weiss, 1983; Sommerfeldt and Rubin, 2001). Osteocytes reside in 
lacuni and communicate with one another, and with other cells at the bone surface, via 
an extensive network of cytoplasm processes running through pre-mineralisation 
formed canals, the canaliculi. Being part o f this three dimensional syncitium is what 
defines the function of osteocytes as regulators o f bone matrix maintenance. It has 
been suggested that by responding to external mechanical signals transmitted through 
the lacuno-canalicular network, osteocytes orchestrate the recruitment of cells in bone 
construction and resorption (Sikavitsas et al., 2001). Playing an active role in 
mineralised bone resorption, the osteoclast is third bone-associated cell type. Unlike 
osteoblasts, osteoclasts originate from haematopoietic, as opposed to stromal,
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mesenchymal stem cells o f the marrow (Gay et al., 2000). Osteoclasts differentiate 
from mononuclear monocytes and macrophages that migrate, in response to hormonal 
or physical stimuli, towards the bone remodelling site. Osteoclasts are located in 
resorption pits, or Howship’s lacunae and can be microscopically distinguished by 
their large size, multinucleated cytoplasm and high motility rate (Sambrook et al.,
2 0 0 1 ).
1.6.2.3 Bone structural properties and architecture
Newly laid osteoid consists mainly o f organic substance, primarily collagen Type I, 
which forms 95% of the bone ECM. Following the onset o f mineralisation however, 
this structure is gradually replaced by an inorganic mineral, hydroxyapatite (HA). The 
mature calcified bone is made up from 25% organic substance including collagen, 
cells and water; and 70% inorganic HA crystals (Sikavitsas et al., 2001; Sommerfeldt 
and Rubin, 2001). Collagen fibrils, whether in osteoid or mineralised bone, are linked 
together in regular alignment thus providing bone with structural cohesion and 
stability; shape; and tensile and compression resistance. This is achieved by the 
presence o f proteoglycan (PG) protein species. In bone, PGs are synthesised by the 
osteoblasts in the two major forms PG-I and II (biglycan and decorin respectively). 
The PG core protein is covalently attached to one or more glycosaminoglycans 
(GAG) chains and to oligosaccharides at the N- and O- ends (Grzesik et al., 2002). 
PGs non-covalently bind to collagen via the sugar group and GAG chains form 
duplex GAG complexes between two adjacent collagen molecules (Scott, 2003). 
Several groups o f bone-associated transmembrane proteins and soluble factors are 
present in the matrix and are o f extreme importance for the maintenance and function 
of bone (Sikavitsas et al., 2001; Hing, 2004). A brief description o f the most 
important o f these molecules and their role in coordinating bone and cell function is 
outlined in table 1.2. It should be also noted that most o f these transmembrane 
proteins, growth factors in particular, play similar role in regulating fibroblast 
function and matrix turnover in the soft connective tissue.
Architecturally, bone can be classified as either cortical (also referred to as compact) 
or cancellous (also referred to as trabecular or spongy). The two types are 
histologically and biochemically identical but differing in their structural organisation,
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porosity and soft tissue content. Cortical bone forms 80% of the skeleton and is 
present mainly in the diaphyses o f long bones. Whilst, forming only 20% of the 
skeletal structure, trabecular bone is found principally in the epiphysis o f long bones, 
cranium and vertebrae (Weiss, 1983). At a microscopic level, mineralised bone can be 
subdivided into two structural categories, woven and lamellar. Woven or immature 
bone is rich in osteocytes and generally exhibiting disorganised structural 
arrangement where collagen fibrils are small, irregular and disorientated. It is 
primarily formed in the embryo, during fracture healing and at the sites o f certain 
pathologic conditions where rapid bone formation occurs (Sommerfeldt and Rubin, 
2001). Woven bone however, will eventually be remodelled and replaced by the more 
organised, structurally superior, lamellar bone. Lamellar bone is less mineralised and 
generated at a slower rate than woven bone and is characterised by the presence of 
structural subunits, the lamellae, which are arranged in adjacent layers. Collagen 
fibres are preferentially orientated and extend between adjacent lamellae thus 
contributing to the structural strength o f bone (Weiss, 1983).
Table 1.2 ECM proteins and factors involved in bone remodelling and cell 
function
(Sikavitsas et al., 2001).
Osteocalcin (OC) May inhibit mineralisation and participates in 
resorption.
Osteonectin (ON, SPARC) A mineralisation nucleator with high affinity to both 
collagen and HA.
Osteopontin (OP) Mediates cell attachment to the bone matrix.
Bone Sialoprotein (BSP) Mediates cell attachment to the bone matrix.
Alkaline Phosphatase (ALP) Promotes mineral crystal formation
Fibronectin Mediates cell attachment to collagen and fibrin
Calcitonin Osteoclast function inhibitor.
Biglycan (PG-I) Affects collagen fibre growth and diameter.
Decorin (PG-II) Affects collagen fibre growth and orientation.
Bone morphogenic Proteins 
(BMP)
Stimulate chondrocyte and osteoblast proliferation and 
ECM synthesis. Induce MSCs differentiation into 
osteoblasts.
Fibroblast growth factors 
(FGF)
Stimulate MSCs differentiation, chondrocyte and 
osteoblast proliferation. May induce angiogenesis.
Insulin-like growth factor 
(IGF)
Stimulate chondrocyte and osteoblast proliferation and 
ECM synthesis.
Transforming growth factor- Induce chondrocyte differentiation and osteoblast
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|3 (TGF-(3) proliferation. May act as a bone remodelling regulator.
Epidermal growth factor 
(EGF)
Stimulates chondrocyte proliferation. Inhibits ECM 
synthesis.
Platelet-derived growth 
factor (PDGF)
Stimulates osteoblast differentiation. May stimulate 
bone resorption
Prostaglandin Regulates osteoclast differentiation, proliferation and 
function.
Interleukin-I (IL-I) Stimulates preosteoclast differentiation
Parathyroid hormone Both stimulates and inhibits osteoclast differentiation
Thyroxin Stimulate osteoclast mediated resorption
Estrogen Resorption inhibitor. Remodelling regulator
Dexamethasone Induces endochondral ossification
Vitamin D Regulator o f bone associated protein synthesis. Bone 
remodelling regulator.
In cortical bone (Figure 1.6), the lamellae are arranged in concentric layers around 
central capillaries forming cylinders o f 200-300 pm in diameter. These arrangements 
are referred to, and depending on the pattern o f development, as either osteons or 
Haversian systems where up to 20 lamellar plates surround a central canal (Haversian 
canal) containing blood vessels, nerves and connective tissue (Weiss, 1983). 
Communication among Haversian canals, the periosteum and bone marrow is 
conducted via oblique or transverse channels termed Volkmann’s canals. Each 
Haversian system is surrounded by a cement line, a noncollagenous interface o f 
mineralised mucopolysaccharides (Sambrook et al., 2001). In cancellous bone the 
trabeculae are formed by the incorporation o f trabecular segments, or packets, where 
each packet comprises several horizontally arranged lamellae. Several osteon-like 
structures can also be seen throughout cancellous bone. All bones irrespective o f 
structure and form are covered with periosteum except joint surfaces, which are 
covered with articular cartilage. The periosteum is permeated by blood vessels and 
nerve fibres that pass into the bone via Volkman's canals. The periosteum may also 
serve as an osteogenic layer as the presence stromal and haematopoietic mesenchymal 
stem cells has been detected (Weiss, 1983).
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Figure 1.6 A three dimensional reproduction of lam ellar bone architecture
(a) Subperiosteal outer circumferential lamellae, (b) Periosteum, (c) Interstitial 
lamellae, (d) Concentric lamellae o f osteon (haversian system), (e) Capillaries in 
haversian canals, (f) Capillaries in Volkmann’s canals, (g) vein, (h) Nutrient artery, 
(i) Concentric lamellae of osteon (Haversian system), (j) Nutrient artery, (k) 
Marrow meshwork ( Containing haematopoietic/ stromal stem and fat cells), (1) 
Trabeculae, (m) Central arteriolar branches o f nutrient artery, (n) Peripheral 
arteriolar branch of nutrient artery gives rise to capillaries that enter Volkmann’s 
canals of cortical (compact) bone and, (o) Nutrient artery eventually anastomoses 
with distal metaphyseal arteries. (Sambrook et al., 2001).
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1.6.2.4 Bone mineralisation
Mineralisation can be simply defined as the formation and growth o f HA 
([Caio(P04)(,(OH);]) crystals within the collagenous ECM o f bone. This process is 
preceded by local pH changes and increases in mineral ion concentration levels. The 
exact mechanisms by which the precursors of bone mineral are introduced to the 
matrix are poorly understood. It is believed nonetheless that this involves the release, 
by the osteoblasts, of matrix vesicles and mitochondrial granules containing 
phosphatases (ALP), phospholipids, and calcium ions (Sikavitsas et al., 2001; 
Sommerfeldt and Rubin, 2001). HA deposition is initiated by a process of nucleation 
during which an amorphous mineral nucleus is formed so that cry stal growth, around 
the nucleus, can proceed. Nucleation appears to be closely related to certain molecular 
groups capable of binding calcium and phosphate ions to the matrix. These include 
among various others, phosphorelated amino acid residues such as serine (present in 
collagen and osteonectin); carboxyl groups o f glutamic and aspartic acides (present in 
collagen); and carboxyl groups of hexose or hexoseamines (present in proteoglycans) 
(Hauschka et al., 1989; Hing, 2004). Also, the precise arrangement of collagen 
molecules within the collagen fibrils o f the bone ECM plays a major role in initiating 
nucleation and HA crystal growth. Collagen molecules are arranged in a quarter- 
stagger/ end-overlap manner whereby the “gap” present between collagen molecule 
ends provide the sites for crystal nucleation (Knott et al, 1997; Landis 1999). In 
response to mechanical stimuli and metabolic demands, bone is constantly subjected 
to remodelling throughout which, a balance is struck between the two processes of 
absorption and formation thus maintaining, under normal conditions, a state of 
functional haemostasis.
1.6.2.5 Bone remodelling
Understanding the mechanisms involved in the remodelling process might provide an 
excellent insight into the differentiated function of bone cells. Bone is normally 
maintained in a resting state where the bone surface is lined with the inactive, 
quiescent bone specific precursor cells. Initiated by various factors such as the 
parathyroid hormone (PTH), osteoclast differentiation and recruitment are induced
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primarily by several factors produced by the osteoblasts located at bone remodelling 
sites. Activation o f preosteoclasts from the precursor pool is initiated via a direct 
interaction between RANK-L (osteoblast transmembrane receptor) and RANK 
(osteoclast precursor receptor) and mediated; by macrophage colony-stimulating 
factor (M-CSF) secreted by the osteoblast. This formation o f receptor-1 igand 
complexes on the preosteoclast membrane is followed by the translocation o f 
differentiation transcriptional factors into the nucleus (Sambrook et al., 2001). Such a 
process can also be inhibited by the presence of osteoprotegrin (OPG), a protein 
produced by the osteoblasts, blocking and subsequently deactivating the role of 
RANK-L receptors (Mackie, 2003; Sommerfeldt and Rubin, 2001). As the resorption 
phase begins the osteoclast adhere to the bone surface creating a sealed zone with the 
corresponding cell membrane characteristically exhibiting several folds thus creating 
a ruffled border. This is followed by the onset of phagocytosis, a local drop in pH 
value creating a favourable environment for the activation o f several released 
enzymes, mainly tartrate-resistant acid phosphatise, leading eventually to the 
degradation o f HA crystals and the enzyme mediated breakdown of collagen(Gay et 
al., 2000; Sommerfeldt and Rubin, 2001). Once the resulting cavity (Howship’s 
lacuna or cutting cone) has reached 60-100 pm in depth the reversal stage 
commences. As the osteoclasts disappear, preosteoblasts differentiate into active 
osteoblasts and a cement, or reversal, line is formed encasing the resorption border 
and aiding the adherence o f the newly formed bone at a later stage (Sambrook et al., 
2001). Subsequently, and with the onset o f the formation phase, the invading 
osteoblasts synthesise the collagenous (primarily collagen Type I) ECM which 
undergoes mineralisation once approximately 20 pm of osteoid has been deposited. 
The combined ECM formation-mineralisation process continues until the appropriate 
volume of bone has been formed and the resting state is finally reached. A bone 
remodelling unit (BRU) is schematically illustrated in Figure 1.5.
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Figure 1.7 Schematic illustration of Bone Remodelling Unit (BRU)
(Sambrook et al., 2001).
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1.6.3 Ligaments and tendons
1.6.3.1 Development
During embryogenesis precursors of tendon and ligament formation appear as 
condensations of mesodermal mesenchyme cells closely adjacent, and inserted into, 
the bone forming hyaline cartilage (Birk and Trelstad, 1986; Wolfman et al., 1997). 
Within these mesenchymal aggregates cell differentiation into fibroblasts occurs and 
collagen fibrils continuously and increasingly form within the extracellular space. 
Fibrillogenesis takes place within extracellular compartments (Birk and Trelstad, 
1986) the formation o f which is regulated by the fibroblasts and can be divided into 
three distinct phases. Firstly, collagen molecules are assembled extracellularly and in 
close proximity to the cell membrane to form immature fibril intermediates. This is 
followed, and during the second phase, by the linear growth of the collagen fibrils 
where collagen intermediates assemble end to end forming the first structurally 
functional fibril units. Finally, and characterising the third phase, lateral fibril growth 
occurs whereby adjacent fibrils are cross-linked through certain enzymatic function, 
particularly that of lysyl oxidase, forming larger fibril bundles that eventually 
coalesce into the collagen fibre units o f the mature tendons and ligaments (Kadler et 
al., 1996; Zhang et al., 2005). Flierarchal arrangement of the structure is also 
established in the embryo as collagen fibrils, fibroblasts and extracellular components 
become arranged in subunits or fascicles.
1.6.3.2 Biochemical and structural properties
Ligaments and tendons are microscopically and morphologically identical however, 
minor biochemical and structural differences are present between the two tissue types. 
Despite studies attempting to estimate collagen weight in tendons reporting variable 
results, it is clear that collagen contribution to the dry weight of the structure is in the 
region of 80%. This is mainly formed by collagen Type I although other types, in 
much smaller amounts, such as types III, V, XII and XIV have also been detected 
(Kadler et al., 1996; Kannus, 2000; Lin et al., 2004; Zhang et al., 2005). Tendons also 
contain 1-2 % elastin, a major constituent o f elastic fibres, and proteoglycans o f which
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decorin is predominant at 1% of the dry mass (Gosline et al., 2002). Water constitutes 
approximately 80% of the wet weight of tendons (Lin et al., 2004). Ligaments contain 
similar amounts of collagen, with Type 1 being also predominant, and water 
contributes to 60 % of the wet weight (Frank, 2004). Ligaments however are more 
active metabolically and contain more cells and higher DNA content than tendons 
(Goh et al., 2003). Noncollagenous proteins can also be traced biochemically in both 
structures and appear to provide a binding function between cells, polypeptide 
macromolecules and various ECM components. Among these fibronectin, 
thrombospondin, tenascin-C, and undulin have been identified (Kannus, 2000). The 
description o f the tendon structural arrangement can be applied to ligament, with a 
slight variation in nomenclature, as the two structures are virtually identical. In 
tendons collagen fibres group together in primary fibre bundles or subfascicles which, 
in turn, form larger secondary fibre bundles identified as fascicles. Fascicles are 
grouped into tertiary bundles, several of which make up the structure of the tendon 
proper (Lin et al., 2004; Zhang et al., 2005). Fibre bundles, of all categories, and 
starting from the subfacicle are enclosed and separated by a connective tissue 
structure, the endotenon, containing the nerve and vascular supply networks (Cook 
and Khan, 2001). Surrounding the tendon, and continuous with the endotenon, is a 
dense collagen fibril network termed the epitenon and the entire structure, in most 
anatomical sites, is enclosed in a loose areolar connective tissue, the paratenon, 
containing types I and II collagen and elastic fibrils(Kannus, 2000). Figure 1.8 
illustrates the hierarchal arrangement o f the various subunits. Collagen fibres are 
preferentially arranged to provide the maximum functional strength and adaptation to 
rotational forces. This is achieved through longitudinal, horizontal and transverse 
crossing of adjacent fibres resulting in the formation of plaits and spirals (Culav et al.,
1999). Depending on the anatomical location and the position within the structure, 
collagen fibres can measure up to 300 pm and exhibit a wavy, or crimped, appearance 
that can be easily distinguished under the microscope as periodic cross-striations or 
bands across the fibre width (Figure 1.9). This pattern provides the elasticity and 
stress resistance in tendons and ligaments and is attributed to proteoglycan cross- 
linking between adjacent areas on the fibre surface. When the structure is stretched in 
response to physical strain collagen fibres become increasingly straight only to return 
to the wavy appearance of the resting state once the tensile load is removed (Kannus, 
2000; Lin et al., 2004).
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Figure 1.8 Schematic of the hierarchal arrangement of the tendon subunits
(a) Epitendon, (b) endotendon, (c) tertiary fibre bundle, (d) Secondary fibre bundle 
(fascicle), (e) Primary fibre bundle (subfascicle) and (f) Collagen fibre.
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Figure 1.9 X128000 Transmission Electron Microscope image of Tendon collagen 
fibrils
Reprinted, Electron Microscopy Centre, Babes Bolyai University, Romania.
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1.6.3.3 The fibroblast, ECM turnover and collagen synthesis
Similar to osteoblasts, fibroblasts originate from the stromal stem cells o f the bone 
marrow following several steps o f differentiation (Baksh et al., 2004) and despite the 
presence o f endothelial and mast cells in the tendon and ligament ECM, fibroblasts 
remain the predominant cell population composing almost 3% o f the dry weight o f the 
structure (Hayem, 2001). These cells are elongated, arranged in longitudinal rows in 
close proximity to collagen fibres and contain spindle-shaped nuclei (Kim et al., 2002; 
Claudepierre and Voisin, 2005). Fibroblasts also exhibit numerous, sheet-like, 
cytoplasmic processes extending into the extracellular space and it has been 
demonstrated that adjacent cells communicate via theses processes, and through the 
presence o f gap junctions, thus forming an elaborate three-dimensional network which 
may potentially act as a coordinator o f cellular and metabolic responses o f the tissue 
(Frank, 2004; Claudepierre and Voisin, 2005; Kjaer et al., 2005). In the normal resting 
state fibroblasts appear quiescent however; certain cellular functions are reactivated as 
the ECM is constantly remodelled in response to physical activity, immobilisation and 
injury (Hayem, 2001). Subjected to in vitro mechanical stretch and cyclic loading, 
fibroblasts have expressed increased DNA transcription levels and up-regulated 
collagen synthesis (Kim et al., 2002; Gough et al., 2003). Fibroblasts are also 
responsible for matrix degradation via the breakdown o f collagen molecules, 
particularly during rapid remodelling as in tissue damage o f inflammation, either via 
intracellular lysosomal phagocytosis or extracellularly by the action o f secreted 
enzymes, the matrix metalloproteinases (MMPs) (Federman et al., 2002). Collagen 
synthesis is preceded by the increase o f  interstitial concentration o f several growth 
factors including FGF, IGF, TGF-f) and several interleukin types (Kjaer, 2004; Kjaer 
et al., 2005). These proteins bind to certain receptors/integrins on the cell membrane 
promoting the transcription o f preprocollagen nuclear DNA sequence into the 
corresponding messenger RNA (mRNA). Subsequently, the polypeptide a-chains o f 
procollagen are translated, by ribosomal action, from the mRNA strands and relocated 
to the endoplasmic reticulum where the assembly o f the triple helix o f collagen 
molecule takes place. This action is mediated by several enzymes such as prolyl-4- 
hydroxylase (P-4-H), and it is well described that P-4-H activity levels increase and 
decrease in correspondence with collagen synthesis rates (Kjaer, 2004; Kjaer et al.,
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2005). Procollagen molecules are then transported into the extracellular space, via the 
Golgi apparatus, where the conversion into fibrillar collagen and fibril assembly is 
conducted. Firstly, The 300 nm long procollagen molecule is modified by the removal 
of two N and C ends propeptides (by the action of N and C-protinases respectively) 
into collagen molecules that spontaneously self-assemble into end-overlapped/ cross- 
striated fibrils. These fibrils are then stabilised by covalent cross linking mediated by 
the enzyme lysyl oxidase (Kadler et al., 1996; Kjaer, 2004; Zhang et al., 2005; Kjaer 
et al., 2005). As in hard tissue, cross linking of adjacent collagen molecules is 
achieved by the presence o f PG-GAG complexes (Section 1.6.2.3). Intracellular 
collagen synthesis is outlined in Figure 1.10.
Figure 1.10 Schematic of the mechanisms involved in collagen Synthesis
(1) Signalling molecule-receptor complex formation and collagen synthesis activation,
(2) collagen gene transcription into mRNA, (3) Ribosomal mRNA transcription into 
polypeptide a-chains, (4) Procollagen molecule assembly and (5) Extracellular 
Procollagen molecule transport. Some elements o f the illustration adopted from 
(Nelson and Cox, 2004).
Growth factors
Mechanical stimuli
| | Cell Membrane 
|  Nucleus 
! |  Ribosomes 
|  Endoplasmic reticulum 
|  Golgi apparatus
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1.6.4 The enthesis: The hard-soft tissue interface
Entheses are the insertions o f tendons, ligaments, joint capsules or fascia into bone. 
Soft tissues attachment to bone occurs via a transitional zone composed o f 
histologically distinct layers and depending on the developmental mechanisms 
involved, this zone may assume a fibrous or fibrocartilaginous nature (Claudepierre 
and Voisin, 2005; Doschak and Zemicke, 2005). Tendons and ligaments attach to 
bone mainly through fibrocartilaginous entheses the development of which is an 
integral part o f the endochondral embryonic bone formation. In a process coinciding 
with ossification o f the hyaline cartilage anlagen, cells within the tendon/ ligament 
matrix undergo differentiation into metaplastic chondrocytes and commence 
fibrocartilage matrix synthesis (Doschak and Zemicke, 2005). By the end o f this 
process, the fibrocartilaginous transition from soft to hard tissue is composed o f the 
continuous arrangement o f four structures; ligament/tendon, fibrocartilage, 
mineralised cartilage and bone (Claudepierre and Voisin, 2005) (Figure 1.11). The 
presence o f chondrocytes is characteristic o f the fibrocartilaginous layer, whereby 
these rounded cells are arranged in pairs or rows within lacunae in the ECM. Also, 
collagen fibres can occasionally be detected penetrating the cartilaginous zone, in the 
form of Sharpey fibres, providing additional direct anchorage of the soft tissue into 
the bone surface (Claudepierre and Voisin, 2005). Biochemical analysis o f the 
fibrocartilaginous ECM revealed collagen Type II to be the predominant component 
largely contributing to the mechanical pressure resistance properties o f the structure 
(Sagarriga Visconti et al., 1996; Claudepierre and Voisin, 2005). The structure o f the 
enthesis is greatly committed to the functional role o f gradually distributing 
mechanical load and shear forces from the tendon/ ligament proper into the bone 
surface, thus minimising the stress on individual collagen fibres (Goh et al., 2003; 
Doschak and Zemicke, 2005). Additionally, the combined mineralised/non­
mineralised nature of this structure provides both, stress concentration stiffness and 
compression stress tolerance (Benjamin et al., 2000; Doschak and Zemicke, 2005).
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Bone
Fibrocartilage
Ligament
Figure 1.11 Histological Sections through an enthesis
Insertion of the vastus lateralis on the greater trochanter. X 100 (Claudepierre and 
Voisin, 2005).
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1.7 Tissue Engineering: Repair through regeneration
1.7.1 Introduction
In 1993 in Science magazine, and possibly for the first time in scientific literature, 
Langer and Vacanti defined tissue engineering research as “an interdisciplinary field 
that applies the principles o f engineering and the life sciences toward the development 
of biological substitutes that restore, maintain or improve tissue function.” This 
definition however, was first used by F. C. Fung of University o f California, San 
Diego in 1985 in a proposal for establishing an engineering research centre submitted 
to the National Science Foundation (NSF) in the USA (Langer and Vacanti, 1993). 
Historically, tissue engineering is deeply rooted in clinical medicine and can be 
related to the emergence of organ transplantation where, and at beginning o f the 20th 
century, the first attempts to replace deficient tissue structures were carried out 
(Toledo-Pereyra and Lopez-Neblina, 2003; Aviles et al., 2004). It was in the last two 
decades however, that tissue engineering was conceptualised and well defined as an 
independent research entity, as a shift from the emphasis on tissue replacement to 
tissue regeneration took place (Hench, 1998). Such a shift was based upon the fact 
that conventional tissue replacement through grafting, although effective, is limited by 
various factors accentuating the need o f developing an alternative approach. An 
approach that combines the use o f biocompatible and bioactive matrices as scaffolds 
guiding or supporting tissue growth; the utilisation o f the host cells as means o f 
synthesising the ECM components; and the application o f several extrinsic signalling 
and biomechanical factors so that the in vivo environment necessary for tissue 
formation can be simulated (Berg, 1992; Braddock et al., 2001).
1.7.2 Conductive tissue regeneration
Through the use of acellular biocompatible material configurations, guided tissue 
regeneration aims at reconstructing the deficient structure and preventing the invasion 
o f non-functional scar tissue (Fujihara et al., 2005). Providing that the appropriate 
morphogenetic factors are delivered to the site, these biocompatible matrices may 
serve firstly as pathways for cell migration from the adjacent, intact and healthy tissue
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towards the void and secondly, as scaffolds providing the biomechanical support for 
new tissue formation, vascularisation and integration into the host body (Burg et al.,
2000). This approach is being assessed extensively, and in conjunction with use of 
grafts, for the surgical treatment o f periodontal disease (Alberto, 2004). Recent 
studies reported on the potential use o f biodegradable copolymers, alginate calcium 
membranes and polymer/calcium phosphate composites as periodontal pocket filling 
and graft supporting constructs as these materials have been shown to support cell 
invasion, proliferation and differentiated function (Hokugo et al., 2004; Fujihara et al.,
2005). Demineralised bovine and porcine matrices, polymer and polymer/ ceramic 
composites were also evaluated as scaffolding systems for the in vivo regeneration of 
large bone defects and have been proven to be reasonably biocompatible and, most 
importantly, possess osteoinductive qualities (Burg et al., 2000). The success of 
guided tissue regeneration, however, remains dependent on the availability o f a viable 
and well vascularised host bed and strongly related to the critical size o f the tissue 
loss as large defects, greater than 4 cm, cannot be regenerated unless combined with a 
grafting procedure (Harakas, 1984; Croteau et al., 1999; Gugala and Gogolewski,
2002).
1.7.3. The inductive approach
Frequently referred to as cell transplantation, the concept o f inductive tissue 
regeneration can be accurately described as bioengineering an autograft. This concept 
evolved around developing a cell/ matrix system as a nucleus for the in vitro 
morphogenesis of tissue (Vacanti et al., 1998). Host cell populations, either 
differentiated or mesenchymal stem cells (MSCs) can be isolated, expanded and 
seeded onto biocompatible and biodegradable scaffold constructs so that matrix 
synthesis mechanisms can be invoked leading, ultimately, to the in vitro formation of 
de novo tissue units. These units can be subsequently transplanted into the area of 
need where integration into the deficient site may occur restoring structure, volume 
and function (Alsberg et al., 2001) (Figure 1.12). Capitalising on this inductive 
strategy, naturally derived and synthetic materials fabricated into three dimensional 
and porous scaffolds have been utilized for bone regeneration. It has been shown, in 
numerous studies, that scaffold invasion by the seeded cells and the ensuing
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mineralised tissue formation can be successfully induced (Bruder and Fox, 1999; 
Laurencin et al., 1999; Holy et al., 2000; Salgado et al., 2004). Bioengineered 
replacement systems for the repair o f tendons and ligaments, in the form o f fibroblast 
seeded collagen matrices and polymer fibre scaffolds, are also the subject of constant 
development (Laurencin et al., 1999; Goh et al., 2003; Cooper et al., 2005).
Patient/ Host Autogenous cell population
Biochemical and 
Biomechanical stimuli
Tissue repair
Cell transplantation 
onto the 
biocompatible 
scaffold
In vitro m orphogenesis
Figure 1.12 The concept of inductive tissue engineering
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1.7.5 The role of extrinsic factors and culture environment
As tissue engineering attempts at recreating the biological mechanisms by which 
tissue formation is induced, it is critical that the relevant in vitro culture environment 
is supplemented with the appropriate growth, regulatory, hormonal and mechanical 
factors. Growth factors play an important role in the formation o f tissue and organs 
during embryogenesis, postnatal growth and tissue remodelling in adulthood. As 
signalling molecules and in response to stimuli, growth factors bind to their receptors 
on the cell membrane influencing various cellular events such as cell adhesion, 
proliferation, migration, differentiation of progenitor cells and regulating protein 
synthesis (Schliephake, 2002; Salgado et al., 2004). In vitro studies investigating the 
role o f transforming growth factor (TGF), epidermal growth factor (EGF), platelet- 
derived growth factor (PDGF), and insulin-like growth factor (IGF) have 
demonstrated that the inclusion o f theses factors enhanced both tendon and ligament 
cell proliferation and collagenous matrix formation (Goh et al., 2003). Likewise and 
in accordance with their involvement in bone formation and maintenance, bone 
morphogenic proteins (BMPs) have been shown to induce in vitro bone formation if 
present in sufficient quantities (Boden, 1999; Burg et al., 2000; Vogelin et al., 2000). 
It has been also reported that BMPs, namely types 13 and 13, are capable o f 
stimulating ligament-like tissue formation in animal models (Goh et al., 2003). 
Similarly, biomechanical forces in influencing cell function and tissue formation must 
be taken into consideration. Sensing and responding to mechanical and shear stresses, 
cells activate adaptive biological processes as tissues undergo remodelling (Braddock 
et al., 2001; Oakes, 2004; Kjaer et al., 2005). It is therefore imperative that in vitro 
tissue regeneration should be conducted in a bioreactor environment capable o f 
delivering, through the application o f cyclic loading and fluid dynamics, the 
appropriate mechanical stimuli (Frangos et al., 1987; Brown, 2000; Botchwey et al., 
2001; Salgado et al., 2004). This environment should also be constructed so that the 
adequate and uniform diffusion o f nutrients, waste and scaffold degradation by­
products can be achieved by implementing a continuous flow culture design 
(Grabowski et al., 1993; Botchwey et al., 2001; Navarro et al., 2001)
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1.7.6 The biocompatible scaffold
1.7.6.1 Introduction
The nature o f scaffold forming material enables the fabrication of matrices of 
appropriate shape and form so that in vitro cell invasion is permitted in a uniform 
manner throughout the entire structure and the efficient delivery o f nutrients, growth 
and regulatory proteins is facilitated (Brekke and Toth, 1998). Mechanically, the 
material must be capable o f withstanding the hydrostatic pressures and mechanical 
loads once implanted into the host and o f a volume, shape and size matching those of 
the structure to be replaced (Salgado et al., 2004; Cooper et al., 2005). The chemical 
and biological properties o f the constituting material however, remain critical for the 
success o f this material in supporting cell function and tissue formation.
1.7.6.2 The concept of biocompatibility
When under consideration for tissue engineering, biocompatibility o f a certain 
material is related to the nature o f reaction this material provokes in both, the seeded 
cells and the recipient host tissue. The scaffold material must support and maintain the 
processes involved in cell attachment, differentiated function and long term synthesis 
o f ECM proteins (Ahmad et al., 1999; Cooper et al., 2005). When implanted into the 
host the scaffold material is considered biocompatible if the following criteria have 
been met (Brekke and Toth, 1998),
•  The material elicits low tissue reaction and limited inflammatory response.
• The material is non-immunogenic as foreign body chronic giant cell reaction, 
and the ensuing implant rejection, must not occur.
• The material is non-toxic.
• The material must be free o f transmissible disease.
• If the material is degradable, the degradation must yield biocompatible by­
products that can be removed by metabolic means.
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1.7.6.3 The in vivo bioactivity
Bioactivity is the ability o f the scaffold material to induce a specific biological 
response at the interface with the host tissue leading to the formation o f a biological 
bond between the material and the adjacent tissue structure (Thompson and Hench,
1998). Bioactivity may also identify the capacity of this material in stimulating cell 
migration towards the scaffold (Burg et al., 2000). The formation o f a bioactive bond 
at the scaffold-tissue interface has been attributed to the deposition, and growth, o f a 
dense mineralised layer composed mainly of nano-scale HA crystals that bind 
strongly to collagen fibres (Hench, 1998). It has been shown that the strength o f 
bioactive bonding, to both hard and soft tissue interfaces, is equal to or greater than 
the binding forces in the normal tissue (Hench, 1998). Bioactivity therefore is vital for 
in vivo integration of the scaffold, and must be evaluated when electing certain 
material for the biocompatible scaffold fabrication.
1.7.6.4 The importance of biodegradability
The total biodegradation o f the scaffold forming material eradicates the problems 
associated with chronic foreign body reaction in the host. In the long term, functional 
dependency on the prosthetic device, fatigue properties and the possible mechanical 
failure o f the material are all gradually decreased, and eventually eliminated, as the 
scaffold degrades (Alsberg et al., 2003; Cooper et al., 2005). It is important however, 
that the material solubility characteristics can be controlled and optimised in a manner 
corresponding to ECM deposition so that a linear relationship is established between 
the rate o f scaffold degradation on one hand, and the pace o f functional tissue 
formation on the other (Alsberg et al., 2003; Salgado et al., 2004).
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1.8 Biomaterials for tissue engineering
1.8.1 Naturally derived polymers
Biopolymer-based cellular systems, whether animal or vegetal in origin, have 
attracted wide interest due to their low immunogenic potential, unlimited source and 
the capacity o f interacting with the host tissue (Salgado et al., 2004). Collagen, 
fibrinogen, chitosan, starch, hyaluronic acid, and poly (hydroxybutyrate) are examples 
o f the many biopolymers currently in use among which, fibrillar collagen is broadly 
considered the material o f choice (Novikova et al., 2003). This material is 
considerably bioactive, can be biochemically formulated so that it approximates the 
host tissue’s collagen type and, through the application of purification techniques, can 
be rendered nonimmunogenic (Cancedda et al., 2003). Collagen is also structurally 
versatile allowing the production o f various scaffold configurations such as 
membranes, fibres and foams (Cancedda et al., 2003). The assessment o f collagen 
scaffolds, as porous foams and fibre meshes, has demonstrated a promising potential 
in supporting bone, ligament and tendon tissue regeneration (Itoh et al., 2001; Goh et 
al., 2003). Despite being considerably bioactive, collagen derived material is low on 
mechanical strength and integrity hence necessitating structural modification, through 
incorporating calcium phosphate for example, to improve the in vivo functional 
resistance (Burg et al., 2000). Also, several issues concerning the risk o f xenogenic 
factor transmission and the long term in vitro stability o f collagen may prove to be 
challenging in relation to tissue engineering (Burg et al., 2000; Lee et al., 2001).
1.8.2 Synthetic polymers
Belonging mainly to the polyester family o f organic compounds, soluble synthetic 
polymers are the most commonly assessed substrates in the biomedical engineering 
filed. Polylactic acid (PLA), polyglycolic acid, (PGA) and copolymers, polylactide- 
co-glycolide (PLAGA) are all derivatives o f the poly (a-hydroxy acids) species and 
their use in human subjects is approved by the FDA (Cooper et al., 2005). This class 
of materials can be moulded into porous and fibre mesh structures that have been 
shown, in several animal models, to be potentially suitable as cell delivery
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biocompatible systems (Burg et al., 2000; Holy et al., 2000; Goh et al., 2003; Cooper 
et al., 2005). Structurally, the suitability o f synthetic polymers as scaffold material is 
undermined by their inherent mechanical weaknesses, and structural reinforcement 
into composites is often a requirement (Mooney et al., 1996). The release o f the a- 
hydroxy carbonic acids degradation products, lactic and glycolic acids in particular, is 
associated with the induction o f an acute toxicity inflammatory reaction in the host 
(Meikle et al., 1994; Martin et al., 1996; Winet and Bao, 1997). This toxicity may also 
negatively influence cell proliferation and function compromising the critically 
important in vivo integration o f the implanted cell/ scaffold complex (van Sliedregt et 
al., 1992; van Sliedregt et al., 1994).
1.8.3 Ceramics and bioactive glasses
Bioceramics have been repeatedly nominated as fulfilling almost all the requirements 
of an ideal implant material. Ceramics are nearly biologically inert, can be fabricated 
into porous structures, can be biodegradable and considerably bioactive (Thompson 
and Hench, 1998). The interest in such materials probably emerged by observing their 
bioactive properties when, and in the 1970s, HA coating of stainless steal orthopaedic 
devices resulted in a significantly enhanced bonding to bone (Ducheyne and Qiu,
1999). Nonetheless, the highly organized crystalline structure, brittle nature and the 
extremely slow in vivo degradation o f HA limit its application as tissue engineering 
scaffold material (Ducheyne and Qiu, 1999; Sikavitsas et al., 2001).This has led to 
incorporating HA with soluble tricalcium phosphate slats (TCP, bone ash) producing 
degradable HA/TCP composites (Verdonschot N et al., 2001; Cancedda et al., 2003). 
Solubility trends of TCP, on the other hand, are potentially unpredictable as rapid 
breakdown of the salt crystals, ensuing osteoclastic activity, may compromise the 
scaffold mechanical integrity and induce cytotoxicity as extracellular concentrations 
o f calcium and phosphate are increased (Salgado et al., 2004). It was not until a new 
generation of material emerged, that the bioactive qualities o f calcium phosphate 
based ceramics were truly incorporated in an appropriate biodegradable setting. This 
class A bioactive, silica based glass material form is based on the SI04-4 building 
block combining structural flexibility with biodegradable properties (Thamaraiselvi 
and Rajeswari, 2004). This glass material is based on the generic form Si0 2 -N a :0 -
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CaO-f^O? and is extremely versatile as modifying the glass structure, by varying the 
contribution of the constituent components, will affect the solubility rates and 
mechanical properties (Hench, 1998). The most commonly evaluated form of silica 
glasses is commercially available Bioglass ®45S5. Bioglass contains 45% Si02 and 
have been shown to induce in vitro bone cells proliferation and function and crucially, 
to bind to collagen in both hard and soft tissues (Hench, 1998; Xynos et al., 2000). 
Due to an extremely brittle nature, the use o f silica based glasses as scaffold material 
in load bearing sites is limited and structure enhancing methods, by incorporating 
polymer matrices, may produce non-soluble composites (Thompson and Hench, 
1998).
1.9 Phosphate based glasses
1.9.1 Chemical and physical characteristics
The phosphate glass species polymeric network is formed around the tetrahedral 
phosphate anion and in the ternary form, Ca0 -Na2 0 -P:0 5 , calcium and sodium oxides 
(CaO and Na2 0  respectively) are added as modifiers (Ahmed et al., 2004b) 
(Figure 1.13). Clear phosphate glasses can be generated at relatively low melting 
points and transition temperatures providing that the phosphorous pentoxide ( P 2 O 5 )  
content is above 40 mol% in the ternary composition (Uo et al., 1998). Solubility 
measurements indicated that the degradation trends o f these glasses are predictably 
stable and, by individually modifying each precursor’s contribution within the glass 
generic form, extremely controllable (Knowles et al., 2001). This flexibility allows the 
creation of specific solubility profiles that may correspond to the in vivo scaffold 
degradation-tissue formation balance. Solubility rates o f these glasses appeared to be 
primarily dependent on the inhibitory effect o f the CaO content as, in several studies, 
increasing the CaO mol percentage resulted in reduced glass solubility (Franks et al., 
2000; Ahmed et al., 2004a; Ahmed et al., 2004b). This phenomenon has been 
attributed to the saturation o f the local environment with the ions released from the 
least soluble glass constituent, CaO in this case. However, a more plausible 
explanation may lie in the fact that the Ca cations can form cross links between 
oxygen atoms in different molecular chains within the glass (Uo et al., 1998).
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Another advantage o f the phosphate glass chemical structure is the ability to 
incorporate various additional elements, to produce more complex quaternary 
compositions, thus further enhancing the physical properties. For example, the 
introduction o f iron oxides to the glass network may lead to more favourable 
solubility trends and mechanical strength (Wen et al., 1998; Franks et al., 2001). 
When the in vivo application is targeted, overcoming the mechanical limitations 
imposed by the glass brittle nature is achievable using phosphate based glasses. With 
the low melting temperature as an aiding factor and through reasonably 
uncomplicated processes, phosphate glasses can be drawn into fibres o f considerable 
tensile strength and flexible physical features so that scaffold systems o f suitable 
shapes and volumes can be constructed (Pahler and Bruckner, 1982; Ahmed et al., 
2004a; Ahmed et al., 2004b). Hence the use o f soluble phosphate based glass fibres, 
doped with various inorganic ions, have been highlighted in several reports as 
reinforcement scaffold material for orthopaedic devices (Choueka et al., 1995; 
Charvet et al., 2000; Navarro et al., 2001).
1.9.2 Bioactivity and biocompatibility
As in vivo scaffolds, phosphate based glasses are expected to exhibit bioactive 
features. The breakdown of these glasses is followed by the release o f Na+ and Ca2+ 
cations which are both implicated, as catalysts, in the cascade o f events leading to the 
formation o f the material-tissue bioactive bonding (Hench, 1998). Salih and co­
workers (Salih et al., 2000)studied the effect exerted by the degradation substrates o f a 
series of ternary glass on the morphology, proliferation and protein synthesis of 
human osteoblastic cell lines and concluded, that the incubation in these substrates 
resulted in no negative impact on cell shape, growth and function. On the contrary, the 
presence o f the substrates stimulated an osteogenic response in the targeted cells as 
expression of several ECM associated proteins was up-regulated (Salih et al., 2000). 
These results were in line with similar experimental studies that attempted to evaluate 
the biocompatibility of binary phosphate-calcium/ sodium glasses as scaffold 
material. Seeded macrophages, as manifested by morphology and cell activity, 
expressed low levels of activation as these glasses provoked limited inflammatory 
responses (Gough et al., 2002). Human osteoblasts adhered to these glasses, and
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exhibited the appropriate functional morphology, in a manner indistinguishable from 
those cells seeded on control surfaces and in the long term, cells were capable o f 
maintaining the expression of proteins directly involved in the ECM synthesis (Gough 
et al., 2002; Gough et al., 2003). In fact, and within 28 days in culture, the formation 
of a collagenous matrix did take place on the glass surface.
O
No
Ca
Figure 1.13 Basic molecular unit of a te rnary  phosphate based glass composition 
(C a0-N a20 -P 20 5)
Atoms: Phosphorous (yellow), Oxygen (blue), Calcium (green) and Sodium (red)
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1.10 Summary: A Glass fibre scaffolding system for the hard-soft 
interface repair
As the conventional strategies aiming to replace defective structures suffer many 
limitations, inductive tissue engineering may present the ideal solution by generating 
autogenic de novo tissue units o f biological, histological and biomechanical properties 
matching those o f the recipient structure. Following injury or disease, clinical 
problems associated with tendons and ligaments are common and the cell-matrix 
tissue regeneration approach can potentially succeed in dealing with such problems. It 
is important to recognize however, that this approach must be applied so that the 
structure is generated at the enthesis level as attempting to fuse hard and soft tissues 
by surgical means is often undermined by inferior integration and in some cases, 
failure. Taking the anatomical architecture o f the entheses into consideration, and in 
order to combine two histologically diverse entities so that an interface can be 
established, and evolve, the constituting cells must be seeded separately on one 
continuous incorporating scaffolding system whereby this continuity will later 
guarantee the establishment o f a functional bond between the two tissue elements. 
Fibre-based matrices are therefore structurally suitable when providing the contiguous 
base for a co-culture cell transplantation strategy. Further to the physical 
configuration, the scaffold structure must be generated from a biocompatible and 
biodegradable material in a manner that guarantees the survival and function o f the 
seeded cells on one hand; and the functional integration into the host tissue on the 
other. Owing to their biocompatibility and structural properties, phosphate based 
glasses have been shown as potentially excellent scaffold material for tissue 
engineering and it is important at this stage, that this potential is further investigated 
and developed towards a primary human cell seeded, fibre-based scaffolding system.
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1.11 Aims of this study
(i) To evaluate the biocompatibility of a range of ternary phosphate based 
glass compositions by investigating the seeded primary human osteoblast 
and fibroblast attachment, morphology, survival and expression o f 
phenotypic protein synthesis so that a base composition can be elected for 
glass fibre production.
(ii) To investigate the need of further enhancing the biocompatibility o f the 
ternary glass form by adding a forth modifier to the glass network; and to 
produce glass fibre scaffolds o f suitable configuration for biocompatibility 
testing.
(iii) To asses the suitability o f glass fibre scaffolds as in supporting osteoblast 
and fibroblast long term survival, population growth and the expression o f 
the differentiated cell function in maintaining both, hard and soft tissues 
ECM.
(iv) To investigate the feasibility of incorporating some of the extrinsic factors 
necessary for tissue formation within the cell-scaffold culture through 
stimulating osteogenesis in the fibre seeded osteoblasts; and the design o f 
an open laminar flow bioreactor to provide nutrient, oxygen and waste 
perfusion to the scaffold culture on the other.
(v) Finally, to produce a co-culture system whereby osteoblasts and fibroblasts 
can be seeded separately on a contiguous fibre arrangement so that the 
hard-soft tissue interface can potentially be generated.
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CHAPTER TWO 
MATERIALS AND METHODS
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2.1 Cell Culture
2.1.1 The in vitro cell culture environment
All cultured cells were maintained in a humidified atmosphere, in 5% CO2 and at 37° 
C. The standard growth medium (GM) used was prepared from Dulbecco’s Modified 
Eagle’s Medium (D-MEM) supplemented with 10% (v/v) fetal calf serum (FCS), 
2mM L-glutamine, 100 U/ml penicillin and 100 pg/ml streptomycin (all from 
Invitrogen, Paisley, UK). Cells were grown in 10 ml o f GM using 80 cm2 cell culture 
flasks (BD Biosciences, Oxford, UK) with gas-permeable caps.
2.1.2 Isolating primary human cells
Human osteoblasts (HOB) were isolated by both enzyme treatment and explant 
culture methods. Alveolar bone fragments were obtained from routine third molar 
extractions at the Eastman Dental Hospital and placed immediately in transport 
medium consisting o f a-Minimal Essential Medium (a-MEM) supplemented with 100 
U/ml penicillin, 100 pg/ml streptomycin, 2 mM L-glutamine, 10% FCS and 25 |ig/ml 
fungizone (all from Invitrogen, Paisley, UK). Bone fragments were cut into small 
pieces (~ 2  mm3) using no. 1 0  surgical blades and washed twice in sterile phosphate 
buffered saline (PBS; Invitrogen) to remove blood cells. The bone pieces were then 
digested using 0.02% (v/v) EDTA (Ethylenediaminetetraacetic acid)-trypsin and 
10,000 IU collagenase (both from Sigma-Aldrich, Poole, Dorset, UK) for 1 h at 37°C 
and the digest was centrifuged, resuspended in GM and incubated in 25 cm2 cell 
culture flasks. For explant culture, bone pieces were placed in 6  wellplates (BD 
Biosciences), incubated in a small volume o f GM and left undisturbed for 7-10 days. 
Cells from confluent digest and the explant cultures were then harvested and pooled 
together to establish the primary cell stock. The osteoblastic characteristics o f these 
cells, by the ability to form mineralised nodules in vitro, were confirmed by Salish 
and co-workers (Salih et al., 2001). In this work, passages 4 and 5 o f HOB cells were 
used (Figure 2.1 A).
Human tendon fibroblasts (HTF) were prepared by direct explant technique (obtained 
by Dr. V. Mudera, Institute o f Orthopaedics & Musculo-Skeletal Science, UCL, UK).
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Briefly, tissue taken from the flexor tendon o f the hand was rinsed twice in PBS and 
cut into pieces (2mm x 2mm x 2mm). These pieces were placed in culture dishes for 2 
h in a dry incubator to facilitate tissue adherence to culture dishes and GM 
subsequently added. Sub-confluent primary cultures were propagated in GM and 
experiments were performed using cells between passages 2 and 4.
Human oral fibroblasts (HOF) were isolated, as above, by direct explant culture of 4 
mm punch biopsies o f the buccal oral mucosa (obtained by Dr. C.R. Irwin, Queen’s 
University Belfast, UK) (Irwin et al., 2002). Passages 14, 15 and 16 were used 
throughout the work.
2.1.3 The MG-63 cell line
MG-63 transfected human osteosarcoma cells were used to conduct initial 
biocompatibility experiments. This cell line was selected as it has been shown to 
possess osteoblastic properties (Clover and Gowen, 1994), and an easy to access stock 
is readily available within the Eastman laboratories.
Figure 2.1 Prim ary cells in culture
Phase contrast light microscope images o f (a), Human craniofacial osteoblasts (HOB, 
X20 objective) and, (b), Human oral Fibroblasts (HOF, X4 objectice).
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2.1.4 Expanding the prim ary cell population
Primary cell populations were expanded via the regular passage of culture. At near 
confluence, GM was aspirated and adherent cells washed once in 5ml of PBS. This 
washing step was carried out to remove any traces of the trypsin inhibitor containing 
FCS. A 2.5 ml volume of Trypsin-EDTA solution (Invitrogen) was added and the 
cells were incubated for lOmin to detach. The enzymatic action was inactivated by 
adding 7.5 ml o f GM and the cell suspension was collected and transferred into a 
15ml tube which was, subsequently, centrifuged at 1000 r/min for 5 min. The 
supernatant was later aspirated; the formed cell pellet disrupted; the cells resuspended 
in 10 ml of fresh GM; and the cell population was split 1:4.
2.1.5 Establishing primary cell stocks
Confluent cell populations were harvested as above however, the cell pellet was 
resuspended in 1 ml freezing medium of FCS containing 10% (v/v) dimethyl 
sulfoxide (DMSO, Sigma-Aldrich). The DMSO acts as a cryoprotectant preventing 
ice formation and ice-crystal cell damage. The cells, in freezing medium, were then 
immediately placed in a 1.5 ml cryovial and cooled gradually in an isopropanol 
container, overnight, to -70° C. The vials were later cryopreserved in liquid nitrogen, 
at approximately -196° C, until required. Cell stocks were resurrected by thawing the 
vial, at 37° C, in a water immediately bath after which, the cell suspension was 
transferred into 10 ml o f pre-warmed GM in a 15 ml tube. The tube was then 
centrifuged as previously described, and the cell pellet resuspended in fresh GM.
2.1.6 Cell seeding considerations
To determine the appropriate cell concentration required for a certain seeding density, 
the suspended cells were counted using a counting chamber (Neubauer 
hemocytometer). The Neubauer hemocytometer 0.1 mm deep and subdivided into 9 
main squares, each of 1 mm' surface area, and covered using a glass coverslip (Figure 
2.2), At least lOpl of the sample was collected and pipetted under the coverslip and 
uniformly spread by capillary action. Using an X4 objective light microscope
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objective, the cells were systematically counted in the 0.0625 mm' unit subdivided 
four primary squares. Cells contacting, or falling within, the lower and right 
boundaries o f the main square were disregarded from the count. The average cell 
number, for the 1 mm' defined chamber volume ( 1  x 0 . 1  = 0 . 1  pi) was determined by 
dividing the total cell number by the number o f counted squares, i.e. 4. This value was 
then multiplied by 1 0 4 so that cell density, in 1 ml of medium, was established.
A
Glass cover mounting
support
Counting chamber 
Glass cover
Cell count 
exclusion lines
Primary square 
1mm
Figure 2.2 The haemocytometer
(a), Top and side views, (B), the counting chamber surface.
Cell seeding density may influence the subsequent cell population behaviour in terms 
of proliferation and colonisation of the biocompatible scaffold (Wiedmann-Al-Ahmad
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et al., 2 0 0 2 ) however, and in this study, the main criterion for adopting certain cell 
seeding density was the limited stock o f primary human cells. Mg-63 cells were 
accordingly seeded on borosilicate coverslips at a density of 5 x 103 cells in 1 ml of 
GM (3.2 xlO ’ cell /cm"), in 24 wellplates, and later investigated for protein synthesis 
(Section 2.7.3). Fluorescence microscopy evaluation 24 h in culture have shown 
positively stained and uniformly distributed population with cells exhibiting well 
spread morphology (Section 3.3.2). The seeding density of 3.2 xlO3 cell /cm2 was 
therefore adopted for all biocompatibility assessment procedures for cells seeded on 
glass discs, fibres and control surfaces. This density was increased ten fold, to 3.2 
xlO4 cell /cm", when conducting qPCR experiments in order increase total RNA 
yields thus improving qPCR efficiency and accuracy. The latter density was also 
adopted when seeding the co-culture configuration, and due to the short life span of 
the live staining assay, to maximize results. In vitro work on glass discs took place in 
24 wellplates (BD Biosciences, Oxford, UK); and on glass fibre scaffolds in 55 mm 
petri dishes (Bibby Sterilin, Staffordshire, UK). All control experiments were 
conducted in 24 wellplates (BD Biosciences; and Orange scientific, Belgium).
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2.2 Preparation of glass substrates
2.2.1 Introduction
At the melting point, the fusion of the crystalline glass forming precursor oxides 
forms a viscous slurry. As temperature increases, the crystal forming molecules 
increasingly vibrate around their solid state positions in the structural network until, 
and at the first order phase transition, a complete breakdown of the crystalline 
structure occurs and the molecules begin to flow. This shift from the solid to the 
liquid state of the matter is reversible if the liquid is gradually cooled to below the 
melting point so that crystal nucleation sties are formed, as viscosity increases, and 
the forming molecules are reorganised in an orderly fashion. This thermodynamic 
transition into the energetically favourable crystalline structure may not occur 
however, if the liquid is rapidly cooled so that low viscosity is maintained as 
temperature decreases thus inhibiting crystallisation. This kinetic transition, a second 
order phase transition, will result in glass formation as an amorphous solid of 
disordered molecular arrangement but with enough cohesion to maintain a rigid 
structure. Glass structural properties, density in particular, are strongly related to the 
temperature at which the transition takes place. At a slower cooling rate, glass 
transition is conducted at a lower temperature and higher viscosity, and a denser glass 
structure is therefore produced (Figure 2.3). Structural properties can be further 
enhanced by cooling the glass at an optimised temperature, and in a uniform manner, 
thereby releasing the internal residual stresses and inducing a minimum energy 
molecular arrangement. This annealing process has been shown to yield less brittle 
glass forms. For phosphate based glasses, and as described in Section 1.9.1, the P2O 5 
content plays a major role in the glass formation through affecting the glass transition 
phase. In this study, and for all glass compositions generated, the P2O 5 content was 
fixed at 50 mol% as attempts to produce glass fibres using a lower content o f P2O5 
resulted in crystallisation and glass formation failure.
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Figure 2.3 Density as a function of tem peratu re in the phases of glass formation
(Gibbs, 1996)
2.2.2 Glass batch calculations
The glasses were annotated in such a way that a glass composition, for example, of 40 
mol % CaO, 1 0  mol % N a :0  and 50 mol % P2O 5 was referred to as (CaO)o.4- 
(Na2 0 )o.r(P:0 5 )o.5 . In order to calculate the weight o f each precursor oxide required 
to produce a particular glass form, the molecular weights of the components produced 
by this precursor were first determined. These values were then divided by the 
precursor’s molecular weight and the component-precursor ratio was established. The 
amount of precursor needed, so that a particular molar contribution by this component 
to the final glass form is achieved, was calculated as follows:
(Component mol fraction x component molecular wt)/ component-precursor ratio
For example, and to produce the ternary (CaO)oj-(Na:0 )o.2-(P2 0 5 )o.5 glass form, 
precursors calcium carbonate (CaCo.^), sodium dihydrogen orthophosphate (NaH2Po4 )
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and phosphorus pentoxide (P;0>) were used. During the glass melting process, the 
batch decomposition reaction o f NaH;Po4 will yield the three components sodium 
oxide (Na;()), phosphorus pentoxide (P:Os) and hydrates as detailed below.
Precursor Released components
2 NaH: Po4 Na:() P;(), 2 H;C)
Molecular w eight g mol 240 62 142 36
C omponent-precursor ratio 0.258 0.59 0.15
The amount o f N all;Po 4 needed so that Na:() contribution to the glass composition 
was 2 0  mol% (0 . 2  mol fraction) therefore was,
(0.2 x 62)/ 0.258 ^ 48 g o f NaH;Po4
It is important to recognize however, that 48 g o f NaH;;Po4 will also contribute to the 
glass composition by approximately 2 0  mol% of P:Osas,
(48 x 0.59)/142 = 0.2 mol fraction o f P:0>
This value must be taken into consideration whereby a 30 mol% based batch 
calculation for the precursor PnCT, and due to NaH:Po4 contribution, is conducted. 
Hence, and as the component-precursor ratio for P;0> is 1, the amount of phosphorus 
pentoxide required was ((0.3 x 142)/ 1) 42.6 g. Similarly, CaCo4 decomposition 
results in the release o f CaO and C 02 as components.
Precursor Released components
CaCo4 CaO C0 2
Molecular weight g/mol 
C omponent-precursor ratio
1 0 0 56 44
0.56 0.44
Accordingly, and for 30 mol% CaO contribution, the amount o f CaCo4 required was 
((0.3 x 56)/0.56) 30 g.
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Similarly, batch calculations for quaternary glasses were conducted with the inclusion 
o f iron oxide (FeT),) as the fourth precursor.
Tables 2.1 and 2.2 detail the ternary, and quaternary, glass compositions generated 
throughout this study and the weights o f the relevant precursors used. It should be 
noted however, and due to the volume capacity of the melting crucible, that the 
w eight values are half o f those established by the batch calculation process.
Table 2.1 Precursor weights for ternary glass production
Precursor weight (g)
Glass code N a H : Po4 CaCo.', P2O5
( C a ( ) ) o H N a :0 )„ :- (P :O s)0 s 24 15 21.3
(C aO )0 ’, - (N a :0 )o  ix-(P205)0.5 21.6 16 22.7
(C aO)o ',4-(Na:0)o k,-(P205)0 5 19.2 17 24.1
(C aO )0 v,-(Na20)o.i4-(P205)0 5 16.8 18 25.9
(C a O )„ 4s-(Na:0 ),,.,: -(P2O5 )o 5 14.5 19 26.9
(CaO)o4-(Na20)o r ( P 205)0.5 12.02 20 28.39
(C aO)o 42- (N a20)o ox-( P 2O5 )o 5 9.61 21 29.81
(C aO )0 44-(Na20)ooo-(P 205)0.5 7.2 22 31.2
(C aO  )o 4o-( N a2 0  )o 04-( P 205)0.5 4.8 23 32.6
(C aO)o.4s-(Na20)o.o2-(P 205)0.5 2.4 24 34.08
Table 2.2 Precursor weights for quaternary glass production
Precursor weight (g
Glass code NafCPcu C aC o .4 Fe204 P2O 5
(CaO)o.4<>-(Na20).v-(Fe203)i-(P205)„.5o 3.6 23 0.8 33.37
(CaO )0.4 6 -( N a 2 0 ): -(F e2 0 3  ):-< P 205 )0 50 2.4 23 1.6 34.08
(C aO )o 40 (N a 2 0 ) |—(Fe203)4—(P205)o 50 1.2 23 2.4 34.8
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2.2.3 Glass disc production
Using an analytical balance and in accordance with the desired composition, glass 
starting materials were weighed and thoroughly homogenised into a mix in a sealable 
plastic envelope as a homogenous precursor mix is critical for successful glass 
production. The precursor mix was then placed into a Pt/10% Rh crucible (Johnson 
Matthey, Hertfordshire, UK) which, in turn, was inserted in a preheated RTF 1500 
furnace (Carbolite, Derbyshire, UK) at +1200° C for 75 min. The molten slurry was 
subsequently poured into a preheated graphite mould and placed in a Dicor furnace 
(Dentsply, Surrey, UK) at + 420° C for 60 min. The graphite mould was then left to 
cool overnight, inside the Dicor furnace, as the glass annealing process took place. 
The resulting 50 mm long glass rod was later cut, using a Testboume diamond saw 
(Testboume Ltd., Hampshire, UK) and water as coolant, into 1.5 x 13 mm discs 
(Figure 2.4) which were polished on a Knuth-rotor 6 X using 1200 grit silicon carbide 
paper (6.5 pm average grain size). All glass discs, and prior to in vitro experimental 
procedures, were sterilised by dry heat at +180° C for 120 min and soaked in cell 
culture medium for 24 hours. The latter procedure was conducted to contain an initial 
surge o f Ca2’ and Na+ ion release and, on the other hand, to allow the precipitation of 
dissolution products on the glass surface leading to more linear solubility patterns 
particularly for the highly soluble compositions (Franks et al., 2000).
Figure 2.4 Class rods and polished glass discs prio r to in vitro assessment
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2.2.4 Glass fibre fabrication
As detailed in Section 2.2.4 and excluding the annealing step, glass compositions 
were produced and the glass melt was poured directly onto a stainless steel plate to 
cool at room temperature (RT). Glass batches were then placed in a Lenton furnace 
incorporated Pt 10% Rh crucible to melt and homogenise, at approximately 1300° C, 
for 60 min. Situated below the furnace, and in close proximity to the crucible, a 
rotating stainless steel drum o f 1 m circumference was used as fibre pulling device 
(Figure 2.5). C onnected to a controller motor, the drum could be spun with precision 
at various rotational speeds thus granting the ability of producing various fibre 
diameters as at higher rotational rates; fibres o f smaller diameters are generated. At a 
certain temperature specific to each composition, within the 1230° C to 1270° C 
range, an appropriate melt viscosity was reached and emerging through a 1 mm 
funnel-like outlet in the crucible base, the slow formation of a glass droplet could be 
observed. Using a pointed-end ceramic rod, a fibre precursor was quickly drawn from 
the droplet onto the rotating drum surface where fibre bundle formation can 
henceforth be seen. The appropriate, temperature controlled, viscosity plays a major 
role during this process as a continuous and regular glass flow is vital for an 
uninterrupted, and successful, fibre production.
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Figure 2.5 The glass fibre rig
(A) The melting furnace, (B) the rotor motor, (C) the fibre drum and (D) The 
rotational velocity control unit.
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2.2.5 Glass fibre scaffold  preparation
The fibre-based scaffolds must be designed so that fibres are arranged in a uniform 
and consistent fashion, thus eliminating the experimental variability related to random 
arrangement o f the scaffold and ensuring, at this stage, that glass composition 
variability is the main investigated biocompatibility factor. This can be achieved if the 
fibres were laid, during production, in a manner that guarantees the presence of 
controllable fixed distances between alternating fibres.
fo r  this purpose, the fibre rig was modified to allow a combined rotary-horizontal 
motion o f the fibre drum. The drum was mounted on a horizontally movable plate 
which was, in turn, connected to a stepper motor via a driving centre shaft (Figure 
2.6). The stepper motor was cyclically controlled, via a sweep-function generator, so 
that at 1 Hz frequency 32 steps per minute were generated and the drum mounting 
plate moved horizontally by 160 mm. The desirable value of the horizontal shift (v), 
in mm and in 1 min, was obtained from the equation,
v~ [(d+s)kj/l()3
Where d is the fibre diameter value (pm); ,s is the desired distance between two 
adjacent fibres (pm); and k is the drum rotational frequency (r/min). Therefore, and 
assuming that at a drum rotational frequency o f 800 r/min the generated fibre diameter 
is 2 0  pm; a desired gap o f 1 0  pm for every revolution can be achieved by a horizontal 
shift value o f ([(20+10)800]/103) 24 mm. Accordingly, the stepper motor frequency 
was adjusted to ((24 x 1)/160) 0.15 Hz. The fibre configuration was carefully 
transferred, using adhesive tape, onto 32x32 mm custom made stainless steel frames 
and fibre ends were fixed using cyanoacrylate glue gel (product 01-06854, Henkel UK 
Ltd., Hertfordshire, UK). To prevent non-fibre associated cell adhesion and 
cyanoacrylate-medium contact, the 4 mm frame edges were coated with cell-repellent 
biocompatible RTV 118 silicone (Techsil Ltd. Warwickshire, UK) which was left to 
set overnight (Figure 2.7). A monolayer mesh and single parallel configurations were 
produced corresponding to bone and ligament tissue architecture respectively. 
Scaffolds were sterilised in 70% aqueous ethanol and immersed in GM for 24h prior 
to seeding.
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Figure 2.6 A schematic illustration of the stepper motor mechanism
(a) The fibre drum, (b) The plate track, (c) Metal bearings, (d) lockable tumbuckle, 
(e) Driving shaft, and (j) Stepper motor.
Figure 2.7 A monolayer mesh glass fibre scaffold
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2.3 Co-culture scaffold system
In order for a continuous scaffold design to accommodate the separate seeding o f two 
cell populations, a barrier configuration must be applied across the fibre arrangement. 
This barrier must prevent the mixing o f the seeding media on either side during the 
time required for cell adhesion. Furthermore, the barrier must be removable so that 
any interference with the culture environment is eliminated. When in contact with an 
absolutely dry fibre arrangement, drop formation o f tissue culture medium can be 
sustained and it has been hypothesised therefore, that a minimum dry separation zone 
may permit the segregated presence o f two liquid drops in close proximity. A 100 pm 
dry space barrier, define by two 1 0 0  pm thickness glass coverslips, was therefore 
applied vertically across the fibre arrangement and fixed to the scaffold frame during 
the RTV 118 silicone application process (Figures 2.8a and b). When assessed for co­
culture purpose, the 300 pm separation supported simultaneous, and separate, drop 
formation on either side.
= 300 um
Figure 2.8 Co-culture scaffold design
(a) the glass-air-glass barrier across the fibre arrangement and , (b) An X20 objective 
microscope light image o f the barrier.
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2.4 G lass fibre characterisation
2.4.1 Solubility measurement
To ensure consistency with the cell culture environment, all solubility tests were 
carried out in GM. 30 mm long fibre bundles o f 100 mg weight were placed in 6  well- 
plates (Orange Scientific), incubated in 5 ml GM to insure consistency with in vitro 
culture conditions and at days 1, 4, 7 and 10 fibres were dried and weighed. The 
medium was replaced at 2  day intervals.
2.4.2 Assessment of fibre diameters
Fibres were embedded in epoxy resin (SpeciFix-20, Struers Ltd., Glasgow, UK) 
blocks via a two-step mounting process. For both steps a resin-curing agent mix (7:1 
weight/weight) was thoroughly stirred for 3 min and left to set for 2 min before use. 
Firstly, fibre bundles were placed in a 3 x 3 x 20 mm PTFE mould, embedded and the 
resin mix left to cure overnight at RT. The fibre bundle was placed in a MultiForm 
mounting cup using supporting clamps, embedded as described above and 30 mm 
cylindrical resin blocks were produced. The block was later cut (Testboume diamond 
saw), perpendicular to the fibre axes, and sequentially polished on a combined 
LaboForce/ LaboPol Modular Preparation System (Struers Ltd.)as follows,
Surface Medium/ Lubricant Force (N) Speed
(r/min)
Duration
(min)
SiC 220 Water 30 300 2
MD-Largo Dp-Susspension, P (9 pM) 25 150 5.5
MD-DAC Dp-Susspension, P (3 pM) 25 150 4.5
MD-NAP Dp-Susspension, P (1 pM) 25 150 1.5
Digital light images o f fibre Sections, at X20 magnification, were acquired and 
diameter values o f 50 fibre Sections were obtained using Image-Pro® Plus 
software4.0 (Media Cybernetics UK, Berkshire, UK); exported into spread sheets; and 
analysed to determine the average fibre diameter.
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2.4.3 Scanning electron m icroscopy
Glass fibres were mounted, in their dry state, on aluminium stubs and coated with 
4nm platinum/palladium (80/20) using a high-resolution sputter coater (Agar 
Scientific, Stansted, UK). Samples were later imaged using a Hitachi S-4700II field 
emission scanning electron microscope (Hitachi High Technologies, Berkshire, UK) 
operated in ultra-high resolution mode at an accelerating voltage o f 1.0kV(Hughes et 
al., 2005).
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2.5 The flow culture system
2.5.1 Introduction
The flow culture system aimed at providing the perfusion o f nutrients, and the 
removal o f waste and glass degradation products throughout the scaffold. Therefore, 
and as simulating the physiological shear stresses are at this stage beyond the scope of 
this work, the near zero shear stress o f 1.56 x 10 3 dyne/ cm2 was adopted as a 
benchmark value (Navarro et al., 2001).
2.5.2 The flow cell
A study by Bakker et al., using particle image velocimetry, has shown that fluid flow 
inside a parallel plate chamber occurs at different hydrodynamic velocity profiles 
where the inlet and outlet conditions, and the chamber design, dictate the overall flow 
stability (Bakker et al., 2003). It has been concluded that in configurations where the 
inlet and outlet are horizontal, and at right angles with the flow plane, stable flow can 
be induced over a larger surface area (Figure 2.9). Stability has also been enhanced 
where a smooth transition between the various parts o f the chamber is present. 
Accordingly, the geometrical characteristics o f  the flow cell were based on a parallel 
plate chamber design by Wan and co-workers (Wan et al., 2003); with an inner width 
o f 35 mm so that the 32 x 32 mm fibre scaffold can be accommodated. This particular 
configuration was adopted in order to provide a central region o f stable fluid flow 
across the cell seeded scaffold. The chamber was fabricated from a 3 mm thick 
rectangular stainless steel plate within which, an irregular hexagonal volume was 
subtracted. The 1 mm inlet and outlet ports were drilled through each side o f the plate 
centrally, and along the long axis. The underside o f the chamber consisted o f a 
permanently fixed clear glass sheet. The top aspect was covered with a removable 
glass cover fixed with a rubber O-ring; and sealed with a 1 mm thick, water tight, 
silicon gasket bringing the total chamber height to 4 mm (Figure 2.10).
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Figure 2.9 Confocal scanning laser microscope image of velocity profiles in a 
flow cham ber
This longitudinal cross Section shows a transition from turbulent to steady flow 
occurring, and starting from the inlet, at approximately 15% of the chambers’ length. 
The assessed chamber was geometrically hexagonal with both, inlet and outlet tubes 
parallel to the flow plane. (Bakker et al., 2003)
Top glass cover 
(Removable)
Bottom
3 mm
Silicone gasket ,_L
“ f
 glass cover
(Fixed)
Inlet (or outlet) tube Flow chamber
72 mm
34 mm
|*—  34 mm
64 mm
Figure 2.10 Com ponents and dimensions of the flow cham ber
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2.5.3 O pen flow  perfusion system
A culture medium reservoir (1380 ml total volume) was prepared by linking two gas- 
permeable 150 cm ' flasks (TPP, Trasadingen, Switzerland) and the CO: supply was 
perfused directly into the medium via a regulator. The fluid flow was induced using 
an IPS-12 multi-speed roller pump (Sotax, Basel, Switzerland) as the medium was 
drawn from the reservoir and passed sequentially through the flow cell, the roller 
pump and into the waste contained Figures 2.11 and 2.12). The flow cell was placed 
in a Shellab 2123-2 incubator and linked to the system via an access port (Figure 
2.13). Based on maintaining a near zero shear stress, the medium flow rate value was 
obtained using the equation (Frangos et al., 1987),
Q= (T x bh2)/6p ml/s
Where T is the shear stress (dyne/ cm2), b and h are the width and height o f the flow 
chamber (cm) respectively and p  is the viscosity o f the medium (0.0075 g/cm/s, at 37° 
C for D-MEM containing 10% FCS ) (Shane Croughan et al., 1988). Therefore, and to 
maintain a shear stress value o f 1.56 x 10'3, the flow rate o f the medium was estimated 
at ([0.00156 x (3.5 x 0.42)]/ 0.045) 19,413 x 10' 3 ml/s. At this value, the flow of 
medium is laminar throughout the chamber thus; the subsequent disruption to cell 
attachment is minimised. Flow characteristics are expressed by the Reynolds number 
(Re) which, at less than 1400 is indicative o f a laminar flow nature. The Re is given 
by (Frangos et al., 1987),
Re = T(h2p /p2)
Where T is the shear stress value, h is height o f  the flow chamber (cm), p  is the 
density o f the medium (1.0045 g/ cm2, at 37° C for D-MEM containing 10% FCS) 
(Shane Croughan et al., 1988) and p  is the viscosity o f the Medium (as above). 
Therefore, an Re value o f (0.00156 [(0.42 x 1.0045)/ 0.00752]) 4.77568 indicates the 
laminar nature o f the flow. The flow chamber and medium reservoir were sterilised by 
exposure to UV light, over night, and the flow tubing system was sterilised by 
sequentially injecting 70% ethanol, whilst the pump was operational, followed by
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flushing with sterile PBS. Glass fibre scaffolds were loaded, inside the cell culture 
(laminar flow) hood, into the flow chamber which was, in turn, covered and linked to 
the flow circuit inside the incubator. Samples were later processed so that the medium 
flow effect on gene regulation was assessed using quantitative polymerase chain 
reaction (qPCR).
Figure 2.11 The open flow culture system
(A) Roller pump, (B) Medium reservoir, (C) C 02  Regulator, (D) C 02 supply, and 
(E) Waste container.
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Waste
CO2 supply
Figure 2.12 The open flow culture system unit configuration
Following flow direction: CO: supply, (a) CO: regulator, (b) Medium reservoir, (c) 
Incubator, (d) Flow chamber, (e) Roller pump, and waste outlet.
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Figure 2.13 The flow chamber-scaffold arrangem ent inside the incubator
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2.6 Cell viability  assessm ent
2.6.1 Introduction
The viability o f the seeded cell is a major indicator o f the scaffold biocompatibility. 
Cell survival and proliferation were therefore assessed, on glass discs and fibres, 
using various techniques with the main variants being glass composition, fibre 
diameter and time in culture.
2.6.2 Scanning Electron Microscopy
MG63 cells were seeded on glass discs o f various compositions and the scaffold 
cultures were fixed, after 24 hours in culture, using 3% glutaraldehyde (Agar 
Scientific Ltd., Essex, UK) in 0 .1M sodium cacodylate buffer (Agar Scientific Ltd.)at 
+4° C overnight. Specimens were later sequentially dehydrated in 20%, 50%, 70%, 
90% and 100% ethanol then critical point dried for 5 min following the application of 
hexamethyldisilazane (Taab Laboratories Ltd., Berkshire, UK). Discs were mounted, 
placed in a Polaron E5 100 sputter coater (Quorum Technologies, East Sussex, UK) 
and coated with gold-palladium. Images were obtained using a Stereoscan 90B 
electron microscope (Cambridge Instruments Ltd., Cambridge, UK).
2.6.3 The CyQUANT cell viability kit
2.6.3.1 Introduction
Using the CyQuant cell proliferation assay kit (Molecular Probes Europe BV, Leiden, 
The Netherlands), cellular nucleic acids are labelled with green fluorescein dye which, 
when excited, emits at an intensity directly related to the number o f cells present. The 
unsymmetrical cyanine fluorescent CyQUANT GR dye (Ex/Em, 480/520 nm) can be 
detected, and depending on the cell type, in as little as 10-50 cells.
2.63.2  A ssay preparation
Glass discs o f various compositions were placed in 24-well sterile Optiplates 
(PerkinElmer Life Sciences, Cambridge, UK).Only 1 ml o f GM was used per well and 
the medium changed at 1-2 day intervals. The generic configuration of the disc-well 
arrangement is illustrated in Figure 2.14. At the appropriate time points (Section 
3.2.1), GM was gently aspirated and the cells were washed once in 500 pi PBS to 
remove non-adherent cells and any traces o f phenol red that may interfere with the 
GR dye detection. The PBS was, in turn, aspirated and the Optiplates were stored at - 
70° C for at least 1 week to enhance the efficiency of the cell lysis buffer. This may be 
attributed to fracture formation between the two lipid layers o f the cytoplasmic 
membrane, during the freezing process, lading to increased membrane permeability 
(Wolfe and Bryant, 1999). To perform the quantitative assay, the CyQUANT reagent 
was prepared in distilled water (dFLO) by firstly adding the cell lysis buffer (1:20), 
then the CyQUANT GR stock solution (1 :400). The cells were allowed to thaw, and 
each well was incubated in 300 pi o f the reagent, protected from light, for 2-5 min at 
RT.
2.6.3.3 Fluorescent evaluation of cell density
The Optiplates were placed in a Fluroskan Ascent plate reader (Labsystems, Helsinki, 
Finland) and emitting florescent values obtained, and interpreted, using the Ascent 
software. Based on the optiplate measurements, the number of wells and the well 
diameter; a template was firstly created and loaded via the plate setup process. The 
fluorescence exposure area, within each well, was then defined by nine central points. 
A new step was next created and the preset excitation and emission values, 
approximating those o f the GR dye, were elected (458 and 510 nm respectively). The 
plate was finally loaded into the plate reader (using the Fluroskan plate loader), and 
emission rates were sequentially obtained from wells and exported into spread sheets. 
It has been noticed however, that the background fluorescence values obtained for the 
negative (blank) controls varied for each well plate (assessed for fluorescence 
intensity at each time point). Accordingly, and in order to compare the data obtained 
from various well plates, percent normalisation was performed (De Luca et al., 1997;
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Lemkin et al., 1999). The average negative control value for each well plate was first 
calculated, and these values were later normalized to the lowest control value and 
differences, as percentage increase or decrease, were obtained and applied to the 
corresponding positive value readings.
<i Substrate com positional variability o
1 2 3 4 5 6
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N egative controls 
n o n -seed ed  substrates
Figure 2.14 Generic configuration o f glass discs for CyQUANT cell viability 
assay
2.6.4 Direct cell count
Glass fibre scaffold seeded cells were fixed at several time points in 70% ice cold 
methanol, nuclear DNA stained with 1:1000 concentration o f propidium iodide 
(Ex/Em, 493/630 nm, Sigma-Aldrich) in PBS for 30 minutes. Samples were then 
sandwiched between two 24 x 24 mm glass coverslips in Citifluor mounting medium 
(Section 2.7.4). The nuclei were later visualised under the Leica DMIRB microscope 
where a minimum o f 200 nuclei were directly counted(Mancini et al., 1997; 
Haverstick et al., 2000; Gabriella, V et al., 2000), at X20 magnification, in adjacent 
microscopic fields and the average cell number per field was established.
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2.7 Fluorescence Immunocytochemistry
2.7.1 Introduction
Cytoplasmic proteins can be localised, and visualised, through the application o f 
fluorescent staining. These proteins can be labelled with fluorescent dyes 
(fluorochromes) by exploiting antibody-antigen binding. Using a fluorescent 
microscope, fluorochromes can then be excited at a certain wave length and an image 
is formed by the emitted light at a certain, longer, wave length.
2.7.1.2 The function and structure of antibodies
Antibodies are immunoglobulins that are naturally produced, as part of the immune 
response, against invading pathogens (antigens) by immunoglobulin-producing B- 
lymphocytes. By injecting an animal with an antigen, several antibodies (clones) are 
produced which are capable o f binding, with variable degrees of strength (affinity), to 
the multiple molecular binding sites (epitopes) o f the antigen. The immunoglobulin 
molecular structure consists o f two identical light polypeptide chains and two 
identical heavy polypeptide chains linked together via disulphide bonds (Figure 2.15). 
The antigen domain binding region o f the antibody (fragment antigen binding, Fab), 
o f 110-130 amino acids, is hypervariable thus corresponding to the diversity and 
specificity o f the immunoglobulin-antigen interaction. Composed o f the heavy chains, 
the other major component o f the antigen is the constant Fc domain. This domain is 
antigenic in nature and responsible for compliment activation and the binding of, for 
example, natural killer cells and neutrophils to the antigen. Most o f the antibodies 
used in biochemical assays belong to the immunoglobulin G (IgG) class and are used 
in both polyclonal and monoclonal forms. In the polyclonal form, a mixture o f the 
various clones o f the antibody is introduced binding, competitively, to several 
epitopes in the antigen. A more intense signal can therefore be obtained, however, 
with an increased potential for non-specific binding. Monoclonal antibodies on the 
other hand, are single immunoglobulin species produced specifically against single 
antigen epitopes. The use o f monoclonal antibodies therefore greatly reduces 
background staining. This use, nonetheless, is sometimes associated with cross
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reaction as the variable domain may bind to similar amino acid sequences on various 
antigens.
2.7.1.3 Immunocytochemical assay formats
In direct fluorescent labelling, the fluorochrome is covalently linked (conjugated) to 
the antibody which will then bind to its respective protein domain (Figure 2.16A). 
This method is often used as a rapid procedure and where great specificity, as non­
conjugated antibody binding may occur, is not a major requirement. Indirect labelling 
is based on the capacity o f the Fc fragment o f the antibody to act as an antigen. 
Antibodies against a certain protein are produced in an animal, a mouse for example, 
and later introduced to a second species where secondary antibody formation, a goat- 
anti-mouse antibody for example, is induced. The secondary antibody is then 
conjugated to a fluorochrome so that a two-step immunolabelling can take place 
(Figure 2.16B). Using this method can significantly increase specificity as primary 
antibodies can be use in low dilutions and a strong fluorescent signal can be obtained, 
at a later stage, by the abundant application o f the secondary conjugated antibody.
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Figure 2.15 A schematic illustration of the antibody structure
The heavy chains are in blue and the light chains in red. (Nelson and Cox, 2004)
B
□  Fluorochrome
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Figure 2.16 Im m unocytochemical assay form ats
A, Direct fluorescent immunolabelling and B, indirect fluorescent immunolabelling
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2.7.2 Preparation o f control surfaces
To maximise cell adhesion to control surfaces, the 13mm diameter borosilicate glass 
coverslips (BDH, UK) were coated with poly-l-lysine. The presence of this positively 
charged polymer has been shown to greatly enhance cell adhesion due to the strong 
interaction with the cell membrane anionic groups. The cover slips were soaked in 
70% ethanol for 24 h to remove contaminants then, placed in glass petri dishes 
(Pyrex) and tissue culture grade water, sterilised using dry heat at 200° C for 2h. Next, 
the coverslips were placed sterile plastic petri dishes, incubated in 0 .0 1 % high 
molecular weight poly-l-lysine (Sigma-Aldrich) and agitated on a shaker for 3 h. 
Subsequently, coverslips were washed with dfUO overnight, on a shaker, and air- 
dried in the tissue culture hood before use.
2.7.3 Fluorescent Immunolabelling of ECM turnover associated 
proteins
Prior to sample processing, HOB, HOF and HTF cells were incubated for 24 h in 1 
pM monensin sodium salt (Sigma-Aldrich) to slow their metabolic rate and prevent 
the glycosylation o f bone associated proteins. Monensin induces an increase o f 
intracellular Ca:+ and subsequently inhibiting the terminal glycosylation of proteins 
(Mollenhauer et al., 1990). Consequently, these glycoproteins were accumulated in 
the cytoplasm to enhance their immunolocalisation.
This was conducted following the use o f MG-63 cells as a model to investigate the 
effect o f supplementing GM with monensin sodium salt on protein accumulation 
within the cytoplasm. MG-63 cells were seeded on the poly-l-lysine treated control 
surfaces and incubated in GM containing 1 pM monensin sodium salt (Thomas et al., 
2001). At 24 h in culture, immediately following medium removal, the cells were 
fixed in 100% ice-cold methanol for 10 min. The samples were then washed 3 times 
in PBS and treated with 0.25% Triton-XlOO (Sigma-Aldrich) for 10 min to further 
permeabilise the cell membrane, reduce non-specific antibody binding and reduce the 
samples’ surface tension. Following a second triple wash with PBS, and to increase 
the immunolabelling specificity, secondary antibody non-specific binding was 
blocked incubating the samples in 10% denatured donkey serum albumin (Serotec,
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Oxford, UK) in PBS for 30 min. The primary polyclonal antibody against osteonectin 
(ON) (1:100; all gift o f Dr. L. Fisher, N1H, Bethesda, USA) (Fisher et al., 1995) was 
then applied, immediately after removing the PBS-donkey serum albumin solution, 
for 60 min. This was followed by the application o f the secondary, FITC (Ex/Em, 
480/530 nm)-conjugated, donkey anti-rabbit IgG (1:200, Jackson ImmunoResearch 
Laboratories, Inc., West Grove, PA, USA) for 30 min. The same experimental 
procedure was carried out using GM only (monensin sodium salt free) to incubate 
MG-63 cells. As an early marker for osteoblastic activity, ON synthesis is likely to be 
detected at an early time point (Dhore et al., 2001).
HOB cells seeded onto phosphate glass discs and control coverslips were fixed, 
treated exactly as above and labelled for primary polyclonal antibodies against bone 
sialoprotein (BSP), ON and osteopontin (OP) (1:100; gift o f Dr. L. Fisher, NIH, 
Bethesda, USA) (Fisher et al., 1995) were applied for 60 min, whilst the negative 
control cells were incubated only in 10% denatured FCS in PBS. This was followed 
by the secondary labelling with FITC-conjugated, donkey anti-rabbit IgG.
HOF and HTF cell seeded samples were similarly treated however, primary labelling 
was conducted using mouse monoclonal anti-P-4-H (prolyl-4-hydroxylase) antibody 
(IgG 1, clone 5B5, 1:50; Dako Ltd., Cambridge, UK) whilst negative control cells 
were incubated in a 1:50 dilution o f mouse IgGl (Negative control, Dako Ltd. ) for 
the same period o f time. Cells were subsequently incubated in 1:200 dilution o f FITC- 
conjugated monoclonal donkey anti-mouse IgG (Jackson ImmunoResearch 
Laboratories). All immunocytochemistry reagents were applied in 50 pi volume 
aliquots using P200 pipette tips.
For all samples, DNA binding DAPI (Sigma-Aldrich) at 1:1000 dilution was included 
in the secondary staining procedure in order to visualise the nuclei. Glass disc samples 
were finally washed in PBS, and prepared for microscopic viewing by mounting the 
cell seeded surface, o f both sample and controls, on 22 x 40 mm rectangular glass 
slides using AF2 antifadent aqueous glycerol solution (Citifluor Ltd., London, UK).
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2.7.4 Fluorescent Immunolabelling of the cytoskeleton
To visualise and detect any cell morphology changes in relation to the phosphate glass 
substrates, the vimentin intermediate filament network was directly labelled with a 
fluorescent dye. At the appropriate time points the medium was aspirated and cells 
seeded on glass discs, and fibres, were fixed in 1 0 0 % ice cold methanol for lOmin. 
Samples were washed 3 times in PBS and incubated in 1:300 dilution of Cy3 (Ex/ 
Em, 530/590 nm)-conjugated mouse monoclonal anti-vimentin antibody (IgGl, clone 
V9, Sigma-Aldrich) for 30 min. A 1:1000 dilution DAPI solution was also included in 
the labelling step. All immunocytochemistry reagents were applied in 50 pi volume 
aliquots directly onto the disc samples whilst fibre scaffolds were treated with 300 pi 
reagent volume inside the petri dishes. Finally, the samples were washed and glass 
discs were mounted as described in Section 2.7.3 for microscopic assessment. Fibre 
scaffolds, on the other hand, were sandwiched between two 25 x 25 mm square 
coverslips in the AF2 aqueous mountant.
2.8 The CellTracker™ assay: Co-culture assessment
In order to observe migration patterns and morphology for both HOB and HOF cell 
populations, separately and over a period o f time in culture, HOF cells were labelled 
with chloromethyl derivative reagent. The CellTracker green CMFDA probes (5- 
chloromethylfluorescein diacetate, Invitrogen) diffuse freely across the cell membrane 
and bind, through the chloromethyl group, to thiols on proteins or peptides thus 
becoming cell membrane-impermeant. Within 24 hours o f loading into the cell and 
through the action o f esterases, the acitate group is cleaved off releasing the 
fluorescent product (Ex/Em, 492/517 nm) (Boleti et al., 2000; Evans et al., 2003). 
These fluorescent properties are transferred through cell division and can be clearly 
detected, in culture, up to 72 h post incubation. As described in Section 4.3.5, a 
working concentration o f 10 pM has been established as optimal when staining 
control surface seeded HOF cells.
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2.8.1 C o-culture cell population identification
As a dry fibre arrangement is critical for the success o f drop culture, fibre scaffolds 
were sterilised overnight under UV light. HOF cells were incubated in suspension at 
37°C in pre-warmed, serum free, GM containing 10 pM of CMFDA dye for 45 min. 
The CMFDA medium was then replaced with fresh GM and the cells were carefully 
seeded, using a P I000 pipette tip, in a 250 pi drop culture on one side o f the glass 
barrier. HOB cells were subsequently seeded on the opposite side and the 
configuration was incubated for 3 h to allow cell attachment to take place. The 
scaffold was then gently washed twice in GM to remove any non-adherent cells and 
all traces o f CMFDA, 5 ml o f  GM added, and the barrier carefully removed using 
sterile disposable surgical scalpels and the culture re-incubated. At the desired time 
points, the medium was aspirated and the cells fixed in 1 0 0 % ice cold methanol for 1 0  
min. Subsequently, cells were washed twice in PBS and labelled using the combined 
anti vimentin-DAPI process as previously described. Finally, the mounting process in 
Citifluor was applied and the dual population seeded scaffold was assessed under the 
fluorescent microscope.
2.9 Fluorescence microscopy
Using a Leica DM-IRB inverted microscope (Leica Microsystems UK Ltd., 
Buckinghamshire, UK), a Hg' lamp generated epifluorescent light induces the 
fluorescence o f the antibody-conjugated fluorochromes. When a sample is excited, 
only the light emitting at a certain wave length (corresponding to the investigated 
fluorochromes’ emission wave length, e.g. 530 nm for FITC) is allowed to pass 
through the objective, through an emission filter, to form an image (Figure 2.17). As 
emission filters o f various spectra can be used, when viewing the same sample, 
images o f several cell components can be composed as their labelling fluorochromes 
can be individually excited and captured. Images were captured via a CoHu CCD 
camera; through a Matrox Meteor-II monochrome frame grabber (Matrox Europe 
Ltd., Bucks, UK); and the Leica FW4000 software was used for digital image 
acquisition and pseudo colour application. Images o f the various fluorochrome species 
o f the sample were then composed using the Leica FW4000 software.
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To ensure consistency, negative control cells were excited at the same fluorescence 
intensity used to detect positive staining.
M icroscope
objective Sample
Excitation filter
Fluorescent light 
source
Emission filter
To capture device
Dichroic mirror
Figure 2.17 Excitation and emission light control in a fluorescent microscope
9 8
2.10 Q uantitative polym erase chain reaction
2.10.1 Introduction: mRNA synthesis and function specific gene 
regulation
The committed function o f the differentiated cell is expressed and maintained by 
protein synthesis. When the production o f a certain protein is activated, its template 
DNA strands are transcribed into complementary (primary transcript) RNA chains in 
the nucleus by RNA polymerase. These RNA chains are processed into functional 
messenger RNA (mRNA) that will later encode the polypeptide chains of the protein. 
mRNA is transported into the cytoplasm where, by ribosomal action, the four base 
code o f mRNA is decoded (translated) into protein forming amino acids (Figure 2.18). 
This process is controlled so that when higher levels o f protein synthesis are required, 
the corresponding mRNA transcription rate is up-regulated. By assessing the 
transcription rate, through quantifying mRNA yields, the presence and intensity of a 
certain differentiated cellular function can be determined.
Growing 
protein chain
G e n e  mRNA
copying 
DNA in 
Nucleus
mRNA
NUCLEUS
Amino
acids
^  j c r
Free amino acids
—o —
tRNA transferring 
an amino acid 
ribosome
mRNA
Ribosom e incorporating 
amino acids into the 
growing protein chain
CYTOPLASM
Figure 2.18 Gene transcrip tion , mRNA synthesis and translation
The “central dogma” o f molecular genetics: DNA codes for RNA and RNA codes for 
protein. The DNA to RNA step is transcription, and the RNA to protein step is 
translation. Modified, Primer on Molecular Genetics, DOE Human Genome Program, 
U.S.A Department o f Energy, 1992.
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2.10.2 Quantitative Polymerase Chain Reaction (qPCR): an overview
The transcription o f a certain gene can be detected, and evaluated, by processing the 
resulting mRNA. When total RNA strands are extracted form the cell, complementary 
DNA copies (cDNA) maintaining the gene specific structure can be made (Figure 
2.19.A). This cDNA can be then amplified into a detectable level using the 
Polymerase Chain Reaction (PCR) process. Heated to 95° C, the double-helix cDNA 
molecule is first denatured (melted) into two single strands. Next, and by lowering the 
temperature to 50-60°C, a synthetic oligonucleotide sequence (primer) 
complementary to the cDNA, and therefore the mRNA, sequence of interest is 
hybridized. The primers then act as starting sites for the extension of 
deoxynucleotides (dNTPs) bases and a double-stranded cDNA molecule is 
recompiled. Nucleotide annealing is induced by the presence o f a temperature- 
resistant enzyme, Taq polymerase, and by increasing the temperature to an optimal 72 
°C. Repeating this cycle o f heating and cooling will lead to the exponential 
amplification o f cDNA as with each cycle repeat, the primer associated nucleotide 
sequences are doubled (Figure 2.19B). As a quantitative relationship is present 
between the amount o f the starting target sequence and amount o f PCR product at any 
given cycle, highly transcribed mRNA sequences amplification profiles can be 
detected at earlier cycles. This is achieved by real time monitoring o f the 
amplification progress through the inclusion o f fluorogenic probes in the PCR reagent 
where these probes, and during the strand extension process, release a fluorescent 
reporter dye fragment (FAM, 6 -Carboxyfluorescein) every time a new cDNA strand is 
synthesized (Figure 2.20). Gene regulation therefore, as an indicator o f differentiation, 
can be monitored and most importantly, the regulation trend at different time points 
and under various culture conditions can be established by plotting against the 
constant expression o f house keeping genes.
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Figure 2.18 (A), cDNA synthesis from mRNA and (B), cDNA PCR amplification
(Lodish et al., 2004)
101
P olym erisa tion
F O RW A RD
PRIM ER
R E V E R S E
PR IM ER
Strand d isp la cem en t
f ___ *
Two fluorescent dyes, a reporter 
(R) and a quencher (Q), are 
attached to the 5' and 3' ends o f a 
TaqM an® probe.
When both dyes are attached to 
the probe, reporter dye emission is 
quenched.
C le a v a g e
®L
A
P olym erisation  co m p leted
,._A
During each extension cycle, the 
Taq DNA polymerase cleaves the 
reporter dye from the probe.
Once separated from the 
quencher, the reporter dye emits 
its characteristic fluorescence.
Figure 2.20 The TaqM an®  probe function during  PCR
Modified, User Bulletin #2, ABI PRISM 7700 Sequence Detection System, Applied 
Biosystems, 2001.
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2.10.3 Total RNA extraction
The RNeasy Mini Kit (Qiagen Ltd., W Sussex, UK) was used to extract total RNA 
from Cells grown on glass fibres, and in the control 24 wellplates (Orange scientific, 
Belgium). The procedure was conducted according to the manufacturers' instructions 
as follows:
• Prior to use, the RTF cell lysis buffer was supplemented with (3- 
Mercaptoethanol ((3-ML) atl:100 (v v) concentration. Similarly, one volume 
of P R f buffer was diluted in four volumes of near pure (99%) ethanol.
• At the desired time points, adherent cells from each sample were lysed directly 
using 350 pi o f RUT buffer; the lysate collected with a P I000 pipette tip; and 
placed in a 1.5ml microfuge tube.
• In order to reduce viscosity, and to increase RNA yields, the lysate was passed 
1 0  times through a 2 0 -gauge needle fitted to a syringe to homogenise.
• 350 pi o f 70% ethanol (in molecular biology grade, nuclease-free FUO) was 
then added to the lysate and mixed thoroughly by pipetting.
• The 700 pi mixture was transferred into the RNeasy mini column and placed 
in a 2  ml collection tube and centrifuged, at 1 0 0 0 0  r/ min, for 15 sec.
• The collection tube was reused and 700 pi RW1 buffer (700 pi) were added to 
the mini column and subsequently centrifuged, at 1 0 0 0 0  r/ min, for 15 sec.
• The collection tube was replaced and RPE buffer (500 pi) was added and the 
mini column was centrifuged, at 1 0 0 0 0  r/ min, for 15 sec.
• The latter step was repeated however, the mini column containing collection 
tube was centrifuged for 2 min.
• The RNeasy mini column was finally placed in a 1.5ml collection tube, 30 pi 
o f RNase-free FUO added and centrifuged at 10000 r/ min, for 1 min.
• The eluant containing tube was then labelled, and stored at -70°C until 
required.
Prior to cDNA preparation, all RNA samples were verified for purity (RNA quality) 
as RNA may undergo contamination related degradation. RNA quality was assessed 
using Ultrospec 2000 UV spectrophotometer (Pharmacia Biotech, Cambridge, UK) 
where the spectrophotometer was firstly calibrated using a blank cuvette loaded with
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dH ;0 . Subsequently, RNA samples were loaded (1:100 in dhhO) and assessed for 
quality by measuring the sample UV absorbance ratio at 260 and 280 nm wave 
lengths and the OD260/280 (optical density) ratio was obtained. OD260/280 is the 
ratio o f absorbance for nucleic acid (260nm) to protein (280nm) and is a measure of 
protein contamination. RNA samples were considered to be of acceptable quality to 
perform qPCR When 01)260/280 was > 1.8(Xinmin et al., 2005).
To reduce contamination, qPCR related sample handling and processing were 
performed using PCR clean pipette tips (Fisher Scientific, Leicestershire, UK).
2.10.4 Preparation of cDNA
The extracted RNA was converted via reverse transcription (RT), using the High 
Capacity cDNA Archive kit (Applied Biosystems, Cheshire, UK), into single-stranded 
cDNA. The 2X RT master mix was prepared so that a similar volume of the RNA 
elute could be treated. Accordingly, and for 30 pi of RNA solution, the RT master 
mix components were mixed at the follow ing volumes,
10X Reverse Transcription Buffer 6  pi
25X dNTPs 2.4 pi
10X random primers 6  pi
MultiScribe™ Reverse Transcriptase 3 pi
Nuclease-free H 20 1 2 . 6  pi
The master mix was prepared in 0.2 ml microfuge tube and the RNA solution was 
later added and pipetted twice to mix. The tubes were then placed in an Eppendorf 
thermal cycler (Mastercycler, Eppendorf UK Ltd., Cambridge, UK) and the RT 
reaction conducted at 25°C for 10 min, then at 37°C for 120 min. cDNA tubes were 
later stored at -70° for further analysis.
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2.10.5 Relative quantification o f gene expression and regulation
The qPCR assay took place using Optical 96-Well Reaction Plates (Applied 
Biosystems) at 25 pi per-well reaction volume. This volume was prepared by mixing 
2.5 pi o f the cDNA solution with various reagents as outlined below.
TaqMan Universal PCR Master Mix (2X) 12.5 pi
20X Assays-on-Demand™ Gene Expression 
Assay Mix (containing: TaqMan® probe; 
foreward and reverse primers)
1.25 pi
Nuclease-free 1UO 8.75 pi
The mix was then transferred into the 96-well reaction where three aliquots of each 
sample were processed (Figure 2.21). An endogenous control reaction, for the house­
keeping rRNA (ribosomal RNA)-encoding 18S gene, was included in every well-plate 
so that relative quantification o f gene expression, among various plates, can be 
performed. Consequently, TaqMan® probes for 18S were designated as an 
endogenous control during the plate setup process. The TaqMan® probes used to 
label the investigated genes cDNA are detailed in Section 5.2.3.
An example of the generic assay design adopted, assuming that four gene expression 
trends were to be quantified, is illustrated in Figure 2.21. The plates were loaded into 
the ABI PRISM® 7300 Sequence Detection System (Applied Biosystems) and cDNA 
amplification was conducted through 40 thermal cycles; at an assay volume of 25 pi. 
Relative quantification (RQ) took place using the 7300 SDS software whereby 
various plates, either time point or glass-composition related or both, were added to 
the RQ study. cDNA amplification curves for all target genes were normalised 
against the endogenous control expression o f 18S. This Comparative Ci method was 
automatically preformed using the 7300 SDS software.
Firstly, the Baseline value (the average background fluorescence value detected at the 
early cycles) across the entire reaction plate was determined. Secondly, the Threshold 
representing the statistically significant numerical point above the Baseline value was 
calculated for the entire reaction plate. Finally, and for each sample well (target and 
endogenous), the C| (Threshold Cycle) value where the florescence value for each
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sample crosses the Threshold was obtained. Conducting Comparative Cj, the amount 
o f target, normalised to the endogenous control was given by the equation,
r .Y \ ( 'l
This equation was derived by determining the Threshold number ( X | )  for each target 
gene using the target C | value. A Threshold number (R| ) for the endogenous control 
was similarly obtained. X|  was then divided by R] was to produce a constant value 
(K) which was used in the equation,
X N = K x (1 + H) AC 1
Where X \  is the normalized amount o f target, A ( 1 is the difference between the target 
and endogenous control C i values and E is the efficiency of probe cleavage. A 
calibrator (cb) sample was chosen against which all target amounts were compared 
thus,
X N/ X Nxb = K x (1 + E) A(' 7  K x (1 + E) ACl ch = (1 + E) AACI
Where X Ncb is the normalized amount o f the calibrator. According to Applied 
Biosystems, the efficiency o f probe cleavage (E) for TaqMan® probes can be 
considered to be equal to one ( 1 ) therefore, the amount o f target normalised to the 
endogenous control and relative to the calibrator was 2 ~AAt'.
To compare several well plates in a RQ study, the endogenous control fluorescence 
values were normalised first then the target gene values were normalised, in turn, to 
their corresponding endogenous control. The normalised amount for each target was 
obtained as an RQ (relative quantification) value.
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Figure2.21 Exam ple of qPCR  assay 96 well plate configuration to investigate the 
expression of four genes sim ultaneously
2.11 Statistical analysis
Statistical differences were obtained through applying a 1-way ANOVA test using 
SPSS for windows (release 11, SPSS UK L td ., Surrey, UK) followed by Tukey post- 
hoc analysis at 95% confidence interval. When /?<0.05, data values differences were 
considered significant.
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CHAPTER THREE 
RESULTS ONE
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3.1 Introduction
The short term biocompatibility o f the ternary glass compositions was assessed by 
evaluating cell attachment, proliferation and maintenance o f the osteoblastic and 
fibroblastic phenotypes. These glasses were evaluated in their disc form as changes in 
cell morphology and phenotype protein expression were visually assessed using 
fluorescence microscopy against the flat, borosilicate glass, control seeded cells. This 
was conducted in order to determine the relationship between each glass composition 
solubility trend and the seeded cell behaviour with the overall aim of electing the most 
appropriate ternary glass composition, or compositional range, as a base form for 
glass fibre production. As concluded by Salih et al.(Salih et al., 2000), incubating 
osteoblastic cell lines in glass substrates containing < 28 mol% CaO content resulted 
in inhibiting cell proliferation and bone associated gene regulation therefore, and in 
this study, only glasses o f > 30 mol% CaO content were considered for 
biocompatibility assessment. Throughout this work, The P2O 5 content for all glass 
compositions was fixed at 50 mol% as attempts to produce glass fibres from glasses 
containing less than 50% P2O 5 were unsuccessful (Section 2.2.1). As described in 
Section 1.9.1, ternary phosphate based glasses solubility patterns are primarily 
dependant on the inhibitory effect o f  CaO as increasing CaO content resulted in 
reducing the corresponding glass dissolution rates (Franks et al., 2000; Franks et al., 
2001; Knowles et al., 2001; Ahmed et al., 2004). Accordingly, the 11 glass 
compositions produced (Table 3.1) were nominated as a low solubility form (> 40 
mol% CaO), and a high solubility form (< 40 mol% CaO).
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Table 3.1 Ternary phosphate based glass compositions considered for the initial 
biocompatibility assessment
For practical and time scale considerations, CaO was added at an increment o f 2 
mol% (30, 32, 3 3 ...etc) so that the number o f glass compositions to be investigated 
was reduced.
Precursor content (mol%)
Glass Code P 2 O 5 CaO Na20
(CaO)o3o-(Na20)o.2o-(P205)o.5o 50 30 2 0
(CaO)o 32-(Na2 0 )o.i8-(P:0 5 )o.5o 50 32 18
(CaO)o.34-(Na20)o.i6-(P205)o.50 50 34 16
(CaO)o.3s-(Na20)o.i5_(P205)o.5o 50 35 15
(CaO)o 36-(Na2 0 )o.|4-(P2 0 5 )o.50 50 36 14
(CaO)o.38-(Na20)o.i2-(P205)o.5o 50 38 1 2
(C aO )o 4o-( N a2 0  )o. i o-( P2O 5 )o.so 50 40 1 0
(CaO)o.42-(Na20)o.o8-(P205)o.5o 50 42 8
(CaO)o.44-(Na2 0 )0 .o6-(P2 0 5 )o.5o 50 44 6
(CaO)o.46-(Na20)o.o4-(P205)o.5o 50 46 4
(CaO)o.48-(Na20)o.o2-(P205)o.5o 50 48 2
3.2 Experimental protocol
3.2.1 The CyQUANT assay
To determine the capacity o f the relatively high solubility glass compositions (i.e. o f < 
40 mol% CaO) to support initial non-specific cell adhesion (Section 6.7), MG-63 cells 
attachment at the early time points o f 30, 120 and 180 min in culture were assessed. 
Cells were seeded onto discs containing 30, 35 and 40 mol% of CaO and the tissue 
culture plastic surfaces o f the Optiplate was used as a control surface (Figure 3.1 A)
As a limited stock o f HTF cells was available, only HOB and HOF cells were used for 
this assay. Glass discs containing > 40 mol% o f CaO were placed in the 24-well 
Optiplates and seeded, as seen in Figure 3.1 B, taking into account the inclusion of the 
non-seeded control discs. Due to the high number o f glass compositions investigated 
and taking into consideration primary cell stock availability, cell density was 
evaluated at 3 day intervals at day 1, day 4 and day 7 in addition to the early time 
point o f 180 min in culture. The cells were fixed and the nucleic acids were
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fluorescently labelled and later quantified giving an indication o f the corresponding 
cell density.
A B
CaO content
(mol%) CaO content (mol%)
-[C]
Figure 3.1 CyQUANT assay Optiplate configuration for (A), MG-63 cells and
(B), Primary HOB and HOF cells
+[C] = positive cell seeded controls and; -[C] = negative non-seeded controls.
3.2.2 Scanning Electron Microscopy
Further to the CyQUANT assay, evaluating MG-63 cell attachment on ternary glass 
compositions containing 30-40 mol% CaO took place using SEM. This however was 
conducted at 24 h time point, as opposed to the early time points adopted for the 
CyQUANT analysis (30, 120 and 180 min), in order to asses the attached cell 
morphology and detect any presence o f cell spreading (Shieh, 2000). Accordingly, 
MG-63 cells were seeded on the glass discs, incubated for 24 h, then fixed and the 
samples were processed for SEM (see Section 2.6.2)
3.2.3 Fluorescence Immunocytochemistry
Following the use o f MG-63 cells to assess the effect o f monensin supplemented GM 
on ON cytoplasmic localisation (Section 2.7.3) HOB, HOF and HTF cells were 
seeded onto the glass discs of the compositional range 40-48 mol% CaO; and the 
poly-l-lysine treated control coverslips (fig 3.2.). In line with the time points selected 
for the CyQUANT assay, and at day l, day 4 and day 7 in culture, the cells were fixed
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and indirectly labelled with the appropriate antibodies against markers of osteoblastic 
and fibroblastic phenotype activity(Section 6.2.2). HOB cells were investigated for 
BSP, ON and OP synthesis whilst, HOF and HTF cells were labelled against the 
enzyme Proline-4-Hydoxylase (P-4-H) using the 5B5 monoclonal antibody (Section 
2.7.3). This was followed by the secondary; F1TC (fluorescein isothiocyanate) 
conjugated antibody labelling.
To asses the attached cell morphology in relation to the seeded glass composition, a 
similar experimental procedure was conducted (Figure 3.2) and at time points at 24 h, 
day 4 and day 7 in culture, cells were fixed and directly labelled with Cy3 
(carbocyanine 3) conjugated anti-vimentin antibody. Results were obtained using the 
Leica fluorescent microscope.
Figure 3.2 Fluorescent Immunocytochemistry assay 24-wellplate configuration
This configuration was adopted for each investigated antibody and at each time point.
[C]= poly-l-lysine treated borosilicate control coverslips.
CaO content (mol%)
40 42 44 46 48
oooooo
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3.3 Results
3.3.1 Initial evaluation of biocompatibility: MG-63 cell attachment to 
the highly soluble glass compositions
When compared to the control surface, and by fluorescent quantification o f nucleic 
acids, glass discs o f  30 and 35 mol% CaO supported less cell attachment after 30 min 
in culture (Figure 3.3A).At 120 min time point, and on all glass compositions, cell 
density was less than that on the control surface (Figure 3.3B). However and after 180 
min in culture, glasses containing 40 mol% CaO supported significantly higher cell 
attachment than those o f  the lower CaO content. Furthermore, cell attachment rates to 
the 40 mol% glass surface matched those o f  the tissue culture plastic c control (Figure 
3.3C).
Using SEM and after 24 h in culture, only (CaO)o.4-(Na2 0 )o.r(P 2 0 5 )o.5 glass discs 
exhibited a clear, well distributed, cell attachment across the entire disc surface 
(Figures 3.4A and B). In comparison, fewer cells remained attached to compositions 
with lower calcium content (Figure 3.4D) and no cells were attached to discs 
containing 30, 32 and 34 mol% o f  CaO (Table 3.2). All glasses containing less that 40 
mol % CaO exhibited a fissured and irregular appearance o f the disc surface as 
demonstrated by Figure 3.4C and 3.4D. This might be an indication o f these glasses 
undergoing rapid surface degradation thus compromising cell attachment.
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Figure 3.3 CyQUANT evaluation of MG-63 cell density on ternary glass discs
After 30 min (A), 120 min (B) and 180 min in culture(C). Significantly different 
values (/?<0.05) are indicated using square brackets and dashed lines across the graph 
bars. [C]= Tissue culture plastic control surface. (au)= Fluorescence intensity arbitrary 
unit. (n= 4; error bars +SD)
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Figure 3.4 Scanning electron m icrographs of MG-63 cells seeded on ternary  glass 
discs
A (attached MG-63 cells marked by white arrow heads) and B showing (CaO)o.4- 
(Na2 0 )o.r(P2 0 5 )o.5 glass composition (51,1 and 588 magnification respectively). C 
and D showing (CaO)o.36-(Na2 0 )0 .i4-(P2 0 5 )o.5 glass composition (53,2 and 300 
magnification respectively).
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Table 3.2 An evaluation of MG63 cell attachment after 24 h in culture on glass 
surfaces of various compositions
(-) indicates that no cells were present on the disc surface; (-/+) indicates the presence 
o f few isolated cells with an irregular distribution pattern on the disc surface and; (+) 
indicates the clear presence o f cell populations distributed regularly on the disc 
surface.
Precursor content (mol%) Cell Attachment
Glass Code P2O5 CaO Na20 MG63
(CaO)ojo-(Na20)o.20“(P205)o.5o 50 30 20 -
(CaO)o.3o-(Na20)o |g-(P205)o.5o 50 32 18 -
(CaO)o 34-(Na20)o.i6-(P205)o.50 50 34 16 -
(CaO)0.36-(Na20)o.i4-(P205)o.5o 50 36 14 -/+
(CaO)o.38-(Na20)o.i2-(P205)o.5o 50 38 12 -/+
(CaO)o.4o-(Na20)o.io-(P205)o.5o 50 40 10 +
3.3.2 Characterisation of primary cell phenotype
The inclusion o f monensin salt in GM resulted in the localisation o f ON in the 
cytoplasmic vesicles o f MG-63 cells seeded on the control coverslips (Section 2.7.3). 
Subsequently, positive staining o f ON was detected at 24 h in culture as seen from 
figure 3.5A. negative results were obtained from MG-63 cells seeded in normal GM 
as only background staining was detected (Figure 3.5B). Accordingly, all samples 
were incubated for 24 h in 1 pm monensin salt containing GM prior to 
immunocytochemistry processing.
In order to characterise primary cell populations, cells were seeded on the poly-1- 
lysine treated control surfaces and labelled with their respective phenotypic activity 
markers. This was also conducted to provide the template against which, cell 
phenotype maintenance on the ternary glass compositions could be assessed.
HOB cells expressed intracellular punctate staining for BSP, ON and OP as shown in 
Figures 3.6A, 3.6B and 3.6C, respectively. This positive staining was predominant 
throughout the population suggesting a homogenous culture o f osteoblasts. Only 
background fluorescence was detected from the negative control cells, i.e. cells 
treated with 10% denatured donkey serum albumin as a polyclonal primary antibody
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substitute (Figure 3.6D). This may be attributed to a degree of non-specific binding of 
both the primary, polyclonal antibodies and the secondary, FITC-conjugated antibody 
(Section 2.7.1.2). Cy3 conjugated anti-vimentin staining (Figure 3.6E) indicated well- 
spread cell morphology and an extensive intermediate filament vimentin network.. 
Similarly, HOF cell population expressed positive staining for prolyl-4-hydroxylase 
(Figure 3.7A) and similar results were obtained for HTF cells (Figure 3.7B). For both 
HOB and HTF cells, mouse IgGl labelled monoclonal control cells exhibited neither 
positive, nor background staining when excited at the same intensity and duration as 
the positively labelled cells (Section 2.9) thus confirming the specificity o f the 
positive staining. These cells also exhibited well-spread morphology with extensive 
cytoplasmic processes (Figure 3.7C and D).
Figure 3.5 X63 objective Leica DM IRB fluorescent microscope images of MG-63 
cells cultured on 13 mm borosilicate coverslips at 24 h time point
(A) Punctate FITC staining (white arrow heads) for ON following 24 h incubation in 
1 pM monensin salt supplemented GM. (B) Background staining of FITC in cells 
seeded in normal GM (i.e. without monensin). Scale bar = 20pm.
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Figure 3.6 Leica DMIRB fluorescent microscope images of HOB cells cultured 
on 13 mm borosilicate coverslips at 24 h tim e point
Punctate FITC staining (white arrow heads) for BSP (A), ON (B), OP (C) (green 
colour, X63 objective, scale bar = 20pm). Negative control cells labelled using 10% 
denatured donkey serum albumin showing background staining (D). Red Cy3 anti- 
vimentin staining o f intermediate cytoskeletal filaments (E and D) (red colour, X20 
objective, scale bar = 50pm).Where applicable, nuclei are labelled with the DNA- 
binding dye DAPI (yellow).
Figure 3.7 Leica DM IRB fluorescent microscope images of HOF and HTF cells 
cultured on 13 mm borosilicate coverslips at 24 h time point
Punctate FITC staining (white arrow heads) for 5B5 in HOF cells (A), and HTF cells 
(B) (green colour, X63 objective, scale bar = 20pm). Red Cy3 anti-vimentin staining 
of intermediate cytoskeletal filaments in HOF cells (C), and HTF cells (D) (red 
colour, X20 objective, scale bar = 50pm).Where applicable, nuclei are labelled with 
the DNA-binding dye DAPI (yellow).
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3.3.3 Evaluation of ternary glasses biocompatibility: Craniofacial 
Osteoblasts
3.3.3.1 Preservation of cell phenotype
The HOB phenotype characteristics, through bone associated protein synthesis, were 
clearly expressed in culture on the glass containing 48 mol% CaO. This was 
demonstrated by the presence o f cytoplasmic vesicles containing BSP (Figure 3.8), 
ON (Figure 3.9) and OP (Figure 3.10) at all time points in culture. It is clear that an 
adequate degree o f cell spreading as the main criteria required to attain protein 
production, therefore, positive results were mainly obtained from cells cultured on the 
48 mol% CaO content glass compositions.
*
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Figure 3.8 X63 objective Leica DMIRB fluorescent microscope images of HOB 
cells Labelled for BSP
Punctate green (FITC) staining for BSP in HOB cells cultured on (CaO)o.48- 
(Na20)o.o2-(P205)o.5 glass composition after 24 h (A) and 7 days (B) in culture. Nuclei 
are labelled with the DNA-binding dye DAPI (yellow). Cells incubated in for 24 h in 
1 pM monensin prior to the fixing process. Scale bar = 20pm.
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Figure 3.9 X63 objective Leica DM IRB fluorescent microscope images of HOB 
cells Labelled for ON
Punctate green (FITC) staining for ON in HOB cells cultured on (CaO)0 .48-(Na2O)0.02- 
(P2 0 5 )o.5 glass composition after 24 h (A) and 7 days (B) in culture. Nuclei are 
labelled with the DNA-binding dye DAPI (yellow). Cells incubated in for 24 h in 1 
pM monensin prior to fixing process. Scale bar = 20pm.
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Figure 3.10 X63 objective Leica DM IRB fluorescent microscope images of HOB 
cells Labelled for OP
Punctate green (FITC) staining for OP in HOB cells cultured on (CaO)o.48-(Na20)o.o2- 
(P2C>5)o.5 glass composition after 24 h (A) and 7 days (B) in culture. Nuclei are 
labelled with the DNA-binding dye DAPI (yellow). Cells incubated in for 24 h in 1 
pM monensin prior to fixing process. Scale bar = 20pm.
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3.3.3.2 Cell morphology and attachment patterns
After 24 h in culture, HOB cells were present on all glass discs. Rounded cell 
morphology remained predominant on glasses with lower calcium content (Figure 
3.11 A), whilst a degree o f cell spreading was observed on the composition o f 48 
mol% CaO content (Figure 3.11B) when compared to the control cells (Figure 3.11C). 
At day 4 a similar pattern was noticed (Figures 3.1 ID and E) with cells retaining 
spread morphology on higher calcium containing compositions. By day 7 only 
composition (CaO)o.48-(Na2 0 )oo2-(P2 0 5 )o.5 supported cell adhesion however, the 
rounded morphology o f the attached cells became more conspicuous (Figure 3.11G 
and 3 .11H) compared with the spread appearance o f the control surface seeded cells 
(Figure 3.1 II). Cell numbers, through visual observation and in correspondence with 
the CyQUANT evaluation o f cell density (see Section 3.3.3.3), were highest on the 48 
mol% CaO containing glass composition.
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Figure 3.11 HOB cell m orphology on te rn a ry  glass compositions
X20 objective Leica DMIRB fluorescence micrographs of HOB cells (i) cultured on 
(CaO)o.4-(Na2 0 )o.i-(P2 0 5 )o.5 glass (A), (CaO)o.48-(Na20)o.o2-(P205)o.5 glass (B) and 
borosilicate coverslips (C) after 24 h in culture, (ii) cells cultured on (CaO)o.4- 
(Na20)o.r(P205)o.5 glass (D), (CaO)o.48-CNa20)o.o2-(P205)o.5 glass (E) and borosilicate 
coverslips (F) after 4 days in culture and (iii) cells cultured on (CaO)o.4-(Na20)o.i- 
(P2O 5 )0 .5 glass (G), (CaO)o.48-(Na20)o.o2-(P205)o.5 glass (H) and borosilicate coverslips 
(I) after 7 days in culture. Cells stained with anti-vimentin cy3 conjugated antibody 
(red). Scale bar = 20pm.
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3.3.3.3 C ell survival and proliferation
As seen from figure 3.12, and using the CyQUANT analysis o f the attached cell 
density, only HOB cells seeded on glass compositions containing 44 and 48 mol% 
CaO underwent considerable increase in density (/?<0.05) by day 4 in culture. No 
further increase was noticed, however, by day 7 in culture. No proliferation pattern 
was associated with 40, 42 and 46 mol% CaO containing discs over time in culture. 
Cells seeded on the tissue culture plastic control surfaces exhibited considerable 
population growth, starting at day 1 time point, as a function o f time in culture. 
Comparing density data for cells seeded on different glass compositions at each time 
point revealed that after 3 h in culture, no significant differences in density were 
present among cells seeded on all glass compositions (Figure 3.13A). By day 1, 
however, significantly fewer cells attached to the glass compositions of 40, 42 and 44 
CaO content than those higher on CaO compositions (46 and 48 mol% CaO) where 
differences in the attached cell numbers against the control surfaces were insignificant 
(Figure 3.13B). By day 4 in culture, all glass compositions accommodated less 
attached cells than the control surface nonetheless, higher cell density was present on 
glass discs containing 44 and 48 mol% CaO in comparison with the 40 mol% CaO 
composition (Figure 3.13C). Similarly, and at day 7 time point, more cells attached to 
the control surfaces than to the glass discs o f all compositions. Moreover, and as seen 
at day 1 and day 4 time points, more cells remained attached to the 48 mol% 
containing glass discs than to the lower on calcium, 40 mol% CaO containing, glass 
composition.
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Figure 3.12 CyQUANT analysis of attached  HOB cell survival and proliferation
Fluorescent evaluation o f nucleic acid content for HOB cells seeded on glass discs 
containing 40, 42, 44, 46 and 48 mol% CaO and on the tissue culture plastic control 
surfaces ([C]) at 3 h, day 1, day 4 and day 7 in culture. For each composition, (*) 
indicates a significant (p<0.05) increase in cell density over time in culture. Data 
obtained by measuring the CyQUANT GR dye intensity using the Fluroskan Ascent 
plate reader, au = Fluorescence intensity arbitrary unit, (n = 3; error bars +/-SD)
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Figure 3.13 CyQUANT analysis of attached HOB cell density in relation to glass 
composition
Fluorescent evaluation o f nucleic acid content for HOB cells seeded on glass discs 
containing 40, 42, 44, 46 and 48 mol% CaO and on the tissue culture plastic control 
surfaces ([C]) at 3 h (A), day 1 (B), day 4 (C) and day 7 (D) in culture. Significant 
differences in fluorescence values obtained from cells seeded on different glass 
compositions, at each time point, are linked using horizontal brackets ( p  ). Data 
obtained by measuring the CyQUANT GR dye intensity using the Fluroskan Ascent 
plate reader, (au), Fluorescence intensity arbitrary unit. (n= 3; error bars +/-SD)
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3.3.4 Evaluation of ternary glasses biocompatibility: Oral and tendon 
fibroblasts
3.3.4.1 Preservation of cell phenotype
As seen from Figures 3.14A and B, HOF cells maintained the expression o f P-4-H on 
the 48 mol% CaO composition ((CaO)o.4g-(Na2 0 )o.o2-(P2 0 5 )o.5) throughout time in 
culture (time points day 1, day 4 and day 7). Again, this was primarily associated with 
the well spread cellular morphology. HTF cells labelled for 5B5 demonstrated a 
similar staining pattern, at the same time points, only when cultured on the 48 mol% 
CaO containing glass (Figures 3.15A and B)
Figure 3.14 X63 objective Leica DMIRB fluorescent microscope images of HOF 
cells Labelled against P-4-H
Punctate green (FITC) staining for 5B5 in HOF cells cultured on (CaO)o.48-(Na20)0.o2- 
(P2 0 5 )o.5 glass composition after 1 day (A) and 7 days (B) in culture. Nuclei are 
labelled with the DNA-binding dye DAPI (yellow). Scale bar = 20pm.
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Figure 3.15 X20 objective Leica DM IRB fluorescent microscope images of HTF 
cells Labelled against P-4-H
Punctate green (FITC) staining for 5B5 in HTF cells cultured on (CaO)0.48-(Na:0)o.o2- 
(P2C>5)o.5 glass composition after 1 day (A) and 7 days (B) in culture. Nuclei are 
labelled with the DNA-binding dye DAPI (yellow). Scale bar = 50pm.
3.3.4.2 Cell morphology and attachment patterns
All glass compositions, at all time points, appeared to accommodate the adhesion and 
survival o f  HOF cells and, with the exception of day 4 in culture, no significant 
differences in cell density were visually detected on different substrates. However, the 
nature o f cell adhesion varied considerably depending on the glass composition used. 
At 1 day attachment patterns for cells cultured on all glasses (Figure 3.16A and B) 
were relatively close to those seen on the control surfaces (Figure 3.16C). By day 4 
increased numbers o f cells were noted on all compositions. Whilst cells on the lower 
calcium containing glass composition (CaO)o.4-(Na2C>)o.io-(P2 0 5 )o.5 exhibited round 
morphology (Figure 3.16D), more cells were present on composition (CaO)o.48- 
(Na20)o.o2-(P205)o.5 (Figure 3.16E) with cells maintaining a spread appearance in 
comparison with that o f the control cells (Figure 3.16F). At day 7, cells on the lower 
calcium-containing composition (Figure 3.16G) were rounded in comparison to the 
cells on composition (CaO)o.48-(Na2 0 )o.o2-(P2 0 5 )o.5 which, clearly, retained a well 
spread appearance (Figure 3.16H; control Figure 3.161).
Vimentin filament staining in HOF cells revealed greater cell numbers related to the 
highest calcium containing glass composition, i.e. 48 mol% CaO at 24 h, day 4 and
day 7 as seen from Figures 3.17A, B and C respectively. At X40 objective 
magnification, HTF cells revealed a spread morphology, on the 48 mol% CaO glass 
composition (Figure 3.17D, E and F), approximating that of the control cells at all 
three time points (Figure 3.17G, H and I).
Figure 3.16 HOF cell M orphology on te rnary  glass compositions
X20 objective Leica DMIRB fluorescence micrographs o f HOF cells (i) cultured on 
(CaO)o.4-(Na20 )o.i-(P2 0 5 )o.5 glass (A), (CaO)o.48-(Na20)o.o2-(P205)o.5 glass (B) and 
borosilicate coverslips (C) after 1 day in culture, (ii) cells cultured on (CaO)o.4- 
(Na20 )o .r(P 205)o.5 glass (D), (CaO)0.48-(Na20)o.o2-(P205)o.5 glass (E) and borosilicate 
coverslips (F) after 4 days in culture and (iii) cells cultured on (CaO)o.4-(Na20)o .r 
(P205)o.5 glass (G), (CaO)o.48-(Na20)o.o2-(P205)o.5 glass (H) and borosilicate coverslips 
(I) after 7 days in culture. Cells stained with anti-vimentin cy3 conjugated antibody 
(red). Scale bar = 50pm.
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Figure 3.17 HTF cell M orphology on te rnary  glass compositions
HTF cells stained with anti-vimentin cy3 conjugated antibody, (i) X20 objective 
Leica DMIRB fluorescence micrographs o f cells cultured on (CaO)o.48-(Na20)o.o2- 
(P2 0 5 )o.5 glass composition after 1 day (A), 4 days (B) and 7 days (C) in culture 
(Scale bar = 50pm).and (ii) X40 objective fluorescence micrographs o f HTF cells 
cultured on (CaO)o.48-(Na20)o.o2-(P205)0.5 glass composition after 1 day (G), 4 days 
(H) and 7 days (I) in culture (Scale bars = 25pm) cells cultured on borosilicate 
coverslips after 24 h (D), 4 days (E) and 7 days (F) in culture.
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3.3.4.3 Cell survival and proliferation
Measuring the CyQUANT GR dye fluorescence intensity revealed a significant 
increase in HOF cell density, between days 1 and 4 in culture, on all seeded glass 
compositions except the 40 mol% CaO containing discs (Figure 3.18). This trend was 
reversed however as by day 7, a significant decline in cell numbers was observed on 
all seeded discs. Similar to the results obtained for HOB cells (Section 3.3.3.3), a 
clear proliferation pattern was associated with cells seeded on the control tissue 
culture plastic surfaces from day 1 onwards. After 3 h in culture, as seen from Figure 
3.19A, similar density values were obtained for HOF cells attached to discs o f all the 
compositions investigated together with the control surfaces. At day 1, the attached 
cell density values for all glass compositions were significantly lower than those of 
the control surfaces with the exception o f the 42 mol% CaO containing glass 
composition (Figure 3.19B). By day 7, fewer cells attached to the 40, 42, 44 and 46 
mol% CaO content glass compositions than to the tissue culture plastic control 
however, 48 mol% CaO content glass discs supported cell attachment at levels similar 
to those on the control surfaces and significantly higher than those on the 40, 42 and 
44 glass compositions (Figure 3.19C). Eventually, and by day 7 in culture, cell 
density values on discs o f all compositions were significantly lower than those 
established for tissue culture plastic (Figure 3.19D).
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Figure 3.18 CyQUANT analysis of attached HOF cell survival and proliferation
Fluorescent evaluation o f nucleic acid content for HOF cells seeded on glass discs 
containing 40, 42, 44, 46 and 48 mol% CaO and on the tissue culture plastic control 
surfaces ([C]) at 3 h, day 1, day 4 and day 7 in culture. For each composition, (*) 
indicates a significant (/?<0.05) increase in cell density over time in culture. Data 
obtained by measuring the CyQUANT GR dye intensity using the Fluroskan Ascent 
plate reader, au = Fluorescence intensity arbitrary unit, (n = 3; error bars +/-SD)
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Figure 3.19 CyQUANT analysis of attached HOF cell density in relation to glass 
composition
Fluorescent evaluation of nucleic acid content for HOF cells seeded on glass discs 
containing 40, 42, 44, 46 and 48 mol% CaO and on the tissue culture plastic control 
surfaces ([C]) at 3 h (A), day 1 (B), day 4 (C) and day 7 (D) in culture. Significant 
differences in fluorescence values obtained from cells seeded on different glass 
compositions, at each time point, are linked using horizontal brackets ( p  ). Data 
obtained by measuring the CyQUANT GR dye intensity using the Fluroskan Ascent 
plate reader, (au), Fluorescence intensity arbitrary unit. (n= 3; error bars +/-SD)
133
3.4 Summary
• Using SEM and the CyQUANT cell proliferation assay, MG-63 cell line 
attachment and survival on 30-40 mol% CaO ternary glass composition discs 
was evaluated. After 180 min in culture, only glass composition of the 40 
mol% CaO content ((CaO)o.4o-(Na2 0 )oo2-(P2 0 5 )o.5) supported cell attachment 
at a level matching that o f  the tissue culture plastic control surfaces. All 
compositions containing less that 40 mol% CaO exhibited little or no cell 
survival, at 24 h time point, when compared with composition (CaO)o.4o- 
(Na:0)o io-(P2 0 5 )o 5o. Accordingly, only glasses containing > 40 mol% CaO 
were considered for the subsequent biocompatibility assessment using 
primary HOB, HOF and HTF cells.
• Fluorescence immunocytochemistry revealed HOB cell bone-associated 
protein synthesis to be primarily associated with the glass composition o f the 
48 mol% CaO content ((CaO)o.48-(Na20)o.o2-(P205)o.5o) and maintained up to 
7 days in culture. This appeared to be directly linked to the well spread cell 
morphology observed on the 48 mol% glass form. This composition 
accommodated higher HOB cell attachment rates at 1, 4 and 7 day in culture 
than the higher on solubility composition o f the 40 mol% CaO content when 
cell density was fluorescently quantified. No significant cell proliferation 
pattern was observed however in comparison with the tissue culture plastic 
control except for 44 and 48 mol% CaO content compositions. This 
proliferation pattern was limited to day 4 in culture.
• Up to 7 days in culture, HOF and HTF phenotype associated P-4-H synthesis, 
together with a well spread in vitro appearance, was clearly expressed and 
maintained exclusively on the 48 mol% glass discs as confirmed by 
fluorescent labelling. Using the CyQUANT analysis, HOF cell density was 
also higher on this composition (48 mol% CaO), at day 4 in culture, than on 
glasses containing 40, 42 and 44 mol% CaO however, and starting at day 4, a 
decrease in the attached cell density occurred over time in culture.
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• As primary cell survival, functional in vitro morphology and phenotype 
protein synthesis appeared to be directly linked to the glass solubility profile, 
with the least soluble glass forms expressing the highest biocompatibility 
features, glass compositions o f the 46 and 48 CaO content ((CaO)o.46- 
(Na20)()(,4-(P:05)o 5 and (CaO)o.48-(Na20)().o2-(P205)o.5o) were elected for glass 
fibre fabrication and the fibre scaffold biocompatibility assessment. The lack 
o f cell proliferation on these compositions however, highlighted the necessity 
o f further optimising glass solubility by generating quaternary glass forms.
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CHAPTER FOUR 
RESULTS TWO
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4.1 Introduction
Glass fibres o f various diameters can be produced by varying the fibre drum rotational 
speeds. By increasing the rotational speed, glass fibres o f smaller diameters can be 
produced (Ahmed et al., 2004). In terms o f biocompatibility, the optimal fibre 
diameter was determined by evaluating HOB and HOF attachment and survival on the 
48 mol% CaO containing ternary glass fibres generated at 3 different rotational 
speeds. Subsequently, solubility profiles and average fibre diameters o f quaternary 
glass fibre forms were evaluated (Table 4.1). Cell survival, proliferation rates and 
maintenance o f morphology on these fibres were established. The most biocompatible 
quaternary glass composition was later utilised for implementing the co-culture 
scaffold design to asses the feasibility o f  interface formation and the subsequent cell 
behaviour.
Table 4.1 Quaternary glass fibre compositions used for biocompatibility testing
Precursor content (mol%)
Glass Code P2O5 CaO Na20 F2O3
(CaO)o.46-(Na20)o.o3-(Fe203)o.or(P205)o.5o 50 46 3 1
(CaO)o.46-(Na20)o.o2-(Fe203)o.o2-(P205)o.5o 50 46 2 2
(CaO)o.46-(Na20)o.or(Fe203)o.o3-(P205)o.5o 50 46 1 3
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4.2 Experimental protocol
4.2.1 Scaffold Preparation
4.2.1.1 Ternary glass fibre system
The rotational speeds 800, 1200 and 1600 r/min were selected to produce fibres o f the 
composition (CaO)0.48-(Na2 0 )o.o2-(P2 0 5 )o.5 as attempts to generate fibres at a speed 
lower than 800 r/min were unsuccessful. When increasing the CaO precursor content, 
higher melting temperatures are required if  glass formation is to take place(Section
2.2.4). Accordingly, the combined fibre formation and glass phase transition 
processes can be induced when the prompt cooling o f the fibre precursor can be 
guaranteed. At slower rotational speeds the fibre precursor is cooled at a lower rate, at 
the crucible outlet, and the transition from the liquid to the solid state o f the mater 
occurs through the crystallisation phase (Section 2.2.1). Fibre production from glass 
compositions o f 40-48 mol% CaO content was therefore constantly interrupted, by 
crystallisation, at slow rotational rates. Based on the previous work conducted by our 
group, fibre diameters were theoretically estimated as seen from Table 4.2 (Ahmed et 
al., 2004a). The fibre scaffold alignment, via the stepper motor function, took into 
consideration the presence o f 5-10 pm fixed distance between adjacent fibres (Section
2.2.5). The scaffolds were also arranged so that fibre configuration took a monolayer 
mesh form, for both HOB and HOF cells, to maximise the substrate surface as at this 
stage, the rate and maintenance o f HOB and HOF attachment to the glass fibre form 
are unknown.
Table 4.2 Estimated fibre diameter at various drum rotational speeds
The stepper motor control frequency was accordingly adjusted so that a hypothetical 
gap o f 5- 10 pm is maintained between adjacent fibres.
Estimated fibre 
diameter (pm)
Drum Rotational speed 
(r/ min)
Stepper motor control 
frequency (Hz)
10- 15 1600 0.15
15-20 1200 ~ 0.19
20- 25 800 0.2
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4.2.1.2 Q uaternary glass fibre system
Quaternary glass production was based on modifying the ternary composition 
(CaO)o.46-(Na20 )o.o4-(P 2 0 5 )o.5 . This composition was chosen as it was, among the 
ternary glass compositions investigated in chapter 3, second only to glass composition 
(CaO)o48-(Na20 )o.o2-(P 2 0 5 )o.5 (o f the 48 mol% CaO content) in terms o f 
biocompatibility and secondly, the molar structure o f this glass permitted the 
inclusion o f  up to 3 mol% o f  F20 3  o f at the expense of reducing the Na20  content. 
Fibre scaffolds were produced using 1, 2 and 3 mol% F20 3  quaternary glass 
compositions and, as means o f comparison, the corresponding ternary 46 mol% CaO 
containing composition. Fibres were drawn at 800 r/min rotational speed and aligned 
following fibre diameter characterisation, with a 0  (nil) pm inter-fibre separating gap 
so the substrate seeded surface could be maximised and the loss o f seeded cells can be 
prevented. A monolayer mesh and a unidirectional parallel fibre arrangement were 
produced to seed HOB, and HOF cells respectively.
The quaternary glass composition o f the 3 mol% Fe20 3  content ((CaO)o.46-(Na20)o.or 
(Fe20 3)o.o3-(P205)o.5o) was used to produce the co-culture scaffold with the fibres 
aligned as above.
4.2.2 Glass fibre characterisation
Following epoxy resin embedding; resin block cutting and polishing, the average fibre 
diameter for each quaternary glass composition was determined (Section 2.4.2). 
Weight loss for each glass fibre composition was obtained by subtracting the dry fibre 
bundle weight, at the appropriate time point, from the weight o f the starting material, 
i.e. 100 mg. Composition related dissolution weight loss values, at days 1, 4, 7 and 10 
were accordingly obtained following fibre bundles incubation in GM. This was 
conducted to establish the in vitro solubility trend for the 3 quaternary glass fibre 
compositions ( 1 , 2  and 3 mol% F2C>3 content); and the corresponding (CaO)o.46- 
(Na20 )o.o4 -(P2 0 5 )o.5 ternary glass fibre form. Additionally, the average hourly weight 
loss value for each glass composition, and at all 4 time points, was calculated to 
determine the effect o f F2C>3 inclusion on the glass solubility profile.
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For SEM, glass fibres o f the 46 mol% CaO content ternary, and 3 mol% Fe2 0 3  
quaternary compositions were produced at 800 r/min and processed as described in 
Section 2.4.3.
4.2.3 Cell density evaluation
The direct cell count method was used to evaluate HOB and HOF cell attachment, 
survival and proliferation through visualising the propidium iodide labelled nuclei.
Cell survival in relation to the seeded fibre diameter, using the ternary 48 mol% CaO 
glass composition, was accordingly established by obtaining adherent cell numbers at 
days 1, 4 and 7 in culture.
1, 2 and 3 mol% F2O 3 quaternary, and 46 mol% CaO ternary, cell seeded glass fibre 
scaffolds were fixed at days 1, 7 and 14 in culture and the glass composition related 
cell survival, and proliferation patterns, were similarly evaluated.
4.2.3 Immunocytochemistry
By immunolabelling the intermediate cytoskeletal filaments with Cy3 conjugated 
anti-vimentin antibody, the maintenance and nature o f cell morphology was assessed. 
Thus, cells seeded on glass fibres o f  the quaternary 2 and 3 mol% F2O3 were fixed and 
stained at days 14 and 21 in culture; fibre scaffolds mounted in the Citifluor mounting 
solution and the samples subsequently examined under the fluorescence microscope.
4.2.4 The CellTracker™ assay
To maintain normal cellular physiology and reduce potential artefacts, the 
concentration o f the 5-chloromethylfluorescein diacetate dye should be kept as low as 
possible however; its use at low concentrations may reduce the efficacy and the in 
vitro lifetime o f the assay. To determine the appropriate concentration o f the CMFDA 
dye so that primary human cells could retain both viability and fluorescence, HOF 
cells were labelled with 5, 10 and 15 pM concentrations o f the green CMFDA dye as 
detailed in Section 2.8. The cells were then incubated with non-labeled cells in 24 
wellplates and observed at days 1, 2 and 3 using the fluorescence microscope.
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Co-culture scaffolds were prepared using the (CaO)o.46-(Na20 )o.oi-(Fe2 0 3 )o.o3- 
(P 2 0 5 ) 0  .5 0  fibre composition and HOF cells, pre-labelled with the optimal 
concentration o f CMFDA, were seeded on one side o f the separation barrier. 
Subsequently, HOB cells were seeded and the scaffolds were processed for 
fluorescent microscopy at days 1, 2 and 3 time points (also see chapter 2).
4.3 Results
4.3.1 Cell attachment and survival in relation to fibre diameter
4.3.1.1 Craniofacial osteoblasts
As seen from Figures 4.1 A, B and C, HOB cell attachment was visualised on fibres o f 
all diameters at 24 h time point however, less cells were seen attached to fibres drawn 
at 1600 r/min. By day 4 in culture, a decline in cell numbers was associated with both, 
1200 and 1600 r/min generated fibres (Figure 4 .ID, E and F). At day 7 time point, cell 
survival was only associated with fibres drawn at 800 r/min (Figure 4.1G).
Visual observation o f cell attachment and survival patterns was confirmed by data 
analysis (Figure 4.2). At 24 h, HOB cell attachment values were significantly higher 
on fibres drawn at 800 r/min than those o f  cells adhered to both, 1200 and 1600 r/min 
drawn fibres. By day 4, no differences in cell numbers were present among all seeded 
scaffolds however, a significant decrease in cell density occurred on the 800 r/min 
produced fibres. This decrease in cell numbers continued in culture up until day 7.
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Figure 4.1 HOB cell a ttachm ent and survival on ternary  glass fibres of various 
d iam eters
X20 objective Leica DMIRB fluorescence micrographs of HOB cells cultured on 
(CaO)o.48-(Na20)o.o2-(P205)o.5o glass fibres drawn at (A and D)1600 r/min, (B and E) 
1200 r/min and (C, F and G) at 800 r/min. Samples were fixed, and processed for 
fluorescence immunocytochemistry at (A, B and C) 24 h, (D,E and F) day 4 and (G) 
day 7 time points. Nuclei are labelled with the DNA-binding dye, PI (Red). Scale bar 
= 50pm.
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Figure 4.2 HOB cell a ttachm ent and survival on fibres of various diameters
Cells were cultured on (CaO)o.48-(Na20)o.o2-(P2C>5)o.5o glass fibres drawn at 1600,1200 
and 800 r/min. For each time point, (a) indicates significant (/?<0.05) differences in 
cell density on various fibre diameter profiles, (b) indicates significant (/K0.05) 
differences in cell density, over time in culture, for cells seeded on the 800 r/min 
drawn fibres. Results were obtained via direct microscopic counting of the PI stained 
nuclei. No cell survival was present on the 1200 and 1600 r/min drawn fibres at day 7 
in culture. (n= 3; error bars +/-SD)
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4.3.1.1 Oral fibroblasts
HOF cell attachment on all seeded scaffolds, irrespective o f fibre diameter profiles, 
was maintained at 24 h in culture (Figure 4.3A, B and C). The same trend, and as seen 
form Figures 4.3D, E and F; was noticed by the forth day in culture nonetheless, signs 
o f scaffold degradation were seen associated with the 1200 and 1600 r/min produced 
fibres( Figure 4.3D and E). By day seven, and as previously noticed with HOB cell 
survival pattern, only the 800 r/min drawn fibres accommodated cell viability (Figure 
4.3G).
G
Figure 4.3 HO F cell attachm ent and survival on ternary  glass fibres of various 
diam eters
X20 objective Leica DMIRB fluorescence micrographs o f HOB cells cultured on 
(CaO)o.48-(Na20)0.o2-(P205)o.5o glass fibres drawn at (A and D)1600 r/min, (B and E) 
1200 r/min and (C, F and G) at 800 r/min. Samples were fixed, and processed for 
fluorescence immunocytocemistry at (A, B and C) 24 h, (D,E and F) day 4 and (G) 
day 7 time points. Nuclei are labelled with the DNA-binding dye, PI (Red). Scale bar 
= 5 0 p m .
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Analysis o f  direct cell count values, at 24 h time point, established no significant 
differences in cell density in relation to fibre diameter (Figure 4.4.). A different result, 
however, was obtained at day 4 as more cells were maintained on the 800 r/min drawn 
fibres. Nonetheless, and despite the absence o f cell number decrease on these fibres, 
no significant cell growth took place over time in culture.
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Figure 4.4 HOF cell attachm ent and survival profiles on fibres of various 
diam eters
Cells were cultured on (CaO)o.48-(Na20)o.o2-(P205)o.5o glass fibres drawn at 1600,1200 
and 800 r/min. For each time point, (a) indicates significant (p<0.05) differences in 
cell density on various fibre diameter profiles. Results were obtained via direct 
microscopic counting o f the PI stained nuclei. No cell survival was present on the 
1200 and 1600 r/min drawn fibres at day 7 in culture. (n= 3; error bars +/-SD)
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4.3.2 Q uaternary glass fibre characterisation
4.3.2.1 Solubility profiles
To insure consistency o f nomenclature, fibres o f the 46 mol% CaO content ternary 
composition are referred to as 0  mol% F2O 3 containing throughout.
When conducting the solubility test, and by day 4 in solution, 0 mol% F2O3 fibre 
compositions experienced clear physical degradation whilst fibres containing 1, 2 and 
3 mol% F2O 3 retained physical integrity throughout the time in solution (Figure 4.5). 
By day 4 in GM, significant glass bulk weight loss was associated with the 0 and 1 
mol% F2O 3 containing glass fibres (Figure 4.6). No further weight loss occurred 
however, for these two compositions at day 7. By day 10, both glass compositions 
experienced significant decrease in weight when compared with their day 4 weight 
values. It should be noted nevertheless, that weight loss progression for these glass 
compositions has been inhibited as a function o f time in solution. This may be 
attributed, as demonstrated by Knowles et al. (Knowles et al, 2001), to glass 
degradation products precipitation on the fibre surface, thus reducing solubility rates. 
In contrast, significant weight loss affecting 2 mol% F2O3 glass fibres was not 
apparent until day 7 and the glass bulk weight remained constant thereafter, and up to 
day 10 in solution. Fibres on the 3 mol% F2O 3 composition underwent no significant 
weight loss until the last designated time point, at day 10 in GM.
In order to determine the exact effect o f  Fe2C>3 inclusion on glass solubility trends the 
hourly weight loss for each glass composition was calculated. For each composition, 
and at each time point, weight loss was divided by the number of forming hours (1 
day = 24 h). The mean o f the values, at the 4 time points, was then obtained as the 
hourly weight loss. As expected, and in line with each composition degradation 
profile, F2O3 acted as a solubility inhibitor. Moreover, increasing F2O3 content lead to 
the corresponding exponential decrease in solubility (Figure 4.7).
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Figure 4.5 Light photograph of glass fibres during solubility profiling
0 mol% F2O 3 containing fibre bundle (left well); and 1 mol% F2O3 containing fibre 
bundle (right well) at day 4 in GM. Experiment conducted in 6  wellplates.
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Figure 4.6 glass fibre weight loss rates for various compositions and at different 
time points
Significant increases in weight loss over time in GM are indicated by (*). (**) is 
significantly higher than (*). (n= 3; error bars +SD)
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Figure 4.7 Glass solubility rates as a function of F2O3 content
Trend line graph. The hourly weight loss value for each composition is represented by
a yellow square (data point). R2 (R-Squared) is the coefficient o f determination. When
R2=l .0, all data points are within the trend line and the model can be considered to be
correct.
4.3.2.2 Glass fibre diameter
Following Image-Pro® Plus software analysis o f fibre Sections, the mean value for 
fibre diameters was established for each glass composition. These values were 
verified however as the mean, and due to the considerable variation in diameter 
measurements, may not be a true representative o f the population (fibre diameter 
values). This was achieved through performing descriptive analysis on the data 
obtained for each composition to obtain the frequency at which various diameter 
values were represented. The mean was considered legitimate, and therefore 
representative o f a population, when the mean value fell within the most frequently 
present data range at 95% confidence level. Accordingly, and for all glass 
compositions investigated, the mean values have been shown to be representative of 
the 800 r/ min drawn fibres diameter (Figure 4.8). The average diameters for 1, 2 and 
3 mol% were 30.040, 30.606 and 29.362 pm respectively. This also data confirmed 
that fibre diameter was relatively independent from glass composition range; as the
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fibre drawing speed appeared to be the main factor in determining fibre diameter 
values. The mean value o f 30.0026 (= 30) pm was thus adopted throughout the work.
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Figure 4.8 Analysis of fibre diam eter values frequency for each glass composition
A descriptive continuous analysis of data. Frequency histograms o f diameter data 
values for glass compositions (CaO)o.46-(Na20)o.o3-(Fe203)o.or(P205)o.5o (top graph), 
(CaO)o.46-(Na20)o.o2-(Fe203)o.o2-(P205)o.50 (centre graph) and, (CaO)0.46-(Na20)o.oi- 
(Fe2C>3)o.o.3-(P2 0 5 )o.5o (bottom graph). For all graphs; (Y) Axis, frequency of 
d iam eter range and (A) Axis, F ibre diam eter (pm). The distribution curve 
(superimposed red line) for each graph illustrates the extent of normality in data 
distribution. Data analysed and graphs generated using SPSS for Microsoft Windows.
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4.3.2.3 G lass fibre surface topography evaluation
As revealed by SEM and at low magnification, fibre compositions (CaO)0 .46- 
(Na:0)()oi-(Fe:00()(B-(P205)o5o (Figure 4.9A) and (CaO)o.46-(Na20)o.o4-(P:05)o.5o 
(Figure 4.9B) exhibited visually smooth surfaces with no apparent surface patterns. 
At higher magnification, no particular surface topographical features were evident for 
both (CaO)0 .46-(Na2O)0 .0 1-(Fe20 3 )0 .0r (P2O 5)o.so (Figure 4.9C) and (CaO)046 - 
(Na20)0 .o4-(P205 )o. 50 (Figure 4.9D) glass fibre compositions however, the presence of 
white dots on the SEM image (Figures 4.9C and D, white arrow heads) might be 
related to a particular surface topography pattern. The SEM related white dot 
phenomenon is a manifestation o f secondary electron (SE) production at low 
accelerating voltages and is strongly related to surface topography(Borovsky and 
Suszcynsky, 1991). This is caused by an incident SEM electron impacting some of 
the lower energy electrons (usually in the K-shell) o f an atom in the specimen 
resulting in the ionization o f the electron in the specimen atom (Borovsky and 
Suszcynsky, 1991). This ionized secondary electron then leaves the atom releasing a 
small kinetic energy detected by the scanning microscope. Each incident electron can 
produce several secondary electrons. Due to their extremely low energy however, 
only secondary electrons that are very near the glass surface (<10nm) can exit the 
sample and be examined (Suszcynsky and Borovsky, 1992). Accordingly, the white 
dot presence may be linked to nano-scale elevations on the glass surface. This, 
however, must be the subject o f further confirmation in future work using higher SEM 
magnification rates. Furthermore and as seen in Figures 4.9C and D, the appearance 
and distribution o f the white dots show slight variations between the ternary and 
quaternary glass fibre surfaces. This might be glass composition related and must also 
be investigated in future work.
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Figure 4.9 SEM m icrographs of ternary  and quaternary  glass fibre surfaces
Hitachi S-4700II field emission scanning electron microscope images of glass fibre 
surfaces o f quaternary, 3 mol% F ^O t, containing glass composition (A and C, X6.932 
x 103 and X86.892 x 103 respectively) and ternary, 46 mol% CaO containing glass 
composition (B and D, X6.075 x 103 and X63.958 x 103 respectively).
Secondary electron production related white dots are marked by white arrow heads (C
4.3.3 Biocom patibility of quaternary glass fibres: Craniofacial 
osteoblasts
4.3.3.1 Cell survival and proliferation
As expected, and as seen from Figure 4.10., no cells were present on the 0 mol% 
Fe20 3 ternary glass fibres by day 7 in culture. A similar pattern however, was 
observed on the mol% Fe20 3  glass fibre form as cell survival ceased at the second 
investigated time point. Cell presence was maintained on the 2 mol% Fe2C>3 
containing glass fibres nonetheless, no significant proliferation occurred over time in 
culture. Analysis o f  cell density on the 3 mol% Fe2C>3 fibre forms revealed a 
significant increase in the adherent cell numbers between days 7 and 14 thus, thus 
indicating the occurrence o f cell growth. Also, and by day 14, cells were present at a 
significantly greater density on the 3 mol% Fe2C>3 fibres than that on the 2 mol% 
Fe2C>3 containing glass.
2  18  i
□  Da y  1 El Day 7 □  Day14
0  1 2  3
Fe2C>3 content (mol%)
Figure 4.10 HOB cell survival and proliferation on quaternary  glass fibres
generated  at 800 r/m in
(*) indicates a significantly higher cell density on a glass composition at one time 
point. Significant differences in cell density on one glass composition as a function of 
time in culture are connected using square brackets. (n= 3; error bars +SD).
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4.3.3.2 M aintenance o f  cell m orphology
Fluorescence microscopy evaluation o f the fibre scaffold samples, for the day 14 time 
point, revealed the prescence o f cell attachment on both, 2 (Figure 4.11. A and B)and 3 
(Figures 4.11C and D) mol% Fe: 0 3  containing, glass fibres. Adherent cells exhibited 
a well spread morphology and were oriented parallel to the fibres axes (Figure 4.11).
F igure 4.11 HOB cell Morphology on quatern ary  glass fibres at day 14 in culture
Composite light-fluorescent Leica DMIRB micrographs o f HOB cells cultured on 2 
mol% Fe2 0 3  glass fibres (A and B; X10 and X20 objective respectively) and 3 mol% 
Fe2 0 3  glass fibres (A and B; X10 and X20 objective respectively). The cytoskeleton 
was labelled with Cy3 conjugated anti vimentin antibody. Nuclei were labelled with 
the DNA-binding dye DAPI (yellow). Glass fibres were pseudo coloured (light 
green). Scale bars, X I0 objective = 100, X20 objective = 50
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By day 21, a noticeable increase in cell numbers was observed and dense HOB 
populations were present on both glass fibre compositions. Cell morphology and 
orientation patterns were also retained as seen from Figure 4.12.
Figure 4.12 HOB cell M orphology on q u aternary  glass fibres at day 21 in culture
X10 objective, Composite light-fluorescent, Leica DMIRB micrographs o f HOB cells 
cultured on 2 mol% Fe20 3 glass fibres (A) and 3 mol% Fe20 3 glass fibres (B). The 
cytoskeleton was labelled with Cy3 conjugated anti vimentin antibody. Nuclei were 
labelled with the DNA-binding dye DAPI (yellow). Glass fibres were pseudo 
coloured (light g reen).). Scale bar = 100pm.
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4.3.4 Biocompatibility of quaternary glass fibres: Oral fibroblasts
4.3.4.1 Cell survival and proliferation
As previously observed for HOB cells, no HOF cells remained attached to the 0 and 1 
mol% Fe^O.  ^ containing glass fibres by day 7 in culture. Cell attachment was 
preserved on the 2 mol% Fe^Os albeit with no significant, time associated population 
growth. On the other hand, and on the 3 mol% Fe2 0 3  fibres, a significant increase in 
cell density occurred by day 14 where this density was of significantly greater value, 
at the same time point, than that o f cells seeded on 2 mol% Fe2 0 3  fibres (Figure 4.13).
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Figure 4.13 H O F  cell survival and proliferation on quaternary glass fibres 
generated at 800 r/min
(*) indicates a significantly higher cell density on a glass composition at one time 
point. Significant differences in cell density on one glass composition as a function of 
time in culture are connected using square brackets. (n= 3; error bars +SD).
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4.3.4.2 Maintenance of cell morphology
Florescent Cy3 conjugated staining o f the vimentin intermediate filaments revealed, 
and at day 14 in culture, a well spread appearance o f the adherent HOF cells (Figure 
4.14). This was associated with both glass fibre compositions (2 and 3 mol% Fe2 0 3  
containing)
Figure 4.14 HOF cell M orphology on quaternary  glass fibres at day 14 in culture
Composite light-fluorescent Leica DMIRB micrographs of HOF cells cultured on 2 
mol% Fe2 0 3  glass fibres (A and B; X10 and X20 objective respectively) and 3 mol% 
Fe2 0 3  glass fibres (A and B; X I0 and X20 objective respectively). The cytoskeleton is 
labelled with Cy3 conjugated anti vimentin antibody. The cytoskeleton was labelled 
with Cy3 conjugated anti vimentin antibody. Nuclei were labelled with the DNA- 
binding dye DAPI (yellow). Glass fibres were pseudo coloured (light green). Scale 
bars, X10 objective = 100pm, X20 objective = 50pm
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Similarly, and by day 21, well spread morphology was maintained on both glass 
compositions and a clear increase in cell density, compared to that o f the earlier time 
point, was present (Figure 4.15). Greater cell density was noticed however, by the 
visual evaluation o f the entire scaffold, on the 3 mol% FeuCb glass fibres.
Figure 4.15 H O F  cell Morphology on quaternary glass fibres at day 21 in culture
X10 objective, Composite light-fluorescent, Leica DMIRB micrographs of HOF cells 
cultured on 2 mol% Fe2 0 3  glass fibres (A) and 3 mol% FezOa glass fibres (B). The 
cytoskeleton was labelled with Cy3 conjugated anti vimentin antibody. Nuclei were 
labelled with the DNA-binding dye DAPI (yellow). Glass fibres were pseudo 
coloured (light green). Scale bar = 100pm.
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4.3.5 Co-culture evaluation
To maintain fluorescence up to 72 h in culture with a minimum impact on HOF cell 
function, the optimal concentration o f CMFDA dye was determined at 10 pM (Figure 
4.16). This concentration o f CMFDA was subsequently used to perform fluorescent 
co-culture population differentiation.
Despite an applied separation space o f 300 pm, initial examination o f the co-culture at 
day 1 revealed the acellular zone, between the two populations, to be approximately 
o f 2800-2000 pm wide. This could be attributed to mechanical agitation, during 
manual barrier removal, disrupting adherent cells situated at close proximity to the 
partitioning structure. By day 3, and as seen from Figure 4.17, marked cell migration 
resulted in reducing the separating space to an approximate distance of a 1000 pm.
Figure 4.16 X20 objective Leica DMIRB fluorescence m icrographs of HOF cells 
labelled with CellTracker™  dye
A mixed labelled (green cytoplasm and yellow nuclei) and unlabelled (yellow nuclei 
only) HOB population at 24 h in culture. Cells were seeded on 24-wellplate control 
surfaces and CMFDA used at 10 pM. Nuclei were stained with the DNA-binding dye 
DAPI. Scale bar = 50pm.
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Figure 4.17 X10 objective fluorescent microscope image of HOB and HOF 
cells in co-culture
HOB cells (red anti-vimentin, left side) and HOF cells (Green CMFDA live dye, 
right side) seeded on (CaO)o.46-(Na20)o.oi-(Fe203)o.o3-(P205)o.5o glass fibres after 3 
days in culture. This composite light-fluorescnet micrograph was composed from 3 
adjacent microscope field images. Glass fibres were pseudo coloured (Light green). 
The nuclei were labelled with DAPI (yellow).
4.4 Sum m ary
• The optimal diameter fibre range supporting cell attachment and survival on 
the ternary composition o f the 48 mol% CaO ((CaO)o.48-(Na20)o.o2-(P205)o.5(>), 
has been determined to be approximately 30 pm and related to the fibre 
fabrication rotational speed o f 800 r/min. Fibres generated at higher speeds, 
and thus o f smaller diameter, failed to sustain cell attachment and exhibited 
signs o f structural degradation by day 4 following incubation in GM. Even at 
the largest diameter values, 48 mol% CaO containing ternary fibres were 
incapable o f supporting cell proliferation, as a decrease in seeded cell density 
was observed over time suggesting the unsuitability if these glasses, in their 
fibre form, as scaffolds for the long-term support o f tissue regeneration.
•  1 ,2  and 3 mol% Fe2 0 3  quaternary glass fibres, produced at 800 r/min, have 
been characterised in terms o f solubility, diameter and surface topography and 
it has been established, that increasing Fe2 0 3  resulted in decreasing the 
solubility rate o f the glass. It has also been concluded that the average 
diameter value o f 30 pm can be adopted when performing controlled fibre 
alignment during scaffold production. No specific glass surface topographical 
features were visible as fibres exhibited a relatively smooth surface however; 
SE production was detected and might be related to the presence o f nano-scale 
surface patterns.
• Using (CaO)o.46-(Na20)o.o4-(P205)o.5o ternary glass fibres as control, cell 
survival and proliferation was assessed on the quaternary glass fibre scaffolds 
where analysis o f direct cell count has revealed, that only 2 and 3 mol% Fe2C>3 
containing glass fibres supported cell attachment up to 14 days in culture. 
Furthermore, a clear proliferation pattern, for both HOB and HOF cell types, 
was associated with composition (CaO)o.46'(Na20)o.or(Fe203)().o.3-(P205)o.5o 
the 3 mol% Fe2 0 3  content).
1 6 0
• Cells seeded on fibres o f  both glass compositions, o f 2 and 3 mol% Fe2 0 3  
content, exhibited a well spread in vitro morphology and this appearance was 
preserved up to 21 days in culture.
•  The co-culture scaffold design, as a precursor for the in vitro regeneration o f 
the hard-soft tissue enthesis, has been successfully implemented using 
(CaO)o.46-(Na20)o.oi-(Fe203)o.o3-(P205)o.5o glass fibre scaffold.
•  Glass fibres o f the 2 and 3 mol% Fe2C>3 quaternary compositions ((CaO)o.46- 
(Na2 0 )o.o2-(Fe2 0 3 )o.o2-(P 2 0 5 )o.5o and (CaO)o.46-(Na20)o.or(Fe203)o.o3_ 
(P2 0 5 )o.5o), generated at 800 r/min rotational speed, have therefore exhibited 
considerable in vitro biocompatibility with no apparent negative impact on cell 
survival and morphology. This biocompatibility however, must be further 
confirmed through evaluating maintenance o f differentiated function o f the 
seeded cells.
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RESULTS THREE
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5.1 Introduction
By conducting qPCR experiments, HOB and HOF differentiated commitment to the 
hard and soft tissue ECM maintenance and turnover, on 2 and 3 mol% Fe2 0 3  glass 
fibre compositions, has been evaluated through assessing gene expression and 
regulation. These two quaternary glass compositions were selected as they supported, 
in their fibre form and produced at 800 r/ min rotational velocity, the attached cell 
survival and proliferation up to 14 days in culture and maintained a well spread 
cytoskeletal morphology up to 21 days in culture (Chapter 4).
qPCR analysis was also conducted to investigate the effect o f extrinsic factor 
inclusion on the in vitro cell-scaffold interaction following supplementing the HOB 
cell culture with osteogenesis inducing medium; and changes in HOB differentiation 
were evaluated.
The impact o f  medium and waste perfusion on cell function, following the use o f the 
open flow laminar bioreactor, has also been established.
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5.2 E xperim ental protocol
5.2.1 Assessment of glass fibre biocompatibility
The 2 and 3 mol% Fe;Oi containing quaternary glass fibres were arranged as 
monolayer mesh and parallel unidirectional scaffold configurations and seeded with 
HOB and HOF cells, respectively at a 3.2 x 104 cell density. At days 14 and 21, HOB 
cell maintenance o f differentiation was evaluated by quantifying gene expression 
levels for ON (Osteonectin; also termed SPARC), Cbfa-1 (core binding factor alpha 1 
subunit isoform; also termed RUNX2) and COL-1 (Collagen Type I). On the other 
hand, and at the same time points, HOF cell related gene regulation was quantified 
through analysing COL1A1 (collagen type I alpha polypeptide 1 subunit) and P4HA3 
(proline 4-hydroxylase alpha polypeptide III subunit) expression levels. The cells 
seeded scaffolds were placed in 50 mm Petri dishes and control cells were grown in 
24 wellplates.
5.2.2 Stimulation of HOB culture mineralisation
Cultures o f HOB cell seeded fibre scaffolds, o f the 2 and 3 mol% Fe2 0 3  compositions, 
were supplemented with GM containing 50 pg/ ml ascorbic acid and 10 mM 0- 
glycerophosphate (both from Sigma-Aldrich). The chemicals were prepared into 
working solutions using dH20  and filtered twice using 0.2 pm syringe filters prior to 
the in vitro application. Following total RNA extraction at days 14 and 21, 
transcription levels for ON, Cbfa-1 and COL1A1 were quantified. The scaffold 
culture was maintained in 50 mm petri dishes and control cells were grown in 24 
wellplates.
5.2.3 The laminar flow system setup
HOB and HOF cells were seeded on (CaO)o46-(Na:0 )().oi-(Fe2 0 3 )o.o3-(P2 0 5 )o.5() fibre 
scaffolds for 7 days after which, scaffolds were transferred into the flow chamber. 
This process took place in the tissue culture hood using sterile forceps. Firstly, the 
rubber tubes connected to the cell inlet and outlet were blocked using stainless steel
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tube clamps. Next, the flow chamber was filled with 5 ml o f GM; the cell seeded 
scaffold transferred from the petri dish; and the glass cover was applied and secured 
using the rubber O-ring. Finally, the chamber was placed inside the incubator and 
connected to the system, the clamps carefully removed and the flow process initiated 
by operating the roller pump.
Cells were subjected to 2 flow rates at 19.413 x 10' 3 ml/s (at near zero shear stress, 
described throughout as flow rate I); and at 9.707 x 10' 3 ml/s (50 % o f the near zero 
shear stress associated flow value, described throughout as flow rate II). Due to the 
open nature o f the flow, and the relatively high GM consumption, the experimental 
procedure was restricted to 8  h as continuous attendance, particularly overnight, was 
practically unattainable. It has been shown in various studies that detectable changes 
in gene expression, in animal and human cells, were induced following an 8  h 
exposure to flow culture conditions (Hilsey et al, Frangos et al). Cells seeded under 
static conditions (i.e. in petri dishes), and on the same scaffold configuration and 
composition, were used as controls.
5.2.3 Quantification of gene expression and regulation
For all experiments, and at the appropriate time points, adherent cells were lysed and 
total RNA extracted and verified for quality. cDNA was produced and labelled with 
the appropriate TaqMan® probes complimentary to the genes to be investigated 
(Figure 5.1.) (Section 2.10.5). HOB cells were labelled with TaqMan® probes for 
ON, Cbfa-1 and COL1A1 (product codes Hs00277762_ml, Hs00231692 m l and 
HsOO 164004 ml respectively, Applied Biosystems). HOF cells were labelled with 
TaqMan® probes for P4HA3 and COL1A1 (product codes Hs00420085_ml and 
HsOO 164004 ml respectively, Applied Biosystems). The ABI PRISM® 7300 
Sequence Detection System was subsequently used to conduct at an assay volume of 
25 pi per well and for 40 thermal cycles. Expression o f the house keeping gene 
encoding 18S rRNA (TaqMan® probe Hs99999901 s i, Applied Biosystems) was 
used as a control to compare transcription levels o f the various genes, at different time 
points and under the various culture conditions.
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5.3 Results
5.3.1 Maintenance of differentiation
5.3.1.1 Craniofacial osteoblasts
At day 14 in culture, no significant difference in ON transcription was present 
between the cells seeded on the cells seeded on fibres of both, 2  and 3 mol% Fe:0 } 
compositions (Figure 5.2a). Scaffold-associated ON transcription levels were also 
similar to those o f the control surface seeded cells. By day 21, ON gene transcription 
was up-regulated as a function o f time in culture in HOB cells seeded on the 3 mol% 
F e ;0 ’, glass composition to a level matching that o f the control cells. Cells seeded on 
the 2 niol% Fe;0;, fibres expressed significantly lower quantities of ON mRNA when 
compared to the control cells.
Quantification o f PCR products for Cbfa-1 cDNA levels, at day 14, revealed equal 
expression among cells seeded on the two glass compositions and the control surface. 
By day 21 however, Cbfa-1 regulation was lower against the control in cells cultured 
on the 2 mol % Fe:Oi composition than those adhered to the 3 mol % Fe: 0 3  fibres 
w here Osteocalcin synthesis matched that o f the control cells (Figure 5.2b).
The COL1A1 gene was expressed at higher levels in control cells, at day 14 time 
point, than in cells seeded on the scaffolds o f both quaternary glass compositions 
(Figure 5.3). Despite no changes in COL1A1 gene regulation against time in culture, 
COF1A1 mRNA synthesis was significantly lower in cells seeded on the 2 mol% 
Fe:0', glass fibres compared to that o f the control seeded HOB cells at day 21. In 
contrast, 3 mol % Fe:Oi seeded cells expressed similar levels o f COL1A1 
transcription compared to those of the control.
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Figure 5.2 Relative quantification of ON (a) and Cbfa-1 (b) gene expression
HOB cells were seeded on 2 mol% FezO} glass fibres (black bars), 3 mol% Fe2 0 3  
glass fibres (gray bars), and tissue culture plastic (white bars) and processed for qPCR 
at days 14 and 21 in culture. (*) indicates significant gene up-regulation on one 
surface against time. Significant differences in gene expression for cells seeded on 
various surfaces, and at each time point, are linked using square brackets. (p<0.05). 
(n=3, error bars +SD)
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Figure 5.3 Relative quantification of COL1 Al gene expression in HOB cells
Cells were seeded on 2 mol% Fe2 0 3  glass fibres (black bars), 3 mol% Fei0 3  glass 
fibres (gray bars), and tissue culture plastic (white bars) and processed for qPCR at 
days 14 and 21 in culture. Significant differences in gene expression for cells seeded 
on various surfaces, and at each time point, are linked using square brackets ([ and ]). 
(p<0.05). («=J, error bars +SD)
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5.3.1.2 Oral fibroblasts
Analysis o f HOF cells cDNA amplification at day 14 revealed similar cellular 
expression o f COL1A1 on the 2 and 3 mol % Fe20 3 glass and the control surfaces 
(Figure 5.4). At day 21 in culture, regulation of COL1A1 was equally expressed by 
the seeded fibroblasts on all surfaces. No changes in COL1A1 gene regulation 
occurred, as a function o f time in culture, in fibre glass scaffold and control seeded 
HOF cells.
Similarly, Quantification o f P4HA3 gene regulation between cells seeded on both 
glass fibre compositions and control tissue culture plastic yielded similar results at 
both time points (Figure 5.5). P4HA3 regulation, overtime in culture, exhibited no 
significant changes on all HOF seeded surfaces.
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Figure 5.4 Relative quantification of COL1 Al gene expression in HOF cells
Cells were seeded on 2 mol% Fe20 3 glass fibres (black bars), 3 mol% Fe20 3 glass 
fibres (gray bars), and tissue culture plastic (white bars) and processed for qPCR at 
days 14 and 21 in culture. (n=3, error bars +SD)
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Figure 5.5 Relative quantification of P4HA3 gene expression in HOF cells
Cells were seeded on 2 mol% Fe2 0 3  glass fibres (black bars), 3 mol% Fe2 0 3  glass 
fibres (gray bars), and tissue culture plastic (white bars) and processed for qPCR at 
days 14 and 21 in culture. (n=3, error bars +SD)
5.3.2. Gene regulation: Induction o f osteogenesis
As seen from Figure 5.6a, Cells seeded on the control surfaces expressed significantly 
higher levels o f ON mRNA than those seeded on the glass fibres o f either 2 or 3 
mol% Fe:Oi compositions. However, the inclusion o f ascorbic acid and P- 
glycerophosphate in the medium induced up-regulation o f ON expression in the 
control and fibre seeded HOB cells for both glass compositions as revealed by PCR 
quantification at day 21. This up-regulation also resulted in increasing ON expression, 
in cells seeded on 2 and 3 mol% Fe^O^ fibre composition, to levels similar to those 
expressed by the control cells.
A similar pattern was observed as higher levels o f Cbfa-1 transcription were 
expressed, by the control cells compared to those associated with both scaffold 
compositions at day 14 (Figure 5.6b). Cbfa-1 transcription was up-regulated however, 
on both glass compositions throughout time in culture with cells seeded on 3 mol% 
Fe^Os containing fibres, yielding similar Cbfa-1 mRNA levels to those o f the control. 
Cbfa-1 transcription remained significantly lower nevertheless, in cells seeded on the 
2 mol% Fe^Oi fibres, than that expressed by the control cells. It should also be noted 
that no changes in Cbfa-1 regulation was associated with the control seeded HOB 
cells.
COL1A1 transcription was regulated at significantly higher levels by the control cells 
than those seeded on the fibre scaffolds at day 14 time point however, 3 mol% Fe2 0 3  
seeded HOB cells expressed higher level o f COL1 A l than those associated with the 2 
mol% Fe2 0 3  containing fibres (Figure 5.7.). Unlike the results obtained under normal 
(non-osteogenic) GM culture conditions, COL1A1 was up-regulated on both scaffold 
compositions as indicated by qPCR analysis at day 21. Again, control cells have been 
shown to yield higher COL1A1 mRNA quantities than those produced by the 
scaffolds seeded cells.
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Figure 5.6 T he effect of osteogenic medium on ON and Cbfa-1 gene regulation
HOB cells were seeded on 2 mol% Fe: 0 3  glass fibres (black bars), 3 mol% Fe^Os 
glass fibres (gray bars), and tissue culture plastic (white bars) and processed for qPCR 
at days 14 and 21 in culture. (*) indicates significant gene up-regulation on one 
surface against time. Significant differences in gene expression for cells seeded on 
various surfaces, and at each time point, are linked using square brackets. (/?<0.05). 
(n-3, error bars +SD)
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Figure 5.7 The effect of osteogenic medium on COL1A1 gene regulation
HOB cells were seeded on 2 mol% Fe20 3  glass fibres (black bars), 3 mol% Fe20 3 
glass fibres (gray bars), and tissue culture plastic (white bars) and processed for qPCR 
at days 14 and 21 in culture. (*) indicates significant gene up-regulation on one 
surface against time. Significant differences in gene expression for cells seeded on 
various surfaces, and at each time point, are linked using square brackets. (p<0.05). 
(n=3, error bars +SD)
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5.3.3 G ene regulation: The effect o f flow culture conditions
5.3.3.1 Craniofacial osteoblasts
ON gene expression has exhibited insignificant differences in HOB cells subjected to 
both, I and II flow rates for 8  h. Also, no significant differences in ON transcription 
rates, when compared to the cells incubated under static culture conditions, were 
registered in the cells exposed to flow conditions (Figure 5.8a).
Similarly, Cbfa-1 mRNA synthesis yields related to flow rates I and II, appeared to be 
similar in the seeded HOB cells. The quantity of these yields also appeared 
independent from the flow culture conditions as no differences in qPCR results were 
obtained for gene expression between cells subjected to both flow rates, and those 
seeded under static culture condition control (Figure 5.8b).
As seen from Figure 5.9, COL1A1 transcription has underwent no significant, flow 
condition related changes for both rates in comparison with the control cells, and no 
significant differences were observed in COL1A1 gene expression when the effects to 
the two flow rate values were compared (Figure 5.9).
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Figure 5.8 The effect of laminar GM flow on ON and Cbfa-1 gene transcription
qPCR analysis results for ON (a) and Cbfa-1 (b) gene expression. HOB cells were 
seeded on (CaO)o.46-(Na2 0 )o.or(Fe2 0 3 )o.o3-(P:0 5 )o.5o glass fibre scaffolds for 7 days, 
subjected to laminar flow at 19.413 x 10' 3 ml/s (Flow rate I) and 9.707 ml/ s x 10‘3 
(Flow rate II) for 8  h. cells seeded under static culture conditions were used as 
controls ([C]). (n=3, error bars +/-SD)
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Figure 5.9 The effect of laminar GM flow on COL1A1 gene transcription in 
HOB cells
qPCR analysis results o f HOB cells seeded on (CaO)o.46-(Na20)o.or(Fe203)o.o3- 
(P:0 5 )o.5o glass fibre scaffolds for 7 days, subjected to laminar flow at 19.413 x 10' 3 
ml/s (Flow rate I) and 9.707 x 10' 3 ml/ s (Flow rate II) for 8  h. Cells seeded under 
static culture conditions were used as controls ([C]). (n=3, error bars +/-SD)
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5.3.3.2 O ral fibroblasts
COL1A1 gene expression levels in HOF cells subjected, for 8  h, to flow rate I 
matched those o f the control as no significant differences were obtained (Figure 5.10). 
At the higher flow rate I however, COL1A1 mRNA synthesis was down-regulated 
ensuing the 8  h flow application as quantification of PCR products revealed 
significantly lower COL1A1 expression values in comparison with both, cells 
exposed to flow rate 1 and the control cells.
On the other hand, and when assessing P4HA3 gene expression, no significant 
changes in gene expression were induced by either flow rate in comparison with the 
control and COL1A1 transcription rates, related to each flow value, were 
insignificantly different when compared (Figure 5.11).
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Figure 5.10 The effect of laminar GM flow on COL1A1 gene transcription in 
HOF cells
qPCR analysis results o f HOF cells seeded on (CaO)o.46-(Na2 0 )o.or(Fe2 0 3 )o.o3- 
(P2 0 5 )o5o glass fibre scaffolds for 7 days, subjected to laminar flow at 19.413 x 10' 3 
ml/s (Flow rate I) and 9.707 x 10' 3 ml/ s (Flow rate II) for 8  h. Cells seeded under 
static culture conditions were used as controls ([C]). (*) indicates significantly 
different gene transcription values between flow subjected, and control cells. (+) 
indicates significantly different gene transcription values between cells subjected to 
different flow rates. (p<0.05) (n=3, error bars +/-SD)
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Figure 5.11 The effect of laminar GM flow on P4HA3 gene transcription in HOF 
cells
qPCR analysis results o f HOF cells seeded on (CaO)o.46-(Na:0 )o.or(Fe2 0 3 )o.o3- 
(P^OsJo.so glass fibre scaffolds for 7 days, subjected to laminar flow at 19.413 x 10‘3 
ml/s (Flow rate I) and 9.707 x 10' 3 ml/ s (Flow rate II) for 8  h. Cells seeded under 
static culture conditions were used as controls ([C]). (n-3, error bars +/-SD)
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5.4 Sum m ary
• Compared to the tissue culture seeded control cells, HOB cell differentiation 
have been maintained on the glass fibre scaffolds o f the (CaO)o.46-(Na20)o.oi- 
(Fe20 3 )ooH P 2 0 5 )o5o composition as no impact on HOB commitment to the 
bone ECM maintenance resulted from the use o f these glasses as substrates. 
Quantification o f PCR for ON and Cbfa-1 cDNA revealed gene expression 
levels closely approximating those o f control cells at all investigated time 
points, with ON gene transcription up-regulated as a function o f time in 
culture. COL1A1 mRNA synthesis was also expressed at similar levels, after 
2 1  days in culture, on the scaffold and control surfaces.
•  HOF cell commitment to the ECM turnover also appeared to have been
preserved on glass fibres o f 2 and 3 mol% fe20 3  content. No significant
differences in COL1A1 and P4HA3 gene transcription levels on theses glasses 
were observed, at all time points, when compared the control surfaces.
• The inclusion o f osteogenic supplements in the HOB cell culture GM resulted
in up-regulating all the investigated genes on fibres o f both 2 and 3 mol%
fe20 3  compositions bringing ON transcription levels in particular, and on both 
glass compositions, to closely match those o f the control. This has highlighted 
the important role o f extrinsic factors in enhancing scaffold associated in vitro 
morphogenesis o f tissue.
•  Subjecting (CaO)o.46-(Na20 )o.or(Fe20 3 )o.o3-(P2 0 5 )o. 5 0  fibre scaffold seeded 
HOB cells to flow conditions, at 19.413 x 10' 3 and 9.707 x 10' 3 ml/ s, induced 
no significant changes in ON, Cbfa-1 and COL1A1 gene expression in relation 
to both flow rates and in comparison to the static cell culture conditions.
• Compared to control and 19.413 x lO’3 flow subjected cells, COL1A1 gene 
ascription was significantly lower in HOF cells exposed to the 9.707 x 10' 3 
ml/s flow rate. P4HA3 transcription on the other hand appeared to be
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unaffected by the application o f medium perfusion at either flow rate and in 
comparison with to control.
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CHAPTER SIX 
DISCUSSION
1 8 2
6.1 Introduction
The use o f artificial materials in the fields of medicine and biology has been the 
subject o f  rapidly increasing interest and continuous development in recent years. 
Concurrently, the multidisciplinary research field of tissue engineering underwent 
considerable advances in utilising such artificial substances as biocompatible and 
bioactive templates (or scaffolds) for regenerating deficient tissue structures with the 
aim o f  overcoming the disadvantages o f conventional therapeutical practices.
In order to apply the principles o f tissue engineering to generate the hard-soft tissue 
interfaces, as an alternative cell transplantation strategy dealing with the clinical 
problems o f ligament/ tendon disease and injury (Section 1.2), an in vitro cell-scaffold 
interaction must be promoted so that the morphogenesis of histologically, 
biomechanically and genetically compatible tissue units can be induced using the 
patient’s own differentiated site specific or mesenchymal stem cells.
It is clear, nonetheless, that the scaffold constituting material must possess 
biocompatible properties permitting cell attachment and viability with no adverse 
effect on cell phenotype characteristics and function. Furthermore, this material must 
allow the long-term maintenance o f the adherent cell differentiated function whereby 
the turnover o f the newly synthesized matrix can be sustained. The material should 
also be soluble in a controllable manner corresponding to the in vitro morphogenesis 
and, if  necessary, the rate o f  the in vivo maturity and integration o f the hybrid tissue. 
Again, the biocompatibility o f the soluble material is o f extreme importance as 
inflammatory, toxic or immunogenic reactions to the in vivo degradation o f the 
material should be o f limited, short term and containable scope.
As outlined in section 1.8, numerous polymeric biodegradable substances are 
currently undergoing extensive assessment as fibre scaffold materials for tissue 
engineering. W hether naturally derived (collagen, fibrinogen, hyaluronic acid) or 
synthetic (PLLA, PGA, PLAGA), several reports have demonstrated the promising 
potential o f  these substances in supporting bone, ligament and tendon tissue 
regeneration (Burg et al., 2000; Holy et al., 2000; Novikova et al., 2003). 
M echanically however, polymers are inherently weak and structural reinforcement 
into composites is often a requirement. Moreover, the release o f the synthetic form 
degradation products has been shown to be associated with the induction o f an acute
183
inflammatory response which may, potentially, hinder the critically important in vivo 
integration o f the implanted hybrid tissue (van et al., 1994; Meikle et al., 1994; Martin 
et al., 1996; Winet and Bao, 1997; Holy et al., 2000).
As several reports have suggested, soluble phosphate based glasses may fulfil the 
benchmark criteria o f biocompatibility and can be considered for in vitro evaluation 
as scaffold forming materials (Section 1.9.2). Furthermore, these glasses were 
frequently described as bioactive promoting the formation o f biological bonding, vital 
for the implant integration to both hard and soft tissues (Hench, 1998). These glasses 
can be produced with controllable degradation profiles and, in the form o f fibres, can 
be fabricated into three dimensional scaffolds o f suitable shape and volume matching 
those o f  the tissue structure to be replaced (Ahmed et al., 2004a; Ahmed et al., 
2004b). Fibres generated from phosphate glass species have also been shown to 
possess considerable tensile strength that may aid in withstanding the mechanical 
forces in an in vivo environment (Pahler and Bruckner, 1982; Lin et al., 1994).
This study therefore assessed the short term biocompatibility o f these ternary glasses, 
o f the generic form, in terms o f HOB, HOF and HTF cell attachment, survival, 
morphology and maintenance o f phenotype. Subsequently, and based on the most 
biocompatible ternary compositions, quaternary Fe2 0 3  containing glass fibre scaffolds 
were produced and evaluated for biocompatibility.
The role o f  extrinsic factors in enhancing in vitro tissue formation has also been 
investigated through inducing scaffold associated osteoblast differentiation, and the 
application o f flow culture conditions. A contiguous co-culture scaffolding system, 
seeded with both HOB and HOF cells, has also been devised.
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6.2 B iocom patibility  o f  ternary glass com positions
6.2.1 Introduction
Studies conducted at the EDI laboratories have demonstrated that substrates obtained 
from the ternary form o f these glasses, particularly those o f 30 mol% CaO content, 
have resulted in no negative impact on osteoblastic differentiation (Salih et al., 2000). 
Accordingly, This study evaluated the short term biocompatibility o f ternary glass 
compositions containing 30-48 mol% CaO, and o f the generic form (CaO)o.x- 
(Na2 0 )o.y-(P2 0 5)o.5 , in terms o f  HOB, HOF and HTF cell attachment, survival, 
morphology and maintenance o f phenotype with the aim o f determining the most 
suitable composition, or compositions, for biocompatible scaffold production. The 
solubility o f these glasses is controlled by the presence o f CaO and as concluded by 
previous reports, increasing CaO content decreases the corresponding glass solubility 
rates (Franks et al., 2000; Knowles et al., 2001; Franks et al., 2001). The ternary 
glasses investigated in this study therefore ranged from the high on solubility, 30 
mol% CaO containing composition to the low on solubility, 48 mol% CaO containing 
glass.
6.2.2 Cell attachment and survival
The survival o f  anchorage-dependent cells such as HOB, HOF and HTF is strongly 
dependant on the appropriate cell attachment to the substrate surface. The presence 
and nature o f this attachment greatly influences essential cellular mechanisms such as 
protein synthesis, proliferation, differentiation, migration and apoptosis (Richman et 
al., 2005). Accordingly, scaffold constituting materials must permit functional cell 
attachment within the 24-48 h following cell seeding (Baeakova et al., 2004).
Initial experiments using the CyQUANT cell density assay revealed, after 180 min in 
culture, considerably lower MG-63 cell density on ternary glass discs containing < 40 
mol% CaO than that on the 40 mol % CaO content where cell density matched that o f 
the control surface(figure 3.3). This result was visually confirmed, using SEM, as 
these compositions o f < 38 mol% CaO content supported little or no cell attachment 
(figure 3.4, table 3.2). It is probable, and due to the high solubility o f these glasses,
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that surface degradation (figure 3.4 C and D) hindered the efficient deposition o f 
ECM molecules required for functional cell attachment thus causing the induction 
apoptosis in the seeded cell population. On the other hand, the lack o f cell survival on 
the highly soluble glasses may be attributed to higher levels o f Na cation release into 
the culture environment. Recent work investigating a 50 mol% P2O 5 ternary glass 
composition has shown that N a+ ion release was proportionate to the rate o f glass 
degradation (Ahmed et al., 2004b). For 30, 35 and 40 mol% CaO containing 
compositions, Na+ ion release levels at day 7 in solution were approximately 65, 40 
and 25 PPM (parts per million: unit o f  concentration by weight) respectively. Several 
studies have suggested that higher concentrations o f Na+ result in the alkalization of 
the local environment (increased pH levels), thus negatively affecting cell viability 
(Jonasova et al., 2002).
In contrast, and as observed by fluorescence microscopy, the 40 to 48 mol% glass 
compositional range supported HOB, HOF and HTF cell survival up to 7 days in 
culture. However, visual observation revealed higher levels of adherent cells on the 48 
mol% CaO glass in comparison with the control surfaces and at all time points. This 
was confirmed when conducting CyQUANT analysis as significantly higher levels o f 
nucleic acid content for the seeded HOB cells (at time points day 1, 4 and 7) (Figure 
3.13), and HOF cells (Figure 3.19), were associated with the glass composition 
containing 48 mol% CaO when compared to the higher on solubility, 40 mol% CaO 
glass form.
The seeded cell viability therefore is clearly dependent on the glass composition and 
in this respect, the least soluble glasses containing 48 mol% CaO emerged as the most 
biocompatible by means o f supporting cell attachment and short term survival.
6.2.3. Cell morphology and phenotype
The nature and extent o f cell attachment, as determined by cell morphology, are 
important factors in assessing the biocompatibility o f the scaffold constituting 
material in terms o f both adhesivity and cytotoxicity. Following cell attachment, 
reorganization o f actin microfilaments results in initiating various intracellular 
signalling mechanisms influencing major cellular events such as proliferation, 
differentiation, protein synthesis and survival. For anchorage-dependant cells, a well
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spread attachment is vital for cell division and population growth whilst an impaired 
round (spherical) attachment will invariably lead to cell death (Dubin-Thaler et al., 
2004). The soluble scaffold material should therefore provide adequate surface 
adhesion to support a well-spread morphology, the maintenance o f which, is 
indicative o f the lack o f  degradation product toxicity. Morphological evaluation o f 
both osteoblasts and fibroblasts revealed rounded cell morphology on lower CaO 
containing glass surfaces in particular that o f the 40 mol% CaO content whilst on 
higher CaO containing glass compositions, mainly that o f the 48 mol% CaO content, 
a considerable proportion o f the cell population exhibited a well-spread morphology 
o f a conformation resembling that o f  the cells seeded on control surfaces.
A well spread cytoskeleton is also important in maintaining the phenotypic function 
o f the cell (Lim et al., 2004). The cell phenotype Is the functional outcome o f its 
differentiated commitment to perform specific tasks as, for example, the osteoblastic 
phenotype Is expressed by the cell ability to synthesize and induce the mineralisation 
o f the bone ECM. This study evaluated the maintenance o f HOB, HOF and HTF 
phenotype by assessing, via immunocytochemistry, the ability o f the seeded cells to 
synthesize the ECM proteins required to maintain both hard and soft tissues.
HOB cells were characterized and the maintenance o f their phenotype on the ternary, 
40 to 48 % CaO containing, glasses was evaluated through immunolabelling the bone 
associated noncollagenous proteins (NCPs): BSP, ON and OP. BSP accounts for 15 % 
o f the NCPs present in bone and has been shown to play an active role in bone ECM 
remodelling and osteoblast differentiation. OP is also implicated in bone remodelling 
through inhibiting nucleation and HA crystal growth. Moreover, both BSP and OP are 
bone specific and both contain RGD m otif peptide sequences and actively engage in 
receptor-mediated cell binding to the bone ECM (Hing, 2004). As a nucleator, ON has 
the capacity to bind to Ca+ and collagen types I and V, thus initiating the process o f 
heterogeneous nucleation necessary for bone mineralisation (Section 1.6.3.2). Studies 
have also suggested a role for ON in regulating cell-matrix interactions (Hing, 2004). 
In a pattern similar to that o f the control cells, and providing that cell spreading was 
present, synthesis o f bone associated proteins BSP, ON and OP by HOB cells cultured 
on the highest calcium containing glass composition, i.e. 48 mol% CaO, was 
observed at all time points and up to 7 days in culture (figures 3.8, 3.9 and 3.10).
The HOF and HTF phenotype was characterized by the 5B5 antibody labelling to 
detect the production o f P-4-H, the enzyme vital for procollagen molecule assembly
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and collagen synthesis (Section 1.6.3.3). Several studies have suggested the use o f the 
5B5 as a marker for fibroblastic activity(Bosseloir et al., 1994; Ohtsubo et al., 2000; 
U lf et al., 2002). HOF and HTF cells seeded on the 48 mol% CaO containing glass 
composition were capable o f synthesising P-4-H, at all time points, as the presence o f 
positive punctate staining for P-4-H was conformed by fluorescence immunostaining 
(Figures 3.14 and 3.15). Again, this was only associated with the presence o f a well 
spread cytoskeleton (Figures 3.16 and 3.17).
6.2.4 Cell proliferation
The fully differentiated cell is post proliferative, i.e. with a suppressed capacity to 
divide, hence the reciprocal relationship between differentiation and proliferation 
(Aparicio et al., 2002). When primary, fully differentiated cells are isolated from 
tissue the population gradually undergoes dedifferentiation and becomes more 
committed to cell division. This process is caused by the lack of biochemical and 
biomechanical inducers o f cell differentiation in the cell culture environment 
(Cervenkova et al., 2001). Cell proliferation however, is an important step in inducing 
in vitro tissue morphogenesis as a high level o f cell density is required for the 
adequate cell invasion o f  the scaffold to take place (Itoh et al., 2001). Once this has 
been achieved and the appropriate cell density has been reached, multi-dimensional 
cell-cell interactions will result in population redifferentiation and the subsequent 
tissue formation (Holmes, 2002). Redifferentiation can also be induced following the 
cell interaction with the newly formed ECM and by providing the appropriate stimuli 
to the cell-scaffold culture environment, e.g. mechanical load or growth factors (Sage, 
2001; Cancedda et al., 2003).
As revealed by the CyQUANT analysis, and despite supporting cell survival and 
phenotype, no significant cell proliferation and population growth was established on 
the least soluble, 46 and 48 mol% CaO containing, glass compositions (Figures 3.12 
and 3.18).
The extent and nature o f cell attachment to substrates is critical for the ensuing cell 
population growth (Cowles et al., 2000). Therefore, and due to the soluble nature o f 
the glass, it is probable that the sufficient attachment necessary to ensure proliferation 
has not been permitted.
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The least soluble ternary glass compositions, particularly o f the 48 mol% CaO 
content, supported cell attachment and survival up to 7 days in culture where a 
significant proportion o f the seeded population exhibited a well spread morphology. 
The biocompatibility o f these glasses appeared to be directly linked to solubility as 
when cell survival and well spread morphology have been supported, no toxic effect 
o f glass degradation products were apparent as phenotypic protein expression o f the 
seeded cells had been maintained. Glass compositions (CaO)o.48-(Na20)o.o2-(P205)o.5 
and (CaO)o.46-(Na20)o.o4-(P205)o.5, o f the 46 and 48 mol% CaO respectively, were 
therefore elected as base compositions for glass fibre production. However, and due to 
the lack o f  the seeded cell proliferation, the solubility o f these glasses had to be 
further controlled by introducing a fourth precursor into the glass formulation.
6.3 The glass fibre system
6.3.1 Introduction
The architectural properties o f the scaffold must take into consideration the 
anatomical nature o f the tissue to be generated. Therefore, and as the main objective 
o f this study was to asses the potential use o f phosphate based glasses as 
biocompatible scaffolds for engineering the hard-soft tissue interface, a fibre-based 
structure may present an ideal scaffold system. Glass fibres provide a contiguous 
matrix onto which, both cellular components o f the interface can be seeded (i.e. 
osteoblasts and fibroblasts). Additionally, these fibres can easily be moulded to fit the 
defect area to be repaired.
The use o f  fibre-based constructs has been evaluated in numerous studies as scaffolds 
for tissue regeneration. Naturally derived fibre systems (collagen and elastin) have 
been investigated for vascular regeneration (Buijtenhuijs et al., 2004; Buttafoco et al., 
2006). Bioactive glasses, particularly Bioglass® 45S5, have also been considered as 
fibre based systems for peripheral nerve and bone repair with promising potential 
(Clupper et al., 2004; Bunting et al., 2005).
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6.3.2 The effect o f  fibre diam eter on cell attachm ent and viability
Surface geometry and morphological characteristics o f the biocompatible scaffold 
greatly influence the seeded cell viability and behaviour (Salgado et al., 2004). For 
example, pore size variations in porous scaffold constructs yield variable surface 
characteristics firstly, by increasing or decreasing the surface area available for cell 
attachment and secondly, by producing different surface topography patterns. This has 
been shown, in numerous studies, to have a direct implication on the seeded cell 
viability, migration and proliferation (Laurencin et al., 1999; Stangl et al., 2001; 
O 'Brien et al., 2005). In this regard however, little information is available on the 
effect fibre diameter may exert on the biocompatibility of fibre-form scaffold systems. 
As detailed in Section 2.2.4, phosphate based glass fibres can be produced at various 
diameters depending on the drum rotational speed. Morphologically, fibres o f various 
diameters differ in their surface area and surface curvature and subsequently, fibres o f 
larger diameters are characterised by a larger surface area and less surface curvature. 
On 48 mol % CaO containing ternary glass fibres, HOB cell attachment pattern and 
viability were proportionate to the seeded fibre diameter where fibres drawn at 800 r/ 
min, i.e. o f  the largest diameters, accommodated higher numbers o f attached cells 
than those o f  smaller diameters after 24 h in culture (figures 4.1 and 4.2). Over time, 
and despite a reduction in the attached cells number, only the 800 r/min produced 
fibres supported the survival o f HOB cells up to 7 days. Similarly, HOF cells survival 
was directly linked to fibre diameter and at day 7 time point, no cells were present on 
the fibres generated at 1200 and 1600 r/ min (Figures 4.3 and 4.4).
These results are in line with recent findings by Spallazzi et al. where it has been 
shown that chondrocyte adhesion to microspheres was affected by the surface 
curvature o f  the material. In fact, an increased curvature resulted in significantly 
delaying cell spreading on the substrate (Spalazzi et al., 2003). It had been also 
suggested, that fibre curvature influenced tendon fibroblast morphology and 
orientation on synthetic polymer scaffold materials (Ricci et al., 1984). The drum 
rotational speed o f 800 r/min was therefore adopted for quaternary glass fibre 
production henceforth.
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6.3.3 G lass fibre structural m odification
Despite maintaining attachment, morphology and phenotype, cells seeded onto ternary 
phosphate based glasses exhibited no significant proliferation trends over time in 
culture. As the biocompatibility o f phosphate based glasses appeared to be directly 
affected by the glass solubility (Section 3.4), the ternary glass form was modified 
into a less soluble quaternary form by adding Fe2C>3 as a fourth precursor. The 
inclusion o f  Fe2C>3 as a network modifier has been shown to strengthen the glass 
network structure and to significantly reduce solubility (Lin et al., 1994; Ahmed et al., 
2004a). This might be attributed to the replacement o f P -O -P  bonds (Figure 1.13) in 
the glass by F e -O -P  bonds, and to the strong cross-linking o f the phosphate chains by 
the iron ions (Ahmed et al., 2004a). In a study by Lin et al., the addition o f Fe2C>3 
resulted in the production o f  phosphate based glass fibres o f reduced solubility, 
increased fibre tensile strength and enhanced glass transition temperature (Lin et al., 
1994). Quaternary Iron-phosphate glass fibres evaluated at the EDI have been shown 
to be o f  considerable biocompatibility as scaffolds for muscle tissue engineering 
(Ahmed et al., 2004a; Shah et al., 2005).
In this study, quaternary iron-phosphate glass fibres of 1, 2 and 3 mol% Fe2C>3 content 
(generic form (CaO)o.4 6-(Na2 0 )o.ox-(Fe2 0 3 )o.oy-(P2 0 5)o.5o) were produced using the 
ternary glass o f  the 46 mol% CaO content as a base composition. This ternary 
composition was chosen as it permitted the addition o f up to 3 mol% Fe2 0 3  into the 
glass network. As expected, solubility measurements have shown that increasing the 
Fe2 0 3  significantly decreased the corresponding glass dissolution rate (Figures 4.6 
and 4.7)
6.3.4 Cell viability, proliferation and morphology
Following direct cell count experiments it appeared that all three quaternary glass 
compositions, and the control 46 mol% CaO containing ternary form, supported cell 
attachment to the fibre surface at day 1 in culture for both HOB and HOF cell types 
(Section 4.3.4). However, and beyond the initial time point investigated, cell survival 
was only retained on glass fibres containing 2 and 3 mol% Fe2 0 3  (compositions 
(CaO)o.46-(Na20)o.o2-(Fe203)o.o2-(P205)o.50 and (CaO)o.46-(Na20)o.oi -(Fe2 0 3 )o.o3-
(P20s)o.5o) where the presence o f a viable cell population was detected up to 14 days
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in culture (figures 4.10 and 4.13). Again, the capacity o f the glass to retain cell 
attachment appeared to be directly linked to its solubility profile and as can be seen 
from Figure 4.6, 2 and 3 mol% Fe2 0 3  containing glasses were the least soluble among 
the compositions investigated.
More importantly, a significant increase in cell density for both cell types, and over 
time in culture, was associated with the 3 mol% Fe2C>3 glass composition (CaO)o.46- 
(Na20 ) 0.o i -(Fe20 3)o.o3-(P205)o.50 suggesting that the substrate properties necessary for 
cell proliferation have been fulfilled. This result was verified by fluorescence 
microscopy as after 21 days in culture where considerable proportions o f the surfaces 
o f the examined scaffolds were invaded by dense populations o f HOB and HOF cells. 
This was, as expected, mainly associated with the 3 mol% Fe2 0 3  fibre composition 
(figures 4.12 and 4.14).
The adhered cells exhibited a well spread morphology across the entire seeded 
population where cell spreading was parallel to the fibre axes. Similar work has 
reported the presence o f this particular form o f cytoskeletal orientation on fibre 
substrates and it has been suggested, that cell spreading occurred in the favourable 
plane along the fibre axis rather than the highly curved fibre circumference (Ricci et 
al., 1984). This orientation may also become reinforced by the scaffold configuration 
where the constituting fibres are arranged with minimum inter-fibre distances, and the 
formation o f  pseudo grooves between adjacent fibres may occur. On grooved 
substrates, the geometrical distribution o f focal adhesions influences the 
reorganisation o f microtubules and actin filaments where subsequent cell spreading 
and migration are oriented parallel to the groove direction (Oakley and Brunette, 
1993).
As a soluble material, the 3 mol% Fe2 0 3  containing quaternary composition has 
demonstrated excellent surface adhesivity by permitting ECM adhesion molecules 
adsorption and the subsequent cell attachment, spreading and proliferation with no 
apparent cytotoxicity in terms o f cell morphology and population growth. This on the 
other hand has highlighted the advantageous surface properties o f these glasses, as 
high levels o f cell adhesivity have been provided without the need for surface 
modification. In comparison, most synthetic polymers are naturally hydrophobic so 
that adsorbed adhesion proteins become rigid and integrin receptor recognition- 
resistant. Accordingly, the use o f these materials as biocompatible scaffolds is often 
dependent on increasing surface hydrophilia (wettability) by various methods such as
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ion bombardment, ultraviolet light irradiation and plasma glow discharge (Khang et 
al., 1997; Baeakova et al., 2004).
6.3.5 Maintenance of cell differentiation
Further to evaluating the seeded cell long term viability and proliferation, the 
biocompatibility o f the quaternary glass compositions, in terms o f cytotoxicity, was 
verified by assessing the maintenance o f cell differentiation. Therefore, and as 
detailed in Section 5.2.1, qPCR experiments were used to quantify mRNA 
transcription levels associated with the regulation o f HOB and HOF cell differentiated 
function in synthesising, and maintaining, the ECM associated with each cell type. It 
has also been established whether ECM turnover related gene transcription has been 
up-regulated by the presence o f any bioactive influence o f the glass. Soluble calcium 
phosphate containing bioceramics and glasses are frequently described as class A 
bioactive materials as possessing firstly; conductive properties by permitting cell 
migration from, and the binding o f adjacent tissue in vivo and secondly; an inductive 
effect, i.e. activating the cellular processes necessary for tissue formation (Hench, 
1998; Gunatillake and Adhikari, 2003). In a study by Knabe et al., primary human 
osteoblasts were seeded onto a Ca2 -KNa(PC>4 )2  based biodegradable scaffold material 
and it has been shown that the presence o f this substrate significantly enhanced gene 
expression for COL-I, ALP, OP, OC and ON when compared with tricalcium 
phosphate substrates (Knabe et al., 2005).
COL-I synthesis by HOB cells is essential for ECM formation and maintenance (see 
chapter one) whilst ON synthesis, and as previously mentioned in this chapter, is 
indicative o f  active involvement in ECM mineralisation. Also, the expression and 
regulation o f  osteocalcin (OC) transcription factor encoding gene, Cbfal, is truly 
indicative o f osteoblastic function as osteocalcin is synthesised when remodelling o f 
the bone ECM is activated (Karsenty, 2000). OC, termed bone Gla (gamma- 
carboxyglutamate) protein, is the most abundant transmembrane protein in bone 
forming approximately 20% o f the total NCPs. OC acts as a potent inhibitor o f 
mineralisation by suppressing nucleation and crystal growth o f HA (Hauschka et al., 
1989; Hing, 2004).
The transcriptions o f ON and Cbfa-1 were activated and maintained on 3 mol% Fe2 0 3  
glass composition ((CaO)o.46-(Na20 )o.oi-(Fe2 0 3 )o.o3-(P2 0 5)o.5o) over time in culture
193
with mRNA synthesis levels, for both genes and at day 14 and 21 time points, 
matching those o f the control cells. Furthermore, ON gene expression was up- 
regulated as a function o f time in culture and no similar trend was associated with the 
control cells. This may suggest that the presence o f the phosphate glass fibres resulted 
in enhancing osteoblastic differentiation by stimulating HOB cell engagement in 
ECM nucleation. On the other hand, no changes were observed in Cbfa gene 
expression against time in culture. This might be attributed to the fact cbfa-1 
transcription is closely related to OC synthesis and as a late marker o f osteoblastic 
activity, OC transcription is normally up-regulated following bone ECM 
mineralisation and maturation, during the bone remodelling phase (Franceschi and 
Iyer, 1992; Xiao et al., 1998). COL1A1 (encoding collagen type I alpha-1 polypeptide 
chains) gene regulation was also maintained and at the most advanced time point, 
similar COL1A1 mRNA synthesis levels were exhibited by the control and the 3 
mol% Fe2 0 3  glass seeded cells.
HOF cell differentiation was also maintained, on both 2 and 3 mol% glass 
compositions and at all the time points investigated (Figures 5.4 and 5.5). The 
capacity o f scaffold seeded HOF cells to deposit and maintain soft tissue ECM by 
synthesising, and assembling, COL-I molecules (Figure 1.10) remained intact when 
compared with that o f the control cells as indicated by qPCR analysis o f COL1A1 
gene expression.
It is worth considering that the control tissue culture polystyrene is treated in a variety 
o f ways to increase wettability by incorporating various anionic groups into the 
surface, thus providing the optimum environment for initial non-specific cell 
adhesion, protein adsorption, integrin-mediated attachment and the subsequent cell 
spreading and function (Scolaro et al., 2005). It is therefore significant, taking into 
consideration the glass solubility and the highly curved surface geometry, that 3 
mol% Fe2C>3 glass fibre scaffolds maintained HOB and HOF differentiation in a 
similar m anner to that o f the control surfaces.
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6.4 Extrinsic factor inclusion: The affect on cell function
As detailed in section 1.7.5, designing cell-scaffold culture systems for tissue repair 
must take into consideration the various extracellular components such as matrix 
proteins (e.g. NCPs and proteoglycans) and soluble factors (e.g. growth factors, 
hormones and vitamins). In vito induction o f tissue morphogenesis must also utilise 
the use o f  bioreactor systems so that mechanical stimuli, medium diffusion and wate 
remocal can all delivered to the culture environment.
6.4.1 Induction of osteogenesis: enhancing scaffold associated 
osteoblast differentiation
As described in Sections 1.6.2.4 and 1.6.2.5, in vivo bone ECM formation and 
mineralisation is a highly organised process sequentially involving (i) preosteoblast 
differentiation into osteoblasts; (ii) the synthesis and deposition of the collagen matrix 
by the differentiated cells and; (iii) the HA nucleation and ECM calcification. Despite 
being prim arily mediated by osteoblastic action, this process is regulated and greatly 
dependent on the presence o f  The application o f tissue engineering strategies must 
therefore address the inclusion o f these factors when attempting to induce in vitro 
bone morphogenesis.
As previously demonstrated (Section 4.3.3), glass fibre composition (CaO)o.4 6- 
(Na2 0 )o.oi-(Fe2 0 3 )o.o3-(P2 0 5 )o.5o exhibited excellent scaffold material properties and it 
is hence important, that mineralised tissue formation is induced by providing the 
appropriate cell-scaffold culture environment.
Ascorbic acid (AA, Vitamin C) induces the in vitro differentiation o f embryonic stem 
cells into osteoblasts(zur Nieden et al., 2003). In the differentiated osteoblast, AA 
transport into the cell is conducted by a Na+ dependent protein, SVCT1 (sodium- 
dependent vitamin-C transporter 1) whose up-regulation is induced by 
dexamethasone. AA has been shown to up-regulate gene expression for Type I 
procollagen and stimulate collagen synthesis (Franceschi and Iyer, 1992). AA also 
plays a major role in regulating mineralised ECM remodelling by influencing OC 
production. OC synthesis is triggered by the action o f OSE2 (osteocalcin gene 2 
promoter) which, in turn, is activated by the interaction between AA and Osf2 (OC 
transcription factor, encoded by Cbfal gene) and the in vitro addition o f AA therefore,
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has resulted in up-regulating OC transcription rate (Franceschi and Iyer, 1992; Xiao et 
al., 1998).
In this study, 2 and 3 mol% Fe2 0 3  containing glass fibre scaffold cultures were 
supplemented with AA and the ensuing effects on HOB differentiation were 
evaluated. The culture was also supplemented with P-glycerophosphate as a source of 
the organic phosphate necessary for HA nucleation and crystal growth(Bcck, Jr. et al., 
2000).
As a result (Figures 5.6 and 5.7), gene expression for COL1A1, ON and Cbfa-1 was 
up-regulated on both glass compositions against time in culture suggesting that the 
scaffold seeded HOB cell capacity to synthesise collagen; and regulate the 
mineralisation o f  bone ECM had been significantly enhanced. This trend was not 
associated with HOB cells seeded in normal GM, i.e. with no osteogenesis inducing 
factors, thus emphasising the importance o f using such factors to induce scaffold 
associated bone formation.
6.4.2 The effects of flow culture conditions
The application o f suitable bioreactor systems is o f extreme importance in enhancing 
the mass transfer o f  medium to the cell-scaffold, by continuous flow perfusion, and in 
order to provide the efficient removal o f scaffold acidic degradation by-products 
should these be present (Park, 2002).Under static culture conditions, the inadequate 
diffusion o f  oxygen, nutrients and waste into three-dimensional cell seeded scaffolds 
may hinder tissue formation. This is frequently manifested as cell survival, growth 
and ECM deposition is limited to surface areas o f such scaffold structures (Botchwey 
et al., 2001; Salgado et al., 2004).
It has been reported by Holtorf et al., that the application o f flow perfusion on three- 
dimensional titanium mesh scaffold cultures induced osteoblast differentiation by up 
regulating ALP and OP expression; enhancing cell population growth; and increasing 
the rate o f ECM mineralisation (Holtorf et al., 2005). Several similar studies, aiming 
at generating various tissue types, utilised the use o f scaffold-associated flow 
perfusion systems all o f which, resulted in enhancing in vitro tissue formation 
(Grabowski et al., 1993; Navarro et al., 2001; Park, 2002; Radisic et al., 2004). It has 
also been shown that the in vitro mechanical strain imposed by fluid induced shear 
stresses can influence both the differentiation and the matrix remodelling capacity of
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bone, tendon and ligament cells (Frangos et al., 1987; Hillsley and Frangos, 1997; 
Hung et al., 1997; van Griensven et al., 2003). Accordingly, and as this study aimed 
primarily at assessing the affect o f  medium perfusion on cell differentiation, the 
lamellar flow rate was regulated such that the flow related shear stress was kept at a 
minimum value (see Section 5.2.3).
Following exposure to the two flow rate values at 19.413 x 10'3 ml/s and 9.707 10'3 
ml/s, and for 8 h in culture, no changes in HOB differentiation were detected, on the 3 
mol% Fe2 0 3  glass fibres and for both flow rates, when compared to the static culture 
control cells (Figures 5.8 and 5.9). Expression o f the HOF cells P4HA3 gene also 
appeared unaffected by the application o f medium flow (figure 5.11). COL1A1 gene 
expression however was down-regulated in response to the higher flow rate o f 19.413 
x 10'3 ml/s (Figure 5.10). This may indicate that medium perfusion, at the higher flow 
rate, exerted a mechanical influence on the seeded HOF population.
These results further confirmed the lack o f cytotoxicity o f glass composition 
(CaO)o.46-(Na20)o.oi-(Fe203)o.o3-(P205)o.5o as no significant differences in Cbfa-1, ON 
and COL-I gene expression were noticed between cells seeded under static and the 
flow conditions o f 8 h duration where glass degradation products were continuously 
removed. Furthermore, these results also validated the flow system configuration, and 
the lamellar nature o f the flow, by demonstrating its capacity o f delivering mass 
medium perfusion whilst maintaining cell differentiation at the lower flow rate value 
(9.707 10'3 ml/s). This system can therefore be applied when the diffusion o f medium 
is critical for maintaining more complex, larger volume, cell-scaffold cultures.
6.5 Contiguous HOB-HOF co-culture implementation
The inadequacies imposed by the limited and functionally inferior integration o f 
surgically inserted grafts, where the reconstruction o f tissue entheses is required 
(Section 1.5.1) , have accentuated the importance o f developing scaffold systems 
capable o f  accommodating the formation o f such interfaces. Not only will this 
approach permit the functional morphogenesis o f the interface; the in vivo fusion o f 
each graft component to the corresponding tissue type will also significantly enhance 
the implant success.
The concept o f generating the hard-soft tissue interface can be implemented in the 
form o f a co-culture seeded scaffold system. For example, such systems have been
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assessed for the in vitro induction o f osteochondral interface formation where 
osteoblasts and chondrocytes were seeded, in co-culture, on three-dimensional 
scaffolds o f various compositions (Spalazzi et al., 2003; Elisseeff et al., 2005).
It is important to recognise, however, and when applicable to generating 
osteoligamentous and osteotendinous interfaces, that fibroblasts exhibit higher 
proliferation and DNA synthesis rates in culture than those o f the osteoblasts and 
consequently, a co-culture o f the two cell types will invariably become predominated 
by the fibroblastic population (Shin et al., 2004). It has been shown that as a result o f 
fibroblast predominance, the capacity o f the co-cultured osteoblastic cells to regulate 
ECM formation and mineralisation was inhibited (Ogiso et al., 1991; Ogiso et al., 
1992). It is vital therefore, that initial development o f each tissue component is 
independently granted via a scaffold configuration that permits, and maintains, the 
separate seeding o f each cell type. Such a configuration is also necessary to allow the 
separate supplementation o f  the extrinsic factors specific to each cell type.
This study has investigated the feasibility o f producing a co-culture scaffolding 
system using a continuous, 3 mol% Fe2 0 3  containing, glass fibre arrangement 
separately seeded with HOB and HOF cells and as seen form Figure 4.16, the use o f 
the separation barrier resulted in creating a clear, well defined, separation zone 
between the two populations. Once significant ECM formation specific to each tissue 
type has occurred, this barrier could be removed so that HOB and HOF interaction 
across the interface may take place.
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6.6 Q uaternary Phosphate based fibre scaffolds: Future work
The 3 mol% Fe2 0 3  containing, phosphate glass fibre system devised in this study have 
fulfilled the criteria required to support the initial phase o f cell-scaffold interaction in 
a cell transplantation process that may lead, ultimately, to in vitro tissue generation 
(Figure 6.1). This system can therefore be further evaluated and developed so that 
tangible tissue formation can take place.
Cell -ECM  interactions 
The application of biochemical and 
biomechanical factors
Scaffold 
associated 
cell attachment 
and invasion
ECM maturation 
and 
in vitro tissue 
formation
Hybrid tissue 
integration 
and scaffold 
degradation
>>
Population
expansion<uo
Tissue repairCell population implantationIsolation of donor Scaffold
cells from tissue seeding redifferentiation into the host
t___________ 1
Current study
Figure 6.2 The sequence of events involved in the cell transplantation approach 
for inductive tissue regeneration
Despite the seeded cells exhibiting an intact ability to regulate collagen gene 
transcription, collagen synthesis and the fibre scaffold ability to support matrix 
formation and the rate o f this formation must be assessed through the use o f SEM, 
immunohistochemistry and protein biochemistry (western blot analysis).
Throughout this work, cell attachment and morphology have been evaluated as major 
indicators o f biocompatibility. Functional cell attachment to substrates, following the 
initial non-specific attachment, is integrin receptor mediated (Richman et al., 2005) 
(Figure 6.2). This type o f adhesion occurs as a result o f the cell membrane integrin 
receptors (transmembrane glycoproteins) binding to the ECM molecules that might 
have adsorbed on the substrate surface from the cell culture medium. Following
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integrin binding to ECM adhesion molecule, integrin receptors are clustered with 
other molecules into adhesion structures termed focal adhesions or focal contacts. 
These focal adhesions play a major role in influencing essential cellular mechanisms 
such as protein synthesis, proliferation, differentiation, migration and apoptosis 
(Richman et al., 2005). It is important, therefore, that future studies evaluate the 
capacity o f the quaternary phosphate glasses to permit ECM adhesion molecules 
adsorption by, for example, X-Ray Photoelectron Spectroscopy (Satriano et al., 2005). 
The distribution and conformation o f focal adhesions should also be investigated, 
using SEM for example (Richards et al., 2001), and related to further possible 
structural enhancement o f  the glasses.
ECM adhesion molecules Integrin receptor mediated Formation of focal
adsorption binding adhesions
Surface properties influencing adhesivity:
Wettability
Electrical charge
Roughness
Topography
Cristallinity
PH
Porosity
Solubility
Carbon, amin or oxygen groups
Figure 6.1 Integrin mediated cell adhesion to biocompatible substrates
Simulating the in vivo environment should also be further promoted through 
developing a culture system within which the extrinsic factors critical for tissue 
formation such as mechanical loading, shear stresses and tissue growth factors can be 
comprehensively included.
As for the scaffold properties, the mechanical capacity o f the fibres to withstand in 
vitro stresses will greatly influence, following in vivo implantation, the subsequent
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clinical strategy determining, for instance, the nature and longevity o f the implant site 
immobilisation. The mechanical properties o f the fibres, particularly tensile strength 
should therefore be quantitatively evaluated using, for example, tensile testing devices 
so that improving the scaffold strength and resistance may be considered. The ability 
to produce complex three-dimensional scaffold configurations, o f shape and volume 
fitting that o f  the structure to be replaced, should also be addressed. Expanding on the 
preliminary findings in this study (Section 4.3.2.3), an in depth analysis o f the fibre 
surface topography must also be carried out as the presence o f specific surface 
patterns play an important role in influencing cell attachm ent Webster et al., 1999). 
The co-culture arrangement can be further enhanced whereby chondrocytes may also 
be included to fully implement the hard-soft tissue interface structure, i.e. bone, 
fibrocartilage and ligament/tendon (Section 1.6.4). This arrangement must also permit 
the initial separate administration o f extrinsic factors specific to each cell type.
Once tissue morphogenesis has been successfully induced, the tissue-scaffold 
complex must be applied in an animal model so that an insight can be gained into 
establishing a linear relationship between the in vivo integration of the engineered 
tissue and the scaffold degradation trend. This is also important to establish the 
efficiency and duration o f the implant integration process; the capacity o f the scaffold 
o f bioactively bonding to the adjacent tissue; and the presence o f any inflammatory 
and immune responses by the host.
For the clinical application o f inductive tissue engineering to become a reality, tissue 
replacement units must be provided on demand and within a reasonable frame o f time 
and the above processes therefore, must be coordinated within a strategy where rapid 
in vitro tissue formation can take place.
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6.8 C onclusion
This study has utilised for the first time, at the time o f writing this thesis, the use of 
non-silica phosphate based glass fibres as a primary human osteoblast-fibroblast 
seeded system with the potential application for the hard soft-tissue interface 
regeneration. Additionally, the capacity o f these scaffolds to accommodate a 
contiguous, segregated and well defined co-culture system has also been explored for 
the first time.
Quaternary phosphate based glass fibres, produced at 800 r/min rotational speed, of 
the composition (CaO)o.4 6-(Na2 0 )o.oi-(Fe2 0 3 )o.o3-(P2 0 5 )o.5o have been shown to 
possess excellent properties as primary human osteoblast and fibroblast seeded fibre 
scaffold for the inductive, in vitro, tissue engineering o f the hard-soft tissue interface. 
These 3 mol% iron oxide containing fibres exhibited firstly, sufficient surface 
adhesivity to support cell attachment and functional, well spread, morphology and 
secondly, high biocompatibility by maintaining the long term cell viability, 
proliferation and expression o f  the cell differentiated function. It is o f considerable 
significance that these properties were present in these glasses in their basic form 
without the need for post-production structural modification.
This work has also demonstrated the feasibility o f  devising a cell-scaffold culture 
system where the extrinsic biochemical and biomechanical factors, necessary for in 
vitro tissue formation, can be included. The application o f an osteogenic medium 
environment promoted the expression o f scaffold associated osteoblastic 
differentiation in terms o f ECM synthesis and remodelling. Medium and waste 
perfusion within the cell-scaffold complex have also been delivered to enhance tissue 
formation with no negative impact, at a certain flow rate, on cell differentiation by 
using an open circuit, lamellar flow, bioreactor.
These scaffolds have also been configured to accommodate a co-culture system onto 
which, the cellular components o f the hard-soft tissue enthesis can be separately 
seeded whereby the anatomical nature o f such an interface can be imitated.
202
Appendix
1. Reagents and Kit
Cell culture
D-M EM
DMSO
Fetal ca lf serum
PBS (sterile, Ca2+/M g2+free)
Penicillin
Streptomycin
Trypsin-EDTA
Immunocytochemistry
AF2 antifadent 
Anti-vimentin Ig G l, clone V9 
BSP polyclonal IgG l 
CellTracker™  green 
DAPI
Donkey serum albumin 
FITC-conjugated donkey anti-mouse IgG 
FITC-conjugated donkey anti-rabbit IgG 
Methanol (grade 99.9 %)
Mouse IgG 1 (monoclonal negative control)
ON polyclonal IgG l
OP polyclonal IgG l
P-4-H monoclonal IgG l, Clone 5B5
Triton-XlOO
Invitrogen, Paisley, UK. 
Sigma-Aldrich, Dorset, UK. 
Invitrogen, Paisley, UK. 
Invitrogen, Paisley, UK. 
Invitrogen, Paisley, UK. 
Invitrogen, Paisley, UK. 
Invitrogen, Paisley, UK.
Citifluor Ltd., London, UK. 
Sigma-Aldrich, Dorset, UK.
Dr. L. Fisher, NIH, Bethesda, USA. 
Invitrogen, Paisley, UK. 
Sigma-Aldrich, Dorset, UK. 
Serotec, Oxford, UK.
Jackson ImmunoResearch, USA. 
Jackson ImmunoResearch, USA. 
BDH, Manchester, UK.
Dako Ltd., Cambridge, UK.
Dr. L. Fisher, NIH, Bethesda, USA 
Dr. L. Fisher, NIH, Bethesda, USA. 
Dako Ltd., Cambridge, UK. 
Sigma-Aldrich, Dorset, UK.
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Quantitative Polymerase chain reaction
ABI PRISM™  Optical Adhesive Covers Applied Biosystems, Cheshire, UK. 
Assays-on-Demand™  Gene Expression assay Mix (including TaqMan® probes)
Applied Biosystems, Cheshire, UK. 
Applied Biosystems, Cheshire, UK. 
Applied Biosystems, Cheshire, UK. 
Applied Biosystems, Cheshire, UK.
Hs00164004_ml
Hs00164004_ml
Hs00231692_m l
Hs00277762_ml
Hs00420085_m l
Hs99999901_sl
Ethanol
High Capacity cDNA Archive kit 
RNeasy M ini Kit
TaqMan Universal PCR M aster Mix
P-mercaptoethanol
Optical 96-W ell Reaction Plates
Applied Biosystems, Cheshire, UK. 
Applied Biosystems, Cheshire, UK. 
BDH, Manchester, UK.
Applied Biosystems, Cheshire, UK. 
Qiagen Ltd., W Sussex, UK. 
Applied Biosystems, Cheshire, UK. 
Sigma-Aldrich, Dorset, UK. 
Applied Biosystems, Cheshire, UK.
Cell density evaluation
Propidium iodide Sigma-Aldrich, Dorset, UK.
CyQUANT Cell Proliferation Assay Kit Invitrogen, Paisley, UK.
Glass substrate/scaffold production and characterisation
CaCo3
NaH2Po4
p 2o 5
Fe203
SpeciFix-20 resin kit 
RTV 118 silicone 
Cyanoacrylate gel (01-06854)
M D polishing cloth (Largo, DAC, NAP) 
DP-suspension (1,3 and 9 pM)
BDH, Manchester, UK.
BDH, Manchester, UK.
BDH, Manchester, UK.
BDH, Manchester, UK.
Struers Ltd., Glasgow, UK.
Techsil Ltd. Warwickshire, UK. 
Henkel UK Ltd., Hertfordshire, UK. 
Struers Ltd., Glasgow, UK.
Struers Ltd., Glasgow, UK.
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2. M edia and Solutions
Growth Medium (GM)
89% DMEM 
10% FCS
1% Penicillin/streptomycin
For 500 ml 
455 ml 
50 ml 
5 ml
Freezing Medium
90% FCS 
10% DMSO
For 1 ml 
900 pi 
100 pi
DAPI
DAPI stock solution (in DMSO) 
PBS
For 1000 pi 
lpl  
999 pi
Propidium iodide
PI stock solution (in DMSO) 
PBS
For 1000 pi 
l p l  
999 pi
Secondary antibody non-specific blocking solution
For 10 ml
Donkey serum albumin 1 nil
PBS 9 ml
Polyclonal antibody negative control
For 10 ml
FCS 1 ml
PBS 9 pi
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0.25% Triton-X 100
Triton-X 100 
dH 20
CyQUANT GR dye
dH 20
CyQUANT cell lysis buffer 
CyQUANT GR stock solution
For 100 ml
2.5 ml o f a 1% stock solution
97.5 ml
For 20 ml 
19 ml 
1 ml
1:400 o f the above
cDNA preparation (High Capacity cDNA Archive kit)
For 60 pi reaction volume 
10X Reverse Transcription Buffer 6 pi
25X dNTPs 2.4 pi
10X random primers 6 pi
Multi Scribe™ Reverse Transcriptase 3 pi
Nuclease-free H 2 0  12.6 pi
RNA solution (in Nuclease-free H 20) 30 pi
qPCR reaction sample
For 25 pi reaction volume 
TaqMan Universal PCR M aster Mix (2X) 12.5 pi
20X Assays-on-Demand™  Gene Expression Assay Mix 1.25 p
Nuclease-free H 2O 8.75 pi
cDNA 2.5 pi
2 0 6
3. A ntibody concentrations
Antibody Function Diluent Concentration
BSP Primary polyclonal PBS 1:100
Cy3-conjugated a- 
vimentin/cloneV9
Primary monoclonal PBS 1:300
FITC-conjugated donkey a  -mouse Secondary
monoclonal
PBS 1:200
FITC-conjugated donkey a-rabbit Secondary polyclonal PBS 1:200
Mouse IgGl Monoclonal negative 
control
PBS 1:50
ON Primary polyclonal PBS 1:100
OP Primary polyclonal PBS 1:100
a-P-4-H/clone 5b5 Primary monoclonal PBS 1:50
4. Equipment
ABI PRISM ® 7300 SD System 
Dicor furnace 
Glass fibre rig
IPS-12 multi-speed roller pump 
Leica DM-IRB inverted microscope 
Fluroskan Ascent plate reader 
RTF 1500 furnace 
Shellab 2123-2 incubator 
Testboume diamond saw 
Ultrospec 2000 UV spectrophotometer
5. Software
• Fluorescence microscopy image acquisition, pseudo colouring and composition: 
Leica FW4000 software Leica Microsystems UK Ltd., Bucks,
UK.
Applied Biosystems, Cheshire, UK.. 
Dentsply, Surrey, UK.
Eastman Dental Institute, London, UK. 
Sotax, Basel, Switzerland.
Leica Microsystems UK Ltd., Bucks, UK 
Labsystems, Helsinki, Finland.
Carbolite, Derbyshire, UK.
Sheldon INC., OR, USA.
Testboume Ltd., Hampshire, UK. 
Pharmacia Biotech, Cambridge, UK.
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• Glass fibre diameter measurement/ image analysis:
Image-Pro® Plus software4.0 Media Cybernetics UK, Berkshire, UK.
• qPCR data acquisition and relative quantification:
7300 SDS software Applied Biosystems, Cheshire, UK
• Raster to vector image conversion:
Autotrace 0.31.1 (open source) www.sourceforge.org
• Statistical analysis:
SPSS for windows (release 11) SPSS UK L td ., Surrey, UK.
• Vector image generation
Inkscape SVG editor 0.42 (open source) www.sourceforge.org
• 3D image generation:
Truespace 3.2 Caligari Corporation, CA, USA.
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